<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2020 - 21
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x243729=_0x2096;function _0xe69f(){const _0x57c0ff=['wfYaB','round','yTcoO','4eGRCcI','Cross\x20resistance','kjBYs','cRvJX','\x22\x20data-src=\x22','<p>The\x20dose\x20of\x20<strong>levothyroxine\x20</strong>in\x20patients\x20who\x20become<strong>\x20pregnant\x20</strong>should\x20usually\x20be<strong>\x20increased.\x20</strong>This\x20is\x20because\x20demand\x20for\x20levothyroxine\x20increases\x20in\x20pregnancy\x20and\x20low\x20thyroxine\x20levels\x20are\x20associated\x20with\x20adverse\x20fetal\x20outcomes\x20such\x20as\x20mental\x20retardation.&nbsp;</p>\x0a<p>The\x20dose\x20of\x20levothyroxine\x20is\x20increased\x20by<strong>\x2030-50%</strong>\x20by\x20asking\x20the\x20patient\x20to\x20take\x202\x20extra\x20pills\x20per\x20week.\x20Increased\x20demand\x20for\x20levothyroxine\x20in\x20pregnancy\x20is\x20due\x20to:</p>\x0a<ul\x20style=\x22list-style-type:\x20circle;\x22>\x0a<li>The\x20increased\x20serum\x20concentration\x20of\x20thyroxine-binding\x20globulin\x20(TBG)\x20induced\x20by\x20estrogen</li>\x0a<li>Increased\x20expression\x20of\x20type\x203\x20deiodinase\x20in\x20the\x20placenta</li>\x0a<li>A\x20small\x20amount\x20of\x20passage\x20of\x20levothyroxine\x20to\x20the\x20fetus</li>\x0a</ul>\x0a<p>Thyroid\x20hormones\x20are\x20not\x20teratogenic.\x20<strong>Liothyronine</strong>&nbsp;is\x20<strong>not\x20preferred</strong>\x20in\x20pregnancy\x20because\x20T3\x20has\x20a\x20short\x20half-life\x20and\x20requires\x20frequent\x20dosing\x20to\x20limit\x20large\x20fluctuations\x20in\x20levels.\x20In\x20addition,\x20excess\x20T3\x20often\x20acts\x20to\x20normalize\x20TSH\x20while\x20lowering\x20T4,\x20thereby\x20risking\x20inadequate\x20T4\x20availability\x20to\x20the\x20fetus.</p>','oXTnA','currentQuestionIndex','NwQTC','get','UVOpJ','mBmcX','OfFrd','Atropine','Methemoglobinemia\x20is\x20caused\x20by:','gowfH','OTijL','KLQHE','Rocuronium','ZlGXJ','bookmarked','<p\x20style=\x22text-align:\x20justify;\x22>The\x20patient\x20in\x20the\x20above\x20scenario\x20has\x20<strong>heparin-induced\x20thrombocytopenia\x20(HIT)</strong>.\x20Direct\x20thrombin\x20inhibitors,&nbsp;such\x20as\x20<strong>argatroban&nbsp;</strong>is\x20the\x20anticoagulant\x20of\x20choice\x20in\x20HIT.</p>\x0a<p>Management\x20of\x20HIT:</p>\x0a<ul\x20style=\x22text-align:\x20justify;\x22>\x0a<li\x20class=\x22p1\x22><strong>Stop</strong>\x20heparin/LMWH</li>\x0a<li\x20class=\x22p1\x22>Give\x20an\x20alternative\x20anticoagulant,\x20such\x20as\x20lepirudin,\x20<strong>argatroban</strong>,\x20bivalirudin,\x20<strong>fondaparinux</strong>\x20or\x20rivaroxaban</li>\x0a<li\x20class=\x22p1\x22>Do\x20not\x20give\x20platelet\x20transfusions\x20(it\x20only\x20worsens\x20the\x20consumptive\x20coagulopathy)</li>\x0a<li\x20class=\x22p1\x22><strong>Do\x20not\x20give\x20warfarin</strong>\x20until\x20the\x20platelet\x20count\x20returns\x20to\x20its\x20baseline\x20level.\x20If\x20warfarin\x20was\x20administered,\x20give\x20vitamin\x20K\x20to\x20restore\x20the\x20INR\x20to\x20normal.</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Increased\x20thrombin\x20generation\x20associated\x20with\x20HIT\x20can\x20cause\x20consumption\x20of\x20protein\x20C.\x20<strong>Warfarin</strong>\x20administration\x20can\x20<strong>further\x20decrease\x20protein\x20C\x20levels</strong>\x20and\x20cause\x20<strong>skin\x20necrosis</strong>.\x20Therefore\x20warfarin\x20is\x20avoided\x20in\x20HIT.</p>','<p><strong>Inhaled\x20insulin</strong>&nbsp;is\x20the\x20<strong>shortest\x20acting</strong>\x20formulation\x20of\x20<strong>insulin</strong>.&nbsp;</p>','XJIJR','gANBI','yQorW','ZXjbK','Mycoplasma','table','console','CYP','Cardiac\x20output','SmOgq','IBQvO','Carbonic\x20anhydrase\x20inhibition','pWfuW','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','hCQeO','A\x20patient\x20with\x20recent-onset\x20primary\x20generalized\x20epilepsy\x20develops\x20a\x20skin\x20reaction\x20due\x20to\x20phenytoin\x20sodium.\x20What\x20is\x20the\x20most\x20appropriate\x20course\x20of\x20action?','UQKGA','BgdfZ','Carbamazepine','mylOR','LDzHZ','hoWIo','Ropivacaine','Chronic\x20gout','remove','attachMedia','Which\x20of\x20the\x20following\x20is\x20more\x20likely\x20to\x20precipitate\x20angina?','Icquc','wiWWp','H1\x20antagonist','Glycopyrronium','startAt','Tobramycin','They\x20have\x20loss\x20of\x20lean\x20body\x20mass','1,\x204\x20and\x205\x20only','Adenosine','28531512QTdLKl','You\x20are\x20counseling\x20a\x20diabetic\x20patient\x20and\x20teaching\x20her\x20the\x20technique\x20to\x20self-administer\x20insulin\x20at\x20home\x20every\x20day.\x20Which\x20of\x20the\x20following\x20sites\x20would\x20you\x20not\x20suggest\x20as\x20the\x20preferred\x20site\x20for\x20insulin\x20administration?','rBRXa','dRhjm','toString','May\x20be\x20used\x20for\x20on\x20/\x20off\x20phenomenon','incomplete','JvLPt','HHipp','No\x20questions\x20available\x20for\x20this\x20quiz.','uMylb','Taper\x20the\x20dose\x20of\x20methyldopa','Neostigmine\x20is\x20administered\x20to\x20a\x20post-op\x20patient\x20to\x20reverse\x20neuromuscular\x20blockade.\x20What\x20is\x20its\x20mechanism\x20of\x20action?','correctAnswers','Heart\x20rate','selected','setItem','QnsWh','rXECK','yLYlj','eiAeZ','wxSUc','markReviewText','rAhjg','src','Gram-negative\x20bacteria','correct','<p><strong>Acarbose</strong>\x20is&nbsp;least\x20likely\x20to\x20cause\x20hypoglycemia\x20among\x20the\x20given\x20options.</p>\x0a<p>It&nbsp;is\x20an\x20alpha-glucosidase\x20inhibitor.\x20It\x20inhibits\x20the\x20intestinal\x20degradation\x20and\x20absorption\x20of\x20starch\x20and\x20disaccharides&nbsp;and\x20thereby\x20lowers\x20the\x20postprandial\x20rise\x20in\x20glucose\x20levels.</p>\x0a<p>It\x20has<strong>\x20no\x20role\x20in\x20stimulating\x20insulin\x20secretion</strong>\x20and\x20is\x20therefore,&nbsp;<strong>least\x20likely\x20to\x20cause\x20hypoglycemia</strong>\x20during\x20monotherapy.&nbsp;</p>\x0a<p>Insulin\x20and\x20insulin\x20secretagogues\x20like\x20sulfonylureas\x20(gliclazide)\x20and\x20meglitinides\x20(repaglinide)\x20can\x20result\x20in\x20hypoglycemia.</p>','NnVKO','gray','A\x2052-year-old\x20man\x20with\x20alcoholic\x20cirrhosis\x20develops\x20ascites.\x20What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20management?','Conjunctival\x20hemorrhage','PhmIL','Stop\x20and\x20restart\x20phenytoin\x20sodium\x20after\x20two\x20weeks','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','CCR5\x20and\x20CD4','XKRtO','key','nav-btn-correct','Vincristine','A\x2040-year\x20old\x20man\x20who\x20is\x20suffering\x20from\x20open-angle\x20glaucoma\x20reads\x20about\x20netarsudil\x20being\x20approved\x20as\x20a\x20novel\x20agent\x20for\x20his\x20condition.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','timerContainer','jhJYy','NlCUN','Which\x20of\x20the\x20following\x20is\x20a\x20true\x20statement\x20regarding\x20inverse\x20agonists?','Which\x20of\x20the\x20following\x20ACE\x20inhibitors\x20is\x20not\x20a\x20prodrug?','Quinidine','rTRdu','NNBEq','JoqET','GEUBY','UDQan','IjNmx','<p>Pitolisant\x20is\x20an\x20<strong>H3\x20receptor\x20inverse\x20agonist.</strong></p>\x0a<p>It\x20has\x20been\x20recently\x20approved\x20by\x20the\x20FDA\x20for\x20the\x20treatment\x20of\x20<strong>excessive\x20daytime\x20sleepiness\x20in\x20adults\x20with\x20narcolepsy.</strong></p>\x0a<p>Contraindications:</p>\x0a<ul>\x0a<li>End-stage\x20renal\x20disease</li>\x0a<li>Severe\x20hepatic\x20impairment</li>\x0a</ul>\x0a<p>Other\x20drugs\x20used\x20for\x20the\x20treatment\x20of\x20daytime\x20sleepiness\x20are:</p>\x0a<ul>\x0a<li>Modafinil</li>\x0a<li>Solriamfetol</li>\x0a<li>Methylphenidate</li>\x0a</ul>','A\x20patient\x20showing\x20treatment\x20failure\x20with\x20multiple\x20antiretroviral\x20drugs\x20is\x20now\x20started\x20on\x20maraviroc.\x20This\x20drug\x20acts\x20against:','NhGml','LDupS','DJTdK','No\x20question\x20text\x20available','Psoriasis','location','QOAaM','<p><strong>Phenytoin</strong>\x20kinetics\x20changes\x20from\x20<strong>first-order\x20to\x20zero-order</strong>\x20kinetics\x20at\x20<strong>higher\x20therapeutic</strong>\x20levels.</p>\x0a<p><strong>True\x20zero-order</strong>\x20kinetics\x20is\x20shown\x20only\x20by\x20<strong>ethanol</strong>.\x20Some\x20drugs\x20have\x20first-order\x20kinetics\x20at\x20low\x20plasma\x20concentrations\x20while\x20at\x20higher\x20plasma\x20concentration\x20(within\x20therapeutic\x20range),\x20the\x20mechanism\x20for\x20elimination\x20gets\x20saturated\x20and\x20they\x20change\x20over\x20to\x20zero-order\x20kinetics.</p>\x0a<p>Drugs\x20that\x20show\x20<strong>early\x20saturation\x20kinetics</strong>\u00a0include:\u00a0</p>\x0a<ul>\x0a<li>Warfarin</li>\x0a<li>Aspirin</li>\x0a<li>Theophylline</li>\x0a<li>Verapamil</li>\x0a<li>Fluoxetine</li>\x0a<li>Phenytoin</li>\x0a</ul>\x0a<p>Some\x20drugs\x20show\x20zero-order\x20kinetics\x20at\x20much\x20higher\x20(non-therapeutic\x20/\x20toxic)\x20levels.</p>\x0a<p>All\x20the\x20other\x20options\x20exhibit\x20first\x20order\x20kinetics.\u00a0</p>','Nicorandil','qScKK','nav-btn-incorrect','Alpha\x20methyl\x20dopa','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','fAJsO','Which\x20of\x20the\x20following\x20drugs\x20do\x20not\x20act\x20as\x20a\x20prokinetic\x20agent\x20by\x205HT4\x20agonism?','wUXgV','OZefP','Nitroglycerin','H1\x20agonist','OFFDh','YduiL','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','SUZBr','Immediately\x20stop\x20methyldopa','.option-button','rspoY','ukhxY','Cisplatin','<p\x20style=\x22text-align:\x20justify;\x22>The\x20scenario\x20given\x20in\x20the\x20question\x20likely\x20points\x20to\x20a\x20diagnosis\x20of\x20<strong>Meniere\x27s\x20disease.\x20</strong>Betahistine\x20is\x20a\x20<strong>selective\x20H<sub>1</sub>\x20agonist&nbsp;</strong>used\x20in\x20this\x20condition.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20causes\x20<strong>vasodilation\x20</strong>in\x20the\x20<strong>inner\x20ear\x20</strong>which\x20improves\x20circulation.\x20Hence,\x20it\x20is\x20used\x20to\x20<strong>treat</strong>\x20<strong>vertigo\x20</strong>in\x20Meniere\x27s\x20disease.</p>','maMfd','fbleJ','QiWvX','<p><strong>Mitomycin\x20C</strong>\x20is\x20used\x20in\x20the\x20treatment\x20of\x20superficial\x20transitional\x20cell\x20carcinoma\x20by\x20intravesical\x20instillation.\x20It\x20is\x20also\x20used\x20in\x20upper\x20gastrointestinal\x20cancers\x20(e.g.\x20esophageal\x20carcinoma),\x20anal\x20cancers,\x20and\x20breast\x20cancers.</p>\x0a<p>Topical\x20mitomycin\x20C\x20is\x20used\x20in:</p>\x0a<ul>\x0a<li>Superficial\x20bladder\x20cancer</li>\x0a<li>Intraperitoneal\x20tumors</li>\x0a<li>Strabismus\x20surgery\x20to\x20reduce\x20scarring</li>\x0a<li>To\x20prevent\x20tracheal\x20and\x20esophageal\x20stenosis</li>\x0a<li>Post\x20nasal\x20surgery\x20synechae\x20formation</li>\x0a</ul>','lyiXF','zDaES','FDA','search','Stop\x20levothyroxine\x20till\x20the\x20end\x20of\x20the\x20first\x20trimester\x20as\x20it\x20has\x20teratogenic\x20potential','Doxycycline','test','bookmarkText','Cxzyf','border-red-500','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','flex','Pharmacology\x20Test','WeRXQ','Norfloxacin','red','Subcutaneous','You\x20observe\x20a\x20nurse\x20administering\x20an\x20intramuscular\x20injection\x20to\x20a\x20patient\x20in\x20the\x20clinic.\x20Which\x20of\x20the\x20following\x20was\x20likely\x20being\x20administered\x20to\x20the\x20patient?','Pseudomonas\x20aeruginosa','It\x20forms\x20amphetamines\x20as\x20metabolites','Rifampicin','wKmRV','Rickettsia','ZrnFk','gAogd','2290608hncAsD','Test\x20dose\x20of\x20drugs','dfEyZ','H1\x20receptor\x20inverse\x20agonism','CUpoL','ZHLoU','cydGu','DTtuc','H2\x20antagonist','vcOWU','BcVnh','FoWlm','KsGIz','KIgwe','zbtSw','explanation_images','strokeDasharray','Amiodarone','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','<p\x20style=\x22text-align:\x20justify;\x22><strong>Bacitracin</strong>\x20acts\x20on\x20the\x20cell\x20wall\x20by<strong>\x20inhibiting</strong>\x20the<strong>\x20synthesis\x20</strong>of\x20the<strong>\x20cell\x20wall</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20interferes\x20with\x20the\x20dephosphorylation\x20of\x20bactoprenol\x20(lipid\x20carrier)\x20which\x20carries\x20peptidoglycan\x20subunits\x20outside\x20the\x20cell\x20membrane\x20to\x20the\x20growing\x20cell\x20wall.\x20It&nbsp;can\x20also\x20alter\x20the\x20integrity\x20of\x20the\x20cell\x20membrane.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Bacitracin\x20is\x20mainly\x20active\x20against\x20<strong>gram-positive\x20cocci\x20and\x20bacilli</strong>.</p>','Low\x20molecular\x20weight\x20heparins\x20should\x20be\x20avoided','zuQeD','button','bind','CwAad','jDHEZ','CvZHW','<p\x20style=\x22text-align:\x20left;\x22><strong>Hypersensitivity\x20reaction</strong>\x20to<strong>\x20phenytoin&nbsp;</strong>warrants\x20<strong>discontinuation</strong>\x20of\x20the\x20drug.&nbsp;<strong>Switching</strong>\x20to\x20<strong>sodium\x20valproate</strong>\x20is\x20the\x20most\x20appropriate\x20course\x20of\x20action\x20for\x20this\x20patient.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22><strong>Sodium\x20valproate</strong>\x20is\x20one\x20of\x20the\x20first-line\x20agents\x20indicated\x20for<strong>\x20GTCS.\x20Clonazepam</strong>\x20and\x20<strong>ethosuximide</strong>\x20are\x20primarily\x20used\x20in\x20<strong>absence\x20seizures</strong>\x20and\x20are\x20not\x20indicated\x20for\x20GTCS.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Clonazepam\x20is\x20indicated\x20as\x20<strong>adjunctive\x20therapy</strong>\x20in\x20the\x20absence\x20seizures\x20when\x20first-line\x20agents\x20(ethosuximide,\x20sodium\x20valproate,\x20lamotrigine)\x20fail\x20to\x20control\x20the\x20seizures\x20adequately.</p>','HbBCI','green','<p>The\x20medial\x20part\x20of\x20the\x20thigh\x20is\x20not\x20a\x20preferred\x20site\x20for\x20insulin\x20administration\x20in\x20patients.\x20This\x20is\x20because\x20of\x20the\x20relatively\x20higher\x20density\x20of\x20blood\x20vessels\x20and\x20nerves\x20in\x20this\x20area.\x20Another\x20consideration\x20is\x20that\x20the\x20inner\x20thighs\x20rub\x20together\x20while\x20walking\x20and\x20may\x20cause\x20soreness\x20at\x20the\x20injection\x20sites.</p>\x0a<p>The\x20<strong>preferred\x20sites</strong>\x20for\x20insulin\x20administration\x20are:</p>\x0a<ul>\x0a<li>Upper\x20arm</li>\x0a<li>Anterior\x20and\x20lateral\x20aspects\x20of\x20the\x20thigh</li>\x0a<li>Buttocks</li>\x0a<li>Abdomen\x20(with\x20the\x20exception\x20of\x20a\x20circle\x20with\x20a\x202-inch\x20radius\x20around\x20the\x20navel)</li>\x0a</ul>\x0a<p><strong>Rotation</strong>\x20of\x20the\x20injection\x20site\x20is\x20important\x20to\x20<strong>prevent\x20lipodystrophy</strong>.\x20However,\x20rotating\x20<strong>within\x20one\x20area</strong>\x20is\x20recommended\x20(e.g.,\x20rotating\x20injections\x20systematically\x20within\x20the\x20abdomen)\x20rather\x20than\x20rotating\x20to\x20a\x20different\x20area\x20with\x20each\x20injection.\x20This\x20helps\x20decrease\x20variability\x20in\x20absorption\x20from\x20day\x20to\x20day.</p>','MzesB','Tztmr','hwxja','udARK','modeModal','canPlayType','sgSGs','lczdN','markReviewBtn','div','Hepatotoxicity','H2\x20agonist','-600\x20text-white\x22>','questionStates','Rifabutin','explanation_video','<p>At\x20<strong>lower\x20doses\x20</strong>(&lt;\x202\x20&mu;g/kg),\x20dopamine\x20only\x20stimulates\x20dopamine&nbsp;receptors\x20in\x20renal\x20vasculature,\x20causing&nbsp;<strong>increased\x20urine\x20output</strong>.</p>\x0a<p>As\x20the\x20dose\x20increases\x20(2-5\x20&mu;g/kg),\x20additional\x20cardiac\x20stimulant\x20action\x20(&beta;<sub>1</sub>)\x20is\x20also\x20seen.</p>\x0a<p>At\x20very\x20high\x20doses&nbsp;(5-15\x20&mu;g/kg),\x20vasoconstriction\x20(&alpha;<sub>1</sub>)\x20is\x20additionally\x20seen.</p>','MNYkk','Penicillin','Ticagrelor','aqFde','usgrv','AeQEH','qIKiB','Pxeyz','NLPqx','4824722xHFebI','QRiLz','\x20-\x20Brain\x20And\x20Scalpel','Duration\x20of\x20action\x20is\x20shorter\x20than\x20normal\x20filgrastim','paCdK','Meperidine','Clopidogrel','Option\x20','Alternative\x20anticoagulant\x20such\x20as\x20argatroban\x20should\x20be\x20administered','Ytiuw','KSVLg','NtESj','data-option-index','bnCLf','pRkEi','fjNTV','<p><strong>Nicorandil</strong>\x20causes\x20activation\x20of\x20<strong>K<sup>+</sup>-ATP\x20channels.&nbsp;</strong>This\x20leads\x20to\x20the\x20hyperpolarization\x20of\x20the\x20smooth\x20muscle\x20cells\x20leading\x20to\x20<strong>vasodilatation</strong>.</p>\x0a<p>It\x20also\x20has\x20nitrate\x20like\x20<strong>cGMP\x20dependent\x20action</strong>.\x20Nicorandil\x20dilates\x20both\x20arteries\x20and\x20veins\x20leading\x20to\x20a\x20decrease\x20in\x20afterload\x20and\x20preload\x20of\x20the\x20heart.</p>\x0a<p>Molsidomine,\x20isosorbide\x20dinitrate,\x20and\x20nitroglycerin\x20are\x20nitrates.\x20They\x20do\x20not\x20act\x20on\x20K-ATP\x20channels.</p>','cXnRz','<div\x20class=\x22mt-4\x22><img\x20src=\x22','Increase\x20the\x20dose\x20as\x20pregnancy\x20causes\x20an\x20increased\x20demand\x20for\x20levothyroxine','totalTime','No\x20solution\x20provided','Prasugrel','ajOsn','DxJyN','https://cdn1.dailyrounds.org/uploads/653b55b4bf464e6ea6e66052cb0912d7.PNG','OsuwC','GKBHz','getElementById','JUDvT','QoGCL','PDOPJ','Which\x20of\x20the\x20following\x20can\x20cause\x20diarrhea?','KwZdZ','https://cdn1.dailyrounds.org/uploads/5ec1504cc1c8408485f6e571e4ee5172.JPEG','Bradykinin\x20B1\x20receptor\x20agonist','<div\x20class=\x22page\x22\x20title=\x22Page\x20818\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Raloxifene\x20causes\x20a\x20<strong>3-fold\x20increase\x20in\x20deep\x20vein\x20thrombosis</strong>\x20and\x20pulmonary\x20embolism.</p>\x0a<p>It\x20is\x20a\x20selective\x20estrogen\x20receptor\x20modulator&nbsp;<strong>(SERM)</strong>\x20with\x20the\x20following\x20actions:</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<ul>\x0a<li><strong>Agonist\x20</strong>actions<strong>:</strong>\x0a<ul>\x0a<li>Bone\x20-\x20increases\x20bone\x20mineral\x20density\x20and\x20reduces\x20the\x20risk\x20of\x20vertebral\x20fracture</li>\x0a<li>Lipids\x20-\x20increases\x20the\x20risk\x20of\x20deep\x20vein\x20thrombosis\x20and\x20pulmonary\x20embolism.</li>\x0a</ul>\x0a</li>\x0a<li><strong>Antagonist\x20</strong>actions<strong>:</strong>\x0a<ul>\x0a<li>Breast\x20-\x20incidence\x20of\x20breast\x20carcinoma\x20is\x20reduced&nbsp;</li>\x0a<li>Uterus\x20-\x20endometrial\x20hyperplasia\x20is\x20avoided</li>\x0a</ul>\x0a</li>\x0a</ul>','NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise','Methylphenidate','sdhFC','className','<p>The\x20given\x20scenario\x20depicts\x20the&nbsp;<strong>neuromuscular\x20blockade</strong>&nbsp;effect\x20of\x20aminoglycosides,\x20and<strong>&nbsp;tobramycin</strong>\x20has\x20the\x20least\x20potency\x20for\x20blockade\x20in\x20this\x20group.</p>\x0a<p>Decreasing\x20order\x20of\x20potency\x20for\x20the\x20neuromuscular\x20blockade\x20is:</p>\x0a<p>Neomycin\x20&gt;&nbsp;Kanamycin\x20&gt;\x20Amikacin\x20&gt;\x20Gentamicin\x20&gt;\x20<strong>Tobramycin</strong></p>\x0a<p>It\x20is\x20a\x20recognized\x20clinical\x20side\x20effect\x20of\x20aminoglycoside\x20antibiotics,\x20and\x20this\x20effect\x20becomes\x20significant\x20(prolonged\x20respiratory\x20depression)\x20when\x20the\x20drug\x20is\x20used\x20in\x20conjunction\x20with\x20<strong>neuromuscular\x20blocking\x20agents</strong>\x20or\x20<strong>calcium\x20channel\x20blockers</strong>.\x20They\x20are\x20avoided\x20in\x20patients\x20with\x20myasthenia\x20gravis.</p>\x0a<p>Aminoglycosides\x20cause\x20neuromuscular\x20blockade\x20by\x20<strong>interfering\x20with\x20calcium\x20channels</strong>\x20and\x20thereby&nbsp;<strong>inhibiting</strong>\x20<strong>acetylcholine\x27s</strong>&nbsp;pre-junctional\x20release\x20and\x20post-junctional\x20sensitivity.\x20The\x20neuromuscular\x20blockade\x20produced\x20by\x20these\x20antibiotics\x20is\x20not\x20reversed\x20by\x20neostigmine\x20but\x20is\x20<strong>reversed\x20by\x20IV\x20calcium\x20gluconate.</strong></p>','questionIndex','dYSuB','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','dVlBu','A\x2033-year-old\x20man\x20with\x20a\x20history\x20of\x20heroin\x20addiction\x20is\x20referred\x20to\x20a\x20rehabilitation\x20center.\x20Which\x20of\x20the\x20following\x20would\x20you\x20use\x20as\x20a\x20substitute\x20drug\x20for\x20maintenance\x20therapy?','not_attempted','A\x20patient\x20requires\x20the\x20shortest\x20acting\x20formulation\x20of\x20insulin\x20to\x20prevent\x20postprandial\x20hyperglycemia.\x20Which\x20of\x20the\x20following\x20formulations\x20would\x20you\x20choose?','lEbfw','cwSYe','<p>The\x20given\x20scenario\x20depicts\x20<strong>red\x20man\x20syndrome</strong>\x20associated\x20with\x20<strong>vancomycin.&nbsp;</strong>It\x20occurs\x20due\x20to&nbsp;a<strong>\x20direct\x20toxic\x20effect</strong>\x20on<strong>\x20mast\x20cells\x20</strong>resulting\x20in\x20the\x20release\x20of<strong>\x20histamine.</strong></p>\x0a<p>Red\x20man\x20or\x20red\x20neck\x20syndrome\x20is\x20a\x20<strong>non-allergic\x20reaction</strong>\x20due\x20to<strong>\x20rapid\x20intravenous\x20infusion</strong>\x20of\x20vancomycin\x20characterized\x20by:&nbsp;</p>\x0a<ul>\x0a<li>Flushing</li>\x0a<li>Erythematous,\x20urticarial\x20reactions</li>\x0a<li>Tachycardia</li>\x0a<li>Hypotension</li>\x0a</ul>\x0a<p>Slow\x20infusion,\x20prophylactic\x20use\x20of\x20antihistamines\x20can\x20reduce\x20the\x20incidence.</p>','ljeHP','qEzcE','Umeclidinium','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','lTXFh','rPYyr','hNHMT','<p><strong>Trastuzumab</strong>\x20is\x20a\x20<strong>humanized\x20monoclonal\x20antibody</strong>\x20against\x20the\x20external\x20domain\x20of\x20<strong>HER2/neu.</strong>\x20In\x20humanized\x20antibodies,\x20all\x20components\x20are\x20identical\x20to\x20human\x20antibodies\x20(95%\x20human\x20component),\x20except\x20the\x20complementary\x20region\x20of\x20the\x20variable\x20chain\x20that\x20<strong>contains\x20sequences</strong>\x20from<strong>\x20other\x20species</strong>.</p>\x0a<p>It&nbsp;is\x20indicated\x20in\x20the\x20management\x20of\x20<strong>adjuvant\x20therapy</strong>\x20in\x20<strong>early</strong>\x20and\x20<strong>metastatic\x20HER-2\x20positive\x20breast\x20cancer.</strong>&nbsp;</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201213\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Human\x20epidermal\x20growth\x20factor\x20receptor\x202\x20tyrosine\x20kinase\x20receptor\x20(<strong>HER-2-TK</strong>)\x20<strong>inhibitors</strong>\x20are:</p>\x0a<ul>\x0a<li>Lapatinib</li>\x0a<li>Neratinib</li>\x0a</ul>\x0a<p><strong>Anti-Her-2\x20monoclonal\x20antibodies</strong>\x20are:</p>\x0a<ul>\x0a<li>Trastuzumab</li>\x0a<li>Pertuzumab</li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','querySelectorAll','Lisinopril','ePTrf','aAaYI','JLDXR','Aluminium\x20hydroxide','yvATo','mUjYY','incorrectAnswers','Avoids\x20endometrial\x20hyperplasia','gSLvC','Which\x20of\x20the\x20following\x20drugs\x20reduces\x20blood\x20pressure\x20primarily\x20by\x20directly\x20decreasing\x20the\x20heart\x20rate?','yJcyT','kqkgM','study','map','nZlbc','DmsBI','The\x20total\x20microbial\x20population\x20was\x20found\x20to\x20be\x20susceptible\x20to\x20antimicrobials\x20on\x20testing\x20but\x20a\x20subset\x20of\x20the\x20same\x20population\x20was\x20resistant\x20which\x20was\x20undetected.\x20What\x20is\x20this\x20phenomenon\x20called?','Switch\x20to\x20clonazepam','Progress\x20loaded.','Anterior\x20part\x20of\x20thigh','bookmarkBtn','FzcsP','timed_study','kMpQJ','border-gray-600','Correct','NXdVm','Inhaled\x20insulin','Incorrect','<p>The\x20only\x20chemotherapeutic\x20agent\x20that\x20has\x20been\x20proven\x20to\x20cause\x20bladder\x20cancer\x20is\x20<strong>cyclophosphamide</strong>.</p>\x0a<p>The\x20risk\x20of\x20the\x20bladder\x20cancer\x20formation\x20is\x20linearly\x20related\x20to\x20the\x20duration\x20and\x20intensity\x20of\x20cyclophosphamide\x20treatment,\x20supporting\x20a\x20causative\x20role.\x20<strong>Phosphoramide\x20mustard</strong>\x20is\x20the\x20primary\x20<strong>mutagenic\x20metabolite</strong>\x20that\x20causes\x20bladder\x20cancer\x20in\x20patients\x20exposed\x20to\x20cyclophosphamide.</p>','SHqiL','removeItem','Insulin\x20lispro','GxAbM','parse','3736088MCgBHD','optionsContainer','TSXsu','filter','SuMVG','vpXEr','Repaglinide','toLowerCase','<p>The\x20given\x20scenario\x20is\x20suggestive\x20of\x20<strong>acute\x20kidney\x20injury</strong>&nbsp;and\x20the\x20cephalosporin\x20that\x20does\x20not\x20require\x20dose\x20reduction\x20in\x20this\x20patient\x20is\x20<strong>cefoperazone</strong>.</p>\x0a<p>All\x20cephalosporins\x20are\x20usually\x20excreted\x20by\x20glomerular\x20filtration\x20and\x20tubular\x20secretion.\x20They\x20need\x20a\x20dose\x20reduction\x20in\x20renal\x20failure,\x20except<strong>\x20cefpiramide\x20</strong>and&nbsp;<strong>cefoperazone</strong>\x20that\x20have\x20<strong>predominant\x20biliary\x20excretion</strong>.</p>\x0a<p>Dose\x20reduction\x20is\x20necessary\x20for\x20cefoperazone\x20and\x20cefpiramide\x20in\x20patients\x20with\x20<strong>hepatic\x20impairment</strong>.</p>','Ipratropium','name','nav-btn-current','question_audio','eHFkG','xHFFV','<p>The\x20given\x20clinical\x20scenario\x20and\x20image\x20showing\x20swelling\x20of\x20the\x20face\x20and\x20lips\x20is\x20suggestive\x20of<strong>&nbsp;hereditary\x20angioedema</strong>.<strong>\x20Icatibant\x20</strong>is\x20a<strong>\x20selective\x20bradykinin\x20B<sub>2</sub>\x20receptor\x20</strong>competitive\x20<strong>antagonist</strong>&nbsp;indicated\x20for\x20the\x20treatment\x20of\x20acute\x20attacks\x20of\x20hereditary\x20angioedema.</p>\x0a<p>The\x20other\x20drug\x20which\x20is\x20approved\x20for\x20the\x20treatment\x20of&nbsp;acute\x20attacks\x20of\x20hereditary\x20angioedema\x20is\x20<strong>ecallantide&nbsp;</strong>which\x20is\x20a\x20<strong>synthetic\x20plasma\x20kallikrein\x20inhibitor</strong>.\x20Both\x20these\x20drugs\x20are\x20<strong>administered\x20subcutaneously</strong>.</p>','Rho\x20kinase\x20inhibition','Bkwco','nHFUU','jsKzD','It\x20is\x20a\x20monoclonal\x20antibody\x20produced\x20by\x20injecting\x20HER-2\x20antigen','ccTSR','Uncontrolled\x20migraine','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','btFia','incorrect','DCGI','QASHz','Neostigmine','Methadone','xckgo','TGdOj','classList','The\x20mechanism\x20of\x20action\x20of\x20pitolisant\x20is:','length','<p>The\x20image\x20shown\x20is\x20of\x20the<strong>\x20periwinkle\x20plant&nbsp;</strong>(<em>Catharanthus\x20roseus)</em>.\x20Vinca\x20alkaloids\x20like\x20vinblastine\x20and\x20vincristine\x20are\x20extracted\x20from\x20this\x20plant.</p>\x0a<p>Sources&nbsp;of\x20few\x20other\x20drugs\x20are:</p>\x0a<ul>\x0a<li>Epothilones\x20-\x20Myxobacterium\x20<em>Sorangium\x20cellulosum</em></li>\x0a<li>Camptothecin\x20analogs\x20-&nbsp;<em>Camptotheca\x20acuminata&nbsp;</em>tree</li>\x0a<li>Taxanes\x20-\x20bark\x20of\x20the\x20western\x20yew\x20tree.</li>\x0a</ul>','accuracy','review-question\x20','loadSource','constructor','1|4|2|0|5|3','solutionVideo','<p>The\x20best\x20course\x20of\x20action\x20for\x20the\x20patient\x20is\x20<strong>close\x20monitoring</strong>\x20for\x20any\x20signs\x20or\x20symptoms\x20of\x20<strong>hemolysis</strong>.</p>\x0a<p>Coombs\x20test\x20is\x20done\x20to\x20test\x20the\x20presence\x20of\x20antibodies\x20against\x20Rh\x20antigens\x20on\x20the\x20red\x20blood\x20cells,\x20which\x20result\x20in\x20hemolysis.\x20Positive\x20Coombs\x20test&nbsp;is\x20seen\x20in&nbsp;20%\x20of\x20patients\x20who\x20receive\x20methyldopa.</p>\x0a<p>However,\x20only&nbsp;1-5%\x20of\x20such\x20patients\x20develop\x20hemolytic\x20anemia\x20and\x20hence,\x20a\x20positive\x20Coombs\x20test\x20is\x20not\x20a\x20necessary\x20indication\x20for\x20stopping\x20methyldopa\x20treatment.&nbsp;They\x20must\x20be\x20monitored\x20closely\x20and\x20any\x20<strong>signs\x20</strong>that\x20indicate<strong>&nbsp;hemolytic\x20anemia</strong>\x20needs\x20prompt\x20<strong>discontinuation\x20of\x20the\x20drug.</strong></p>','bookmarkedQuestions','Continue\x20the\x20same\x20dose\x20but\x20monitor\x20the\x20serum\x20levels\x20on\x20a\x20fortnightly\x20basis','Previous\x20progress\x20cleared.','Regular\x20insulin','custom_quiz.html','split','gmNcw','JKfrL','<p>Methemoglobinemia\x20is\x20caused\x20by\x20prilocaine.</p>\x0a<p>It\x20is\x20due\x20to\x20the\x20metabolism\x20of\x20the\x20aromatic\x20ring\x20of\x20prilocaine\x20to\x20<strong>o-toluidine</strong>\x20which\x20is\x20an\x20<strong>oxidizing\x20agent</strong>\x20and\x20oxidizes\x20hemoglobin\x20to\x20methemoglobin.&nbsp;Methemoglobinemia\x20risk\x20is\x20directly\x20associated\x20with\x20the\x20total\x20dose\x20administered,\x20usually\x20appearing\x20when\x20doses\x20exceed\x208\x20mg/kg.</p>\x0a<p>Intravenous\x20administration\x20of<strong>\x20methylene\x20blue</strong>\x20is\x20the\x20<strong>treatment\x20for\x20methemoglobinemia.</strong></p>\x0a<p><strong>Benzocaine\x20</strong>can\x20also\x20cause<strong>\x20methemoglobinemia\x20</strong>similar\x20to\x20prilocaine.</p>','In\x20combination\x20with\x20a\x20short\x20acting\x20β-2\x20agonist','43-year-old\x20man\x20with\x20chronic\x20liver\x20disease','<p><strong>Mexiletine\x20</strong>is\x20a&nbsp;<strong>class\x201B\x20antiarrhythmic</strong>\x20drug.<strong>&nbsp;</strong>It<strong>&nbsp;</strong>is\x20a\x20lidocaine\x20analog.</p>','https://dhmbxeygs57ff.cloudfront.net/uploads/16c4534451f244bf9c43d74c07268356x510x812.PNG','questionText','526hlLeRJ','CGHeQ','<p><strong>Delamanid</strong>&nbsp;acts\x20by<strong>&nbsp;inhibiting\x20mycolic\x20acid\x20synthesis</strong>.</p>\x0a<p>Pretomanid\x20and\x20delamanid\x20are\x20bicyclic\x20nitroimidazoles\x20that\x20act\x20by&nbsp;<strong>inhibiting\x20mycolic\x20acid</strong>&nbsp;(a\x20component\x20of\x20the\x20mycobacterial\x20cell\x20wall)\x20and&nbsp;<strong>protein\x20synthesis</strong>&nbsp;in\x20the\x20mycobacteria.</p>\x0a<p><strong>Pretomanid&nbsp;</strong>in\x20combination\x20with&nbsp;<strong>bedaquiline&nbsp;</strong>and<strong>&nbsp;linezolid</strong>&nbsp;was\x20approved\x20by\x20FDA\x20in\x202019\x20for\x20the\x20treatment\x20of\x20adult\x20patients\x20with\x20extensively\x20drug-resistant<strong>&nbsp;(XDR)\x20TB&nbsp;</strong>and\x20for\x20patients\x20who\x20are<strong>&nbsp;treatment</strong>-<strong>intolerant\x20or\x20nonresponsive</strong>&nbsp;to\x20multidrug-resistant\x20pulmonary\x20(<strong>MDR</strong>)&nbsp;<strong>TB</strong>&nbsp;treatment.</p>\x0a<p>In\x20India,\x20delamanid\x20is\x20only\x20approved\x20for\x20the\x20management\x20of\x20MDR-TB.</p>\x0a<p><strong>Isoniazid</strong>\x20also\x20acts\x20by\x20inhibiting\x20mycolic\x20acid\x20synthesis.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:&nbsp;<strong>Bedaquiline</strong>&nbsp;acts\x20by&nbsp;<strong>inhibition\x20of\x20ATP\x20synthase.&nbsp;</strong>It&nbsp;is\x20a&nbsp;diarylquinoline\x20that\x20targets\x20the<strong>&nbsp;subunit\x20c&nbsp;</strong>of\x20the\x20ATP\x20synthase\x20of\x20M.\x20tuberculosis.\x20This\x20leads&nbsp;to\x20inhibition\x20of\x20the\x20proton\x20pump\x20activity\x20of\x20the\x20ATP\x20synthase\x20and\x20causes\x20a\x20failure\x20in\x20the\x20bacillary\x20energy\x20metabolism.</p>\x0a<p>Option\x20C:\x20<strong>Fluoroquinolones</strong>\x20act\x20by\x20inhibition\x20of\x20<strong>DNA\x20gyrase.\x20</strong>They\x20are\x20used\x20as\x20second-line\x20agents\x20in\x20the\x20treatment\x20of\x20tuberculosis.</p>\x0a<p>Option\x20D:&nbsp;<strong>Cycloserine</strong>&nbsp;is\x20a\x20D-alanine\x20analogue\x20used\x20as\x20a\x20second-line\x20drug\x20for\x20MDR-TB\x20that\x20acts\x20by&nbsp;<strong>inhibition\x20of\x20alanine\x20racemase.</strong>&nbsp;Alanine\x20racemase\x20converts\x20L-alanine\x20to\x20D-alanine\x20which\x20is\x20needed\x20for\x20the\x20mycobacterial\x20cell\x20wall.&nbsp;</p>','kZqtI','XSvFr','quizFile','Cell\x20wall','Inhibition\x20of\x20mycolic\x20acid\x20synthesis','explanationVideoPlayer','BlZMV','60-year-old\x20woman\x20with\x20myocardial\x20infarction','The\x20maximum\x20approved\x20daily\x20dose\x20of\x20Istradefylline\x20is:','Which\x20of\x20the\x20following\x20drugs\x20causes\x20activation\x20of\x20K+-ATP\x20channels?','KMQWU','sdzXt','UTnfm','customQuizData','.m3u8','UtcXK','toggle','<p>The\x20finding\x20shown\x20in\x20the\x20image\x20is<strong>\x20bulls-eye\x20maculopathy,</strong>\x20and<strong>\x20chloroquine\x20and\x20hydroxychloroquine</strong>\x20use\x20are\x20associated\x20with\x20this\x20side\x20effect.</p>\x0a<p>Bull\x27s-eye\x20maculopathy\x20refers\x20to\x20the\x20ophthalmoscopic\x20appearance\x20of\x20a<strong>\x20central\x20area\x20of\x20retinal\x20pigment\x20epithelial\x20depigmentation</strong>\x20surrounded\x20by\x20relatively\x20normal\x20retinal\x20pigment\x20epithelium,\x20giving\x20a\x20bull\x27s-eye\x20appearance\x20to\x20the\x20macula.</p>','Ceftazidime','{}.constructor(\x22return\x20this\x22)(\x20)','jsnEX','Which\x20of\x20the\x20following\x20statements\x20is\x20false\x20regarding\x20the\x20use\x20of\x20selegiline\x20in\x20Parkinsonism?','Renzapride','Year\x202020\x20-\x2021','<p><strong>Rifaximin</strong>&nbsp;is\x20not\x20used\x20for\x20mycobacterial\x20infections.\x20It\x20is\x20a<strong>\x20synthetic\x20</strong>rifamycin\x20that\x20is\x20<strong>poorly\x20absorbed\x20from\x20the\x20GIT</strong>\x20and\x20is\x20indicated\x20in\x20the\x20management\x20of\x20GI\x20conditions\x20like:&nbsp;</p>\x0a<ul>\x0a<li>Traveler&rsquo;s\x20diarrhea</li>\x0a<li>Irritable\x20bowel\x20syndrome\x20with\x20diarrhea</li>\x0a<li>Hepatic\x20encephalopathy</li>\x0a</ul>\x0a<p>Rifamycins\x20indicated\x20in\x20mycobacterial\x20infections\x20are&nbsp;rifampicin,\x20rifapentine,\x20and\x20rifabutin.</p>','Mark\x20for\x20Review','DOMContentLoaded','Binds\x20to\x20tubulin\x20and\x20inhibits\x20granulocyte\x20migration','DYHzn','Intravenous','progressBar','explanation_audio_hin','Which\x20of\x20the\x20following\x20drugs\x20cause\x20carcinoma\x20bladder?','Qbilv','mfCAF','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','Sugammadex\x20is\x20a\x20reversal\x20agent\x20for:','quizPerformanceData','FQyrp','ezDQX','OQjnp','MZzZi','100\x20mg','XzOaG','Intramuscular','hierarchy','hRFow','OeOFz','94%','log','<p><strong>Iloprost\x20</strong>is\x20a<strong>\x20prostacyclin\x20analog\x20</strong>indicated\x20in\x20the\x20management\x20of\x20<strong>pulmonary\x20artery\x20hypertension</strong>.\x20It\x20falls\x20under\x20the\x20category\x20of&nbsp;IP\x20receptor\x20(prostacyclin\x20receptor)\x20agonists.</p>\x0a<p\x20class=\x22p1\x22>Other\x20drugs\x20falling\x20under\x20the\x20category\x20of\x20<strong>IP\x20receptor\x20agonists</strong>\x20are:</p>\x0a<ul>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Epoprostenol</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Treprostinil</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Iloprost</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Selexipag</p>\x0a</li>\x0a</ul>\x0a<p>Option\x20A:\x20Sildenafil\x20is\x20a\x20PDE-5\x20inhibitor.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>Option\x20B:\x20Misoprostol\x20is\x20a\x20synthetic\x20PGE1\x20analog.&nbsp;</p>\x0a<p>Option\x20C:\x20Dinoprost\x20is\x20a\x20natural\x20PGF2-alpha\x20preparation.\x20It\x20should&nbsp;not\x20be\x20confused\x20with\x20dinoprostone\x20which\x20is\x20a\x20synthetic\x20analogue\x20of\x20PGE2.</p>','question_video','Fosinopril','totalAttempted','sspOV','</span></div>','Which\x20of\x20the\x20following\x20quinolones\x20is\x20not\x20approved\x20for\x20use\x20in\x20a\x20patient\x20diagnosed\x20with\x20urinary\x20tract\x20infection?','Organ\x20transplantation','ohXPF','yFOWY','Monitor\x20for\x20signs\x20of\x20hemolysis','Binds\x20to\x20the\x20receptor\x20and\x20causes\x20no\x20action','solutionContainer','Monitoring\x20of\x20lithium\x20therapy','CkLMC','pathname','UnSYZ','gVcMD','fromCharCode','uLJFV','QhQVw','Intradermal','Which\x20of\x20the\x20following\x20rifamycins\x20is\x20not\x20used\x20for\x20mycobacterial\x20infections?','now','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','Magnesium\x20hydroxide','lWrCf','markedForReview','Gentamicin','Which\x20of\x20the\x20following\x20drugs\x20approach\x20zero-order\x20kinetics\x20at\x20higher\x20therapeutic\x20levels?','FjOyQ','TlGti','Bradykinin\x20B1\x20receptor\x20antagonist','warn','Statins','forEach','mJDkW','QnUkN','getItem','<p>The\x20reason\x20for\x20the\x20<strong>alteration</strong>\x20of\x20<strong>drug\x20dosage</strong>\x20in\x20the\x20<strong>elderly</strong>\x20is\u00a0<strong>decreased\x20baroreceptor\x20sensitivity</strong>\x20due\x20to\x20age-related\x20vascular\x20stiffening.</p>\x0a<p>Reasons\x20for\x20the\x20alteration\x20of\x20drug\x20dosage\x20in\x20the\x20elderly\x20are:</p>\x0a<ul>\x0a<li>Progressive\x20<strong>decline</strong>\x20of\x20<strong>renal\x20function\x20</strong>(option\x20A)\u00a0</li>\x0a<li>Hepatic\x20microsomal\x20function\x20is\x20reduced,\x20thus\x20decreasing\x20the\x20metabolism\x20of\x20drugs\x20with\x20high\x20hepatic\x20extraction.</li>\x0a<li><strong>Loss\x20</strong>of\x20<strong>lean\x20body\x20mass\x20</strong>and\x20an<strong>\x20</strong>increased\x20ratio\x20of\x20fat\x20to\x20muscle\x20(option\x20B),\x20leading\x20to\x20an<strong>\x20</strong>increased\x20volume\x20of\x20distribution\x20(Vd)\x20of\x20lipophilic\x20drugs\u00a0</li>\x0a<li><strong>Decreased\x20body</strong>\x20<strong>water</strong>\x20(option\x20D)\x20causing\x20decreased\x20volume\x20of\x20distribution\x20(Vd)\x20of\x20<strong>hydrophilic\x20drugs</strong></li>\x0a<li>Slower\x20absorption\x20due\x20to\x20reduced\x20gut\x20motility.</li>\x0a<li>Decreased\x20plasma\x20albumin\x20concentration\x20leading\x20to\x20decreased\x20plasma\x20protein\x20binding.<strong><br\x20/></strong></li>\x0a</ul>','Cefoperazone','Qajmq','QuwtH','XOhNC','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','Propranolol','The\x20elimination\x20after\x203\x20half-lives\x20in\x20first-order\x20kinetics\x20is\x20around:','QoGoP','qWyJU','Molsidomine','<p>The\x20proportion\x20of\x20drug\x20eliminated\x20after\x20three\x20half-lives\x20in\x20first-order\x20kinetics\x20is\x20around\x20<strong>87.5%</strong>.\u00a0</p>\x0a<p>After\x20<strong>each\x20half-life,\x2050%</strong>\x20of\x20the\x20drug\x20is\x20<strong>eliminated</strong>\x20or\x20the\x20plasma\x20concentration\x20becomes\x20half\x20the\x20original\x20value.</p>\x0a<p>Therefore,\x20after,\u00a0</p>\x0a<ul>\x0a<li>1\x20half-life\x20=\x2050%\x20drug\x20is\x20eliminated</li>\x0a<li>2\x20half-lives\x20=\x2075%\x20drug\x20is\x20eliminated</li>\x0a<li>3\x20half-lives\x20=\x2087.5%\u00a0is\x20eliminated</li>\x0a<li>4\x20half-lives\x20=\x2093%\x20is\x20eliminated</li>\x0a</ul>\x0a<p>Thus,\x20about\x204-5\x20half\x20lives\x20are\x20required\x20for\x20near-complete\x20drug\x20elimination.\u00a0</p>','Hydrochlorothiazide','ejejN','IcFFy','Buttocks','text','OCliH','GwJoX','Reactivation\x20of\x20AChE\x20enzyme','87.5%','vitND','prevBtn','zArRF','questions','Given\x20below\x20is\x20the\x20ECG\x20of\x20a\x20patient\x20who\x20presented\x20to\x20the\x20emergency\x20room\x20with\x20sudden\x20onset\x20palpitations\x20and\x20breathlessness.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20in\x20this\x20condition?','AjnQd','Reduces\x20incidence\x20of\x20venous\x20thrombosis','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','Nkwjh','BSlUR','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','<p><strong>Netarsudil</strong>\x20is\x20a\x20<strong>rho\x20kinase\x20inhibitor</strong>\x20that\x20acts\x20by&nbsp;relaxing\x20the\x20trabecular\x20meshwork.\x20This\x20increases\x20the\x20outflow\x20of\x20aqueous\x20humor\x20and\x20reduces\x20intraocular\x20pressure.&nbsp;</p>','Iloprost','Acid-fast\x20bacilli','3226590aZHjGl','sZtiG','fhyvS','PCofK','The\x20finding\x20shown\x20in\x20the\x20image\x20below\x20is\x20seen\x20as\x20a\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20drugs?','dataset','Polymyxins\x20are\x20effective\x20against:','Spury','1,\x203\x20and\x205\x20only','totalQuestionsResult','yCCar','PzYZH','YeMgD','findIndex','noHEa','block','submitSection','reload','QkffV','https://dhmbxeygs57ff.cloudfront.net/uploads/95f332d3004e48e6a476a371eecd59f0x1280x2717.JPEG','PMjSo','KWhVF','iiMjU','__proto__','Urine\x20output','TELAj','xAtsY','A\x2064-year-old\x20man\x20was\x20started\x20on\x20heparin\x20postoperatively\x20for\x20thromboprophylaxis.\x20After\x20a\x20week\x20he\x20developed\x20sudden\x20difficulty\x20in\x20breathing.\x20His\x20platelet\x20count\x20was\x20found\x20to\x20be\x2070,000/microliter.\x20Which\x20of\x20the\x20following\x20is\x20incorrect\x20regarding\x20the\x20management\x20of\x20this\x20patient?','Heteroresistance','DSxQM','ZBZgg','wUPMQ','IpGKK','eTrtL','FNyps','<p\x20style=\x22text-align:\x20left;\x22><strong>LABA</strong>\x20is\x20used\x20in\x20<strong>combination\x20</strong>with<strong>\x20inhalational\x20corticosteroids</strong>&nbsp;(ICS),<strong>&nbsp;</strong>preferably\x20in\x20the\x20form\x20of\x20a\x20combination\x20inhaler.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>LABA\x20is\x20never\x20taken\x20alone\x20as\x20it\x20does\x20not\x20treat\x20the\x20underlying\x20chronic\x20inflammation\x20of\x20asthma.\x20Corticosteroids&nbsp;will\x20decrease\x20the\x20underlying\x20inflammation\x20and\x20halt\x20the\x20progression\x20of\x20the\x20disease.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Short-acting\x20&beta;-2\x20agonists\x20(<strong>SABA</strong>)\x20can\x20be\x20given\x20as\x20an\x20add-on\x20therapy\x20to\x20the\x20LABA-ICS\x20combination\x20(<strong>as-needed\x20therapy</strong>).</p>','eLxYk','Absorption','Itivd','<p>Cotrimoxazole\x20is\x20a\x20combination\x20drug\x20consisting\x20of\x20trimethoprim\x20and\x20sulfamethoxazole,\x20of\x20which\x20sulfamethoxazole\x20is\x20a\x20<strong>sulfonamide</strong>.&nbsp;Sulphonamides\x20<strong>displace\x20bilirubin</strong>\x20from\x20plasma\x20albumin,\x20leading\x20to\x20elevation\x20of\x20serum\x20bilirubin\x20levels.</p>\x0a<p>These\x20drugs\x20can<strong>&nbsp;cross\x20the\x20placenta</strong>\x20and\x20are\x20<strong>secreted\x20in\x20milk&nbsp;</strong>and\x20can\x20therefore\x20cause\x20kernicterus\x20in&nbsp;newborn\x20infants\x20if\x20they\x20are\x20given\x20to&nbsp;pregnant\x20women\x20near\x20term\x20or\x20during\x20lactation.</p>','UPmYr','notAttempted','AeLex','wZlMP','It\x20acts\x20as\x20a\x20selective\x20MAO\x20A\x20inhibitor','Blood\x20pressure','A\x20patient\x20with\x20superficial\x20bladder\x20carcinoma\x20is\x20being\x20treated\x20with\x20a\x20drug\x20by\x20intravesical\x20therapy.\x20Identify\x20this\x20drug.','UDypI','IsVvD','aIrXv','Amlodipine','A\x20patient\x20diagnosed\x20with\x20ventricular\x20tachycardia\x20was\x20started\x20on\x20a\x20class1B\x20anti-arrhythmic\x20drug.\x20Identify\x20the\x20drug.','<p>The\x20maximum\x20approved\x20daily\x20dose\x20of\x20Istradefylline\x20is\x20<strong>40\x20mg.</strong></p>\x0a<p>Istradefylline\x20has\x20been\x20recently\x20approved\x20by\x20FDA\x20as\x20an\x20<strong>add-on\x20treatment\x20to\x20levodopa\x20in\x20adults\x20with\x20Parkinson’s\x20disease\x20experiencing\x20off\x20episodes.</strong></p>\x0a<p>It\x20is\x20an\x20adenosine\x20A2A\x20receptor\x20antagonist.</p>\x0a<p>\u00a0</p>','The\x20efficacy\x20of\x20which\x20of\x20the\x20following\x20antiplatelet\x20drugs\x20will\x20be\x20reduced,\x20if\x20omeprazole\x20is\x20used\x20concurrently?','Monitoring\x20of\x20carbamazepine\x20therapy','MRSA','Fall\x20in\x20IOP','BTJGQ','Tiotropium','75%','LaEmH','toISOString','cbUrG','In\x20combination\x20with\x20an\x20inhaled\x20anticholinergic','Alloresistance','You\x20are\x20studying\x20the\x20susceptibility\x20of\x20Streptococci\x20to\x20bacitracin\x20in\x20the\x20lab.\x20What\x20is\x20the\x20site\x20of\x20action\x20of\x20this\x20drug?','zlEbu','haloh','A\x2057-year-old\x20woman\x20diagnosed\x20with\x20breast\x20carcinoma\x20was\x20prescribed\x20trastuzumab.\x20Which\x20of\x20the\x20following\x20statements\x20regarding\x20this\x20drug\x20is\x20true?','Phenytoin','Utrlo','An\x20elderly\x20man\x20with\x20a\x2030-year\x20history\x20of\x20smoking\x20complains\x20of\x20breathing\x20difficulty.\x20A\x20diagnosis\x20of\x20COPD\x20is\x20made,\x20and\x20treatment\x20with\x20a\x20long-acting\x20muscarinic\x20antagonist\x20is\x20initiated.\x20\x20Which\x20of\x20the\x20following\x20will\x20you\x20not\x20prescribe?','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','RMFDX','Penicillin\x20G','Prazosin','Mefloquine','bTIML','TsMsj','tEnwW','Lateral\x20part\x20of\x20thigh','DLGSY','quizHierarchy','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Fibrates','<p\x20style=\x22text-align:\x20left;\x22>The\x20drugs\x20of\x20choice\x20for\x20<strong>type\x20IIa\x20and\x20IIb\x20hyperlipoproteinemias</strong>\x20are\x20<strong>statins</strong>.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>In\x20type\x20IIa\x20or\x20IIb\x20hyperlipoproteinemias,\x20there\x20is\x20increased\x20LDL\x20cholesterol\x20with\x20+/-\x20increase\x20in\x20TG.&nbsp;\x20Statins\x20have\x20the\x20<strong>maximum\x20LDL\x20lowering</strong>\x20property\x20among\x20the\x20hypolipidemic\x20drugs.\x20Therefore,\x20they\x20are\x20the\x20drugs\x20of\x20choice\x20in\x20this\x20case.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>In\x20<strong>type\x20III/IV\x20hyperlipoproteinemias,&nbsp;</strong>there\x20is\x20mainly\x20an\x20increase\x20in\x20triglyceride(TG)\x20level<strong>.\x20Fibrates</strong>\x20reduce\x20the\x20TGs\x20contained\x20in\x20VLDL\x20and\x20increase\x20the\x20HDL.\x20So\x20they\x20are\x20the\x20drugs\x20of\x20choice\x20for\x20these\x20conditions.</p>','Inhibits\x20synthesis\x20of\x20uric\x20acid','MgODO','Co-trimoxazole','performanceModal','TCXpo','Dinoprost','A\x20patient\x20with\x20diabetes\x20mellitus\x20came\x20to\x20the\x20OPD\x20with\x20a\x20history\x20suggestive\x20of\x20recurrent\x20episodes\x20of\x20hypoglycemia.\x20She\x20was\x20recently\x20put\x20on\x20combination\x20therapy.\x20Her\x20symptoms\x20are\x20least\x20likely\x20to\x20be\x20caused\x20by\x20which\x20of\x20the\x20following\x20drugs?','snWqk','hcCfL','EHDbA','<p><strong>Tetanus\x20toxoid</strong><strong>\u00a0</strong>is\x20likely\x20to\x20be\x20administered\x20<strong>intramuscularly</strong>.</p>\x0a<p>The\x20<strong>intramuscular</strong>\x20<strong>route</strong>\x20(IM)\x20of\x20drug\x20administration\x20is\x20mostly\x20given\x20in\x20the\x20<strong>deltoid</strong>,\x20<strong>gluteal\x20region,</strong>\x20and\x20<strong>anterolateral\x20aspect\x20</strong>of\x20the\x20<strong>thigh</strong>\x20where\x20the\x20muscle\x20is\x20bulkier.\x20This\x20route\x20<strong>bypasses</strong>\x20the\x20<strong>first-pass\x20metabolism</strong>\x20and\x20reaches\x20systemic\x20circulation\x20quickly.\u00a0</p>\x0a<p>This\x20method\x20is\x20suitable\x20for\x20moderate\x20volumes,\x20oily\x20vehicles,\x20and\x20some\x20irritating\x20substances.\x20<strong>Absorption</strong>\x20of\x20drugs\x20in\x20an\x20aqueous\x20solution\x20after\x20IM\x20injection\x20depends\x20on\x20the\x20<strong>rate\x20</strong>of\x20<strong>blood\x20flow</strong>\x20to\x20the\x20injection\x20site\x20and\x20can\x20be\x20<strong>relatively\x20rapid</strong>.\x20Thus,\x20the\x20injections\x20given\x20in\x20the\x20gluteal\x20region\x20are\x20relatively\x20more\x20slowly\x20absorbed\x20in\x20females\x20than\x20in\x20males.\x20Depot\x20injections\x20may\x20produce\x20slow\x20and\x20prolonged\x20action.\u00a0</p>\x0a<p>The<strong>\u00a0Z-track\x20technique</strong>\u00a0is\x20used\x20for\x20intramuscular\x20injections\x20in\x20which\x20the\x20needle\x20is\x20inserted\x20at\x20<strong>90\x20degrees</strong>\x20with\x20a\x20quick\x20darting\x20movement.\x20This\x20prevents\x20skin\x20staining\u00a0through\x20the\x20tract\x20to\x20the\x20surface\x20of\x20the\x20skin.\x20Pain\x20intensity\u00a0is\x20also\u00a0reduced.</p>','qORnQ','Switch\x20to\x20ethosuximide','sgRNq','SLAbK','BtgGT','ZbxDf','Which\x20of\x20the\x20following\x20organisms\x20is\x20resistant\x20to\x20tetracyclines?','solutionAudio','In\x20combination\x20with\x20an\x20inhaled\x20corticosteroid','A\x20sanitation\x20worker\x20presented\x20with\x20complaints\x20of\x20blurred\x20vision,\x20breathing\x20difficulty\x20and\x20muscle\x20weakness.\x20He\x20gave\x20a\x20history\x20of\x20spraying\x20malathion\x20this\x20morning.\x20You\x20administer\x20pralidoxime\x20as\x20an\x20antidote.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','rWCtl','xOaau','RnahG','Isosorbide\x20dinitrate','Marked','It\x20is\x20not\x20effective\x20in\x20the\x20treatment\x20of\x20severe\x20neutropenia','<p\x20style=\x22text-align:\x20left;\x22><strong>Ipratropium</strong>\x20is\x20a\x20<strong>short-acting\x20muscarinic\x20antagonist&nbsp;</strong>which\x20is\x20not\x20used\x20for\x20the\x20long-term\x20management\x20of\x20COPD.\x20It\x20can\x20be\x20used\x20to\x20treat\x20<strong>acute\x20exacerbations.</strong></p>\x0a<p\x20style=\x22text-align:\x20left;\x22>The\x20long-acting\x20muscarinic\x20antagonists\x20(<strong>LAMAs</strong>)\x20are:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20left;\x22>Tiotropium</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Glycopyrronium&nbsp;</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Umeclidinium</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Aclidinium</li>\x0a</ul>','reduce','Mwmuc','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','glKgT','kRhBw','gkODo','In\x20which\x20of\x20the\x20following\x20conditions\x20is\x20methotrexate\x20not\x20used?','Mexiletine','CXTku','appendChild','30-year-old\x20woman\x20with\x20electrolyte\x20disturbances','RJiTp','XLLfM','Elimination','pdWLg','Metabolism','target','mNORg','AReGs','uUNrx','40\x20mg','Streptomycin','<p>Pralidoxime<strong>&nbsp;reactivates\x20cholinesterase,&nbsp;</strong>which\x20would\x20have\x20been\x20deactivated\x20by\x20phosphorylation\x20caused\x20by\x20malathion.</p>\x0a<p><strong>Pralidoxime</strong>\x20attaches\x20to\x20the\x20anionic\x20site\x20of\x20the\x20enzyme\x20that\x20remains\x20unoccupied.\x20Then\x20it<strong>\x20reacts\x20</strong>with\x20the\x20<strong>phosphorus\x20atom</strong>&nbsp;of\x20the\x20organophosphorous\x20compound\x20which\x20is\x20attached\x20to\x20the\x20esteric\x20site\x20to\x20form\x20a<strong>\x20phospho-oxime\x20complex.\x20</strong>It\x20then\x20dissociates\x20from\x20the\x20enzyme,\x20regenerating\x20the\x20active\x20enzyme.</p>','Methylmorphine','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><strong>Me-too\x20drugs\x20</strong>are\x20<strong>chemically\x20related</strong>\x20to\x20the\x20prototype<strong>&nbsp;</strong>or\x20other\x20chemical\x20compounds\x20that\x20have\x20an\x20<strong>identical\x20mechanism\x20of\x20action.&nbsp;</strong></p>\x0a<p>Various\x20statins\x20present\x20in\x20the\x20market\x20can\x20be\x20considered\x20as\x20\x22Me-too\x20drugs\x22.\x20The\x20pharmacokinetic\x20parameters\x20(absorption,\x20distribution,\x20metabolism,\x20and\x20elimination)\x20vary\x20significantly\x20between\x20them\x20(atorvastatin\x20and\x20rosuvastatin\x20have\x20a\x20very\x20long\x20duration\x20of\x20action),\x20but\x20the\x20core\x20mechanism\x20of\x20action\x20remains\x20the\x20same:\x20HMG\x20CoA\x20reductase\x20inhibition\x20and\x20decrease\x20in\x20cholesterol\x20synthesis.</p>','kNsNx','<p><strong>Sugammadex</strong>\x20is\x20a<strong>\x20reversal\x20agent\x20</strong>for\x20<strong>rocuronium</strong>\x20and\x20<strong>vecuronium.</strong></p>\x0a<p>Sugammadex\x20binds\x20to\x20plasma\x20rocuronium\x20and\x20thus\x20decreases\x20the\x20plasma\x20concentration\x20of\x20rocuronium.\x20This\x20forms\x20a\x20concentration\x20gradient\x20of\x20rocuronium\x20due\x20to\x20which\x20it\x20moves\x20from\x20the\x20neuromuscular\x20junction\x20back\x20into\x20the\x20circulation\x20where\x20it\x20quickly\x20bound\x20by\x20free\x20sugammadex.\x20It\x20is\x20not\x20recommended\x20to\x20be\x20used\x20in\x20patients\x20who\x20have\x20severe\x20renal\x20impairment.</p>','BYrQN','dUjMt','XaBhe','Marrow','Rifapentine','qbCot','idFwG','nav-btn-answered','JgZLE','exception','closest','<p><strong>Doxycycline</strong>\x20can\x20be\x20taken\x20as\x20prophylaxis\x20by\x20the\x20researcher\x20before\x20going\x20to\x20malaria-endemic\x20places.</p>\x0a<p>Chemoprophylaxis\x20against\x20malaria\x20for\x20travelers:</p>\x0a<ul>\x0a<li>If\x20the\x20duration\x20of\x20travel\x20is\x20<strong>less\x20than\x206\x20weeks</strong>\x20then\x20<strong>doxycycline\x20100mg\x20once\x20a\x20day</strong>&nbsp;is\x20to\x20be\x20started\x20<strong>2\x20days\x20before</strong>\x20travel\x20and\x20continued\x20atleast\x204\x20weeks\x20after\x20travel.</li>\x0a<li>If\x20the\x20duration\x20of\x20travel\x20is<strong>\x20more\x20than\x206\x20weeks</strong>\x20then\x20<strong>mefloquine\x20250mg\x20once\x20a\x20week</strong>&nbsp;is\x20to\x20be\x20started\x20<strong>2\x20weeks\x20before</strong>\x20travel&nbsp;and\x20continued\x20atleast\x204\x20weeks\x20after\x20travel.</li>\x0a</ul>','qELeI','oTuHx','As\x20monotherapy','QRTod','https://dhmbxeygs57ff.cloudfront.net/uploads/336c015a430f474d9d6818f4ee6c4336x472x449.PNG','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','LQgPW','IDzmO','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','Cell\x20membrane','TPZWz','qZjAf','BaaFp','ovQmH','<p><strong>Propranolol</strong>&nbsp;reduces\x20blood\x20pressure\x20by\x20<strong>directly\x20decreasing</strong>\x20the<strong>\x20heart\x20rate</strong>.\x20It\x20is\x20a\x20<strong>nonselective\x20beta-blocker</strong>\x20and\x20blocks\x20the\x20beta\x201\x20receptor\x20of\x20the\x20heart\x20(SA\x20node)\x20thus\x20reducing\x20the\x20heart\x20rate\x20and\x20blood\x20pressure.</p>\x0a<p>It\x20also\x20<strong>reduces\x20renin\x20secretion</strong>\x20by\x20blocking\x20beta\x201\x20receptors\x20in\x20JG\x20cells.\x20Reduction\x20in\x20renin\x20release\x20also\x20contributes\x20to\x20blood\x20pressure\x20reduction.</p>\x0a<p>Option\x20B:\x20<strong>Prazosin\x20</strong>is\x20a\x20<strong>selective\x20alpha\x201&nbsp;blocker</strong>\x20and\x20dilates\x20both\x20arteries\x20and\x20veins\x20and\x20may\x20cause\x20reflex\x20tachycardia.</p>\x0a<p>Option\x20C:\x20<strong>Alpha\x20methyldopa</strong>\x20is\x20a\x20selective\x20<strong>alpha\x202\x20receptor</strong>\x20agonist.\x20Alpha\x202\x20receptors\x20are\x20autoreceptors\x20present\x20on\x20the\x20presynaptic\x20membrane.\x20On\x20stimulation,\x20central\x20sympathetic\x20discharge\x20is\x20reduced.\x20Alpha\x20methyldopa\x20can\x20indirectly\x20reduce\x20heart\x20rate.</p>\x0a<p>Option\x20D:\x20Nitroprusside\x20is\x20a\x20vasodilator\x20and\x20may\x20cause\x20reflex\x20tachycardia.</p>','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','SpmUU','Floaters','NZoWv','referrer','Nifedipine','iaDyd','width','Which\x20of\x20the\x20following\x20are\x20not\x20reasons\x20for\x20the\x20alteration\x20of\x20drug\x20dosage\x20in\x20the\x20elderly?','Cefotaxime','3751365vzLESR','choices','Bradykinin\x20B2\x20receptor\x20agonist','EIvJT','dQMJY','FIpjb','QUPzc','innerHTML','WWqzV','edXCC','What\x20is\x20the\x20current\x20GINA\x20recommendation\x20for\x20the\x20prescription\x20of\x20long-acting\x20β-2\x20agonists\x20in\x20patients\x20suffering\x20from\x20bronchial\x20asthma?','Mannitol','<p>The\x20<strong>sub-family</strong>\x20of\x20<strong>CYP3A4</strong>\x20is\x20<strong>A</strong>.</p>\x0a<p>In\x20CYP\x20enzymes\x20nomenclature,\x20the\x20root\x20CYP\x20is\x20followed\x20by\x20a\x20number\x20designating\x20the\x20family,\x20a\x20letter\x20denoting\x20the\x20subfamily\x20and\x20another\x20number\x20designating\x20the\x20gene.\x20Therefore,\x20in\x20CYP3A4:</p>\x0a<ul>\x0a<li>3\x20-\x20family&nbsp;</li>\x0a<li>A\x20-\x20subfamily\x20A</li>\x0a<li>4\x20-\x20individual\x20gene\x20coding\x20for\x20one\x20specific\x20isoenzyme</li>\x0a</ul>\x0a<p>There\x20are\x20numerous\x20CYP\x20isoenzymes\x20in\x20humans.\x20Among\x20them,&nbsp;<strong>CYP3A4&nbsp;</strong>is\x20the<strong>&nbsp;most\x20abundant</strong>&nbsp;and\x20carries\x20out\x20the\x20metabolism\x20of\x20nearly\x20<strong>50%</strong>\x20of\x20<strong>clinically\x20used</strong>\x20drugs.</p>','Bradykinin\x20B2\x20receptor\x20antagonist','H1\x20receptor\x20agonism','syLVF','<p\x20style=\x22text-align:\x20justify;\x22><strong>Clopidogrel\x20</strong>is\x20a\x20prodrug\x20that\x20is\x20converted\x20into\x20an&nbsp;active\x20metabolite\x20by\x20the\x20<strong>CYP2C19</strong>\x20<strong>enzyme</strong>\x20and<strong>&nbsp;</strong>omeprazole\x20can\x20reduce\x20the\x20efficacy\x20of\x20clopidogrel\x20due\x20to\x20its\x20<strong>CYP2C19\x20inhibitory\x20activity.&nbsp;</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20B:\x20Prasugrel\x20is\x20converted\x20to\x20its\x20active\x20metabolite\x20mainly\x20by\x20<strong>other\x20CYP\x20enzymes</strong>\x20and\x20therefore\x20omeprazole\x20does\x20not\x20interfere\x20in\x20its\x20activation.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20C:\x20Ticagrelor\x20does\x20not\x20require\x20activation\x20and\x20is\x20metabolized\x20by\x20the<strong>\x20CYP3A4\x20enzyme.</strong>&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20D:\x20Vorapaxar\x20is\x20a\x20thrombin\x20receptor\x20antagonist\x20that\x20is\x20also\x20metabolized\x20by\x20the\x20<strong>CYP3A4\x20enzyme</strong>.&nbsp;</p>','Mechanism\x20of\x20action','SwrWg','<p><strong>Ranibizumab&nbsp;</strong>is\x20associated\x20with\x20a\x20raise\x20in\x20IOP,\x20not\x20a\x20fall.</p>\x0a<p><strong>Ranibizumab</strong>\x20is\x20a&nbsp;monoclonal\x20antibody\x20directed\x20against\x20VEGF-A\x20(vascular\x20endothelial\x20growth\x20factor-A).&nbsp;Ranibizumab\x20is\x20indicated\x20in<strong>\x20wet\x20age-related\x20macular\x20degeneration\x20</strong>and\x20is\x20used<strong>\x20intravitreally\x20</strong>where\x20it<strong>\x20inhibits\x20VEGF-A\x20induced\x20ocular\x20neovascularization.</strong></p>','CjgFL','vrdgP','preventDefault','It\x20blocks\x20the\x20action\x20of\x20acetylcholine','Bupivacaine','zyJZP','slIdZ','sflXJ','A\x20patient\x20is\x20to\x20be\x20started\x20on\x20a\x20cephalosporin\x20antibiotic.\x20His\x20serum\x20creatinine\x20levels\x20yesterday\x20at\x20the\x20time\x20of\x20admission\x20was\x201.1\x20mg/dl\x20and\x20now\x20it\x20is\x201.5\x20mg/dl.\x20Which\x20of\x20the\x20following\x20cephalosporins\x20can\x20be\x20started\x20without\x20dose\x20reduction\x20in\x20this\x20patient?','kVvjo','Z\x20track\x20technique\x20is\x20used\x20for?','<p>Moxifloxacin\x20<strong>does\x20not\x20accumulate\x20significantly\x20in\x20urine</strong>\x20and\x20is\x20not\x20approved\x20for\x20the\x20treatment\x20of\x20urinary\x20tract\x20infections\x20(UTIs).</p>\x0a<p>UTIs\x20are\x20the\x20only\x20indication\x20for\x20the\x20use\x20of\x20nalidixic\x20acid.&nbsp;Ciprofloxacin\x20and\x20norfloxacin\x20can\x20be\x20used\x20in\x20UTIs\x20caused\x20by\x20susceptible\x20organisms.</p>','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','BIZfW','<p\x20style=\x22text-align:\x20justify;\x22>Patients\x20with\x20sickle\x20cell\x20anemia\x20should\x20not\x20receive\x20pegylated\x20filgrastim\x20as\x20it\x20can&nbsp;trigger\x20a\x20<strong>sickle\x20cell\x20crisis.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Filgrastim&nbsp;</strong>is\x20a\x20recombinant\x20human\x20G-CSF\x20(granulocyte\x20colony-stimulating\x20factor).\x20The\x20pegylated\x20forms\x20of\x20filgrastim,\x20pegfilgrastim,\x20and\x20lipefilgrastim,\x20are\x20longer-acting\x20forms.\x20It\x20is\x20administered\x20subcutaneously\x20or\x20by\x20slow\x20intravenous\x20infusion\x20only.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Indications\x20of\x20recombinant\x20G-CSF:&nbsp;\x20&nbsp;</p>\x0a<ul\x20style=\x22text-align:\x20justify;\x22>\x0a<li>Severe\x20neutropenia\x20after\x20autologous\x20hematopoietic\x20stem\x20cell\x20transplantation</li>\x0a<li>Severe\x20neutropenia\x20after\x20high\x20dose\x20cancer\x20chemotherapy</li>\x0a<li>Severe\x20congenital\x20neutropenias</li>\x0a<li>Neutropenia\x20of\x20patients\x20with\x20<strong>AIDS</strong>\x20receiving\x20<strong>zidovudine</strong></li>\x0a</ul>','pnjLb','Hypertensive\x20emergency','eJBHU','Bxpme','tWEGL','MYMlx','FPfKK','uWSPm','answered','correct_choice_id','scoreCircle','hVnIx','https://dhmbxeygs57ff.cloudfront.net/uploads/ec6b8af55d8d4214adecf78d326084bex1280x1399.JPEG','TslfA','bUxWh','Gram-positive\x20bacteria','H3\x20receptor\x20inverse\x20agonism','gyAyp','addEventListener','pop','DVGYg','disabled','Camptothecin\x20analogs','\x20>\x20','incorrectResult','What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20delamanid?','border-green-500','2\x20and\x204\x20only','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','A\x20patient\x20has\x20presented\x20to\x20your\x20OPD\x20complaining\x20of\x20hearing\x20loss\x20following\x20an\x20attack\x20of\x20vertigo.\x20He\x20says\x20he\x20has\x20had\x20similar\x20episodes\x20in\x20the\x20past.\x20You\x20decide\x20to\x20prescribe\x20him\x20betahistine.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','VwBZI','Spectinomycin','Promotes\x20excretion\x20of\x20uric\x20acid','TeATk','explanation_audio_eng','BCG\x20vaccine','VGCcV','CDxLS','href','<p><strong>Maraviroc</strong>\x20is\x20a<strong>\x20chemokine\x20receptor\x20antagonist\x20</strong>acting\x20against\x20the\x20<strong>CCR5\x20receptor</strong>.</p>\x0a<p>It&nbsp;binds\x20to\x20the\x20host\x20cell\x20CCR-5\x20receptor\x20and\x20prevents\x20the\x20binding\x20of\x20viral\x20GP-120\x20to\x20host\x20cells.\x20It\x20is\x20indicated\x20in\x20patients\x20with\x20evidence\x20of\x20infection\x20with\x20predominantly\x20CCR-5\x20tropic\x20virus.</p>','<p><strong>Inverse\x20agonists</strong>\x20bind\x20to\x20the\x20receptor\x20and\x20cause\x20an\x20action<strong>&nbsp;opposite\x20</strong>to\x20that\x20of\x20an<strong>\x20agonist.</strong></p>\x0a<table\x20style=\x22width:\x20310px;\x20height:\x20200px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x22>\x0a<p><strong>Type\x20of\x20drugs</strong></p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x22>\x0a<p><strong>Intrinsic\x20activity</strong></p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>1</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Partial\x20agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>0\x20to\x201</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Competitive\x20antagonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>0</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031px;\x22>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20155.766px;\x20text-align:\x20center;\x22>\x0a<p>Inverse\x20agonists</p>\x0a</td>\x0a<td\x20style=\x22height:\x2031px;\x20width:\x20138.234px;\x20text-align:\x20center;\x22>\x0a<p>0\x20to\x20-1</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>The\x20ability\x20of\x20the\x20drug\x20<strong>to\x20bind</strong>\x20with\x20a\x20receptor\x20is\x20called\x20<strong>affinity.</strong></p>\x0a<p>The\x20capacity\x20of\x20a\x20drug\x20to\x20induce\x20a\x20functional\x20change\x20in\x20the\x20receptor\x20is\x20called&nbsp;intrinsic\x20activity\x20or\x20efficacy.</p>','Chloramphenicol','ZLJeE','stringify','timeDisplay','HkWws','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','URbtZ','Anizg','CXCR4','Inhibition\x20of\x20ATP\x20synthase','Inhibition\x20of\x20DNA\x20gyrase','kKeZu','NUjZP','ThmaT','They\x20have\x20decreasing\x20renal\x20function\x20with\x20age','ujvxU','zWvJT','The\x20action\x20of\x20digoxin\x20will\x20not\x20be\x20affected\x20in\x20which\x20of\x20the\x20following\x20patients?','10qMRmnR','Phosphodiesterase\x205\x20inhibition','ovqET','tQUJE','error','VtCge','Wvjbp','Enalapril','Administration\x20of\x20long\x20acting\x20depot\x20antipsychotics','A\x20patient\x20on\x20intravenous\x20vancomycin\x20develops\x20flushing\x20and\x20erythematous\x20lesions.\x20On\x20examination,\x20tachycardia,\x20and\x20hypotension\x20are\x20noted.\x20By\x20what\x20mechanism\x20does\x20vancomycin\x20cause\x20these\x20effects?','correctCount','UxCAt','NlwAa','Moxifloxacin','<p>The\x20scenario\x20is\x20suggestive\x20of\x20<strong>pseudomembranous\x20colitis</strong>\x20caused\x20by\x20<em>Clostridium\x20difficile</em>\x20and\x20<strong>fidaxomicin</strong>&nbsp;is\x20a\x20macrocyclic\x20antibiotic\x20that\x20is\x20indicated\x20as\x20an\x20alternative\x20to\x20vancomycin\x20in<strong>\x20severe</strong>\x20and<strong>\x20recurring\x20<em>Clostridium\x20difficile</em>\x20infections.</strong></p>\x0a<p>It\x20acts\x20by\x20<strong>inhibiting\x20protein\x20synthesis</strong>\x20through\x20the\x20blockade\x20of\x20RNA\x20polymerase.</p>','createElement','wLZdp','Clindamycin','QYron','(((.+)+)+)+$','rKEwR','ODsIu','NJKKo','CUgBq','FHbVO','Binds\x20to\x20the\x20receptor\x20and\x20causes\x20submaximal\x20action','<p>Muscle\x20weakness\x20is\x20improved\x20by\x20<strong>neostigmine</strong>\x20as\x20it\x20<strong>interferes</strong>\x20with\x20the\x20action\x20of\x20<strong>acetylcholine\x20esterase.</strong></p>\x0a<p>Neostigmine\x20is\x20a&nbsp;<strong>cholinesterase\x20inhibitor</strong>&nbsp;used\x20mainly\x20to\x20improve\x20muscle\x20tone\x20in\x20people\x20with\x20myasthenia\x20gravis,\x20and\x20also\x20to\x20reverse\x20the\x20effects\x20of\x20non-depolarizing\x20muscle\x20relaxants\x20such\x20as\x20rocuronium\x20and\x20vecuronium\x20at\x20the\x20end\x20of\x20an\x20operation.&nbsp;</p>\x0a<p>Inhibition\x20of\x20acetylcholine\x20esterase\x20<strong>increases</strong>\x20the\x20<strong>acetylcholine</strong>\x20levels\x20in\x20the\x20<strong>synapse</strong>\x20that\x20can\x20act\x20on\x20receptors\x20over\x20the\x20large\x20surface\x20area\x20and\x20for\x20longer\x20periods\x20of\x20time,\x20reducing\x20the\x20weakness.</p>','NWzLm','OKMQF','xdvkW','NmLBY','Insulin\x20aspart','Fidaxomicin','Stimulation\x20of\x20ACh\x20receptors','ROyQK','priBD','NrzNL','<p><strong>Clindamycin</strong>,\x20a<strong>&nbsp;lincosamide&nbsp;</strong>is\x20used\x20in\x20the\x20management\x20of&nbsp;lung\x20abscess\x20and\x20anaerobic\x20lung\x20and\x20pleural\x20space\x20infections.</p>\x0a<p>Clindamycin\x20is\x20a\x20congener\x20of\x20lincomycin\x20and\x20binds\x20to\x20the<strong>\x2050S\x20subunit</strong>\x20of\x20bacterial\x20ribosomes\x20and\x20<strong>inhibits\x20protein\x20synthesis.</strong></p>\x0a<p>Option\x20A:\x20Telithromycin\x20is\x20a\x20ketolide\x20antibiotic.</p>\x0a<p>Option\x20B:\x20Spectinomycin\x20is\x20an\x20aminocyclitol\x20antibiotic\x20that\x20binds\x20to\x20the\x2030S\x20subunit\x20of\x20ribosomes\x20and\x20inhibits\x20protein\x20synthesis.</p>\x0a<p>Option\x20D:\x20Streptomycin\x20is\x20an\x20aminoglycoside\x20antibiotic.</p>','TifQR','hTIDl','onclick','Which\x20of\x20the\x20following\x20antineoplastic\x20agents\x20is\x20extracted\x20from\x20the\x20plant\x20shown\x20below?','Histamine\x20antagonist\x20action','selectedAnswer','QHpRK','<p\x20style=\x22text-align:\x20justify;\x22><strong>Central\x20Drug\x20Standard\x20Control\x20Organisation</strong>\x20(<strong>CDSCO</strong>)\u00a0regulates\x20the\x20<strong>clinical\x20trials</strong>\x20and\x20<strong>approval</strong>\x20of\x20<strong>investigational\x20new\x20drugs</strong>\x20in\x20India.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>The\x20CDSCO\x20is\x20also\x20responsible\x20for\x20laying\x20down\x20the\x20standards\x20for\x20drugs,\x20controlling\x20the\x20quality\x20of\x20imported\x20drugs\x20in\x20the\x20country\x20and\x20coordinating\x20the\x20activities\x20of\x20State\x20Drug\x20Control\x20Organizations.\x20The\x20proposal\x20for\x20initiating\x20trials,\x20review\x20of\x20clinical\x20trial\x20results,\x20and\x20recommendations\x20for\x20marketing\x20authorization\x20is\x20done\x20through\x20a\x20committee\x20called\x20the\x20<strong>Investigational\x20New\x20Drug</strong>\x20(IND)\x20<strong>Committee</strong>\x20formed\x20by\x20CDSCO.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>The\x20Drugs\x20Controller\x20General\x20of\x20India<strong>\x20(DCGI)</strong>\x20is\x20the\x20head\x20of\x20the\x20CDSCO,\x20under\x20the\x20Ministry\x20of\x20Health\x20and\x20Family\x20Welfare\x20in\x20India.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Preclinical\x20trials</strong>\x20are\x20performed\x20on<strong>\x20animals,\x20</strong>and\x20they\x20are\x20regulated\x20by\x20guidelines\x20prescribed\x20by\x20the\u00a0Committee\x20for\x20the\x20Purpose\x20of\x20the\x20Control\x20and\x20Supervision\x20of\x20Experiments\x20on\x20Animals\x20<strong>(CPCSEA)\x20</strong>in\x20<strong>India</strong>.</p>','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','vYOwW','Taxane','Tamoxifen','timeSpent','status','QdYgu','question_images','Nwkmd','https://cdn1.dailyrounds.org/uploads/05e0376fc11340daa9d74b749ff969d7.PNG','Tetanus\x20toxoid','LJAkM','ZgPIx','AUSyz','<p>The<strong>\x20Z-track\x20technique</strong>&nbsp;is\x20used\x20for\x20the\x20intramuscular\x20administration\x20of\x20<strong>long-acting\x20depot\x20antipsychotics.</strong></p>\x0a<p><strong>Advantages:</strong>&nbsp;</p>\x0a<ul>\x0a<li>The\x20\x27Z-track\x27&nbsp;prevents\x20leakage&nbsp;of\x20the\x20medication\x20into\x20the\x20subcutaneous\x20tissue\x20and&nbsp;skin\x20staining&nbsp;through\x20the\x20tract\x20to\x20the\x20surface\x20of\x20the\x20skin</li>\x0a<li>Pain\x20intensity&nbsp;is\x20also&nbsp;reduced&nbsp;</li>\x0a</ul>','bPKSi','Sickle\x20cell\x20anemia','Rheumatoid\x20arthritis','stats','It\x20interferes\x20with\x20the\x20action\x20of\x20choline\x20acetyl\x20transferase','12.5%','You\x20notice\x20fenoldopam\x20mentioned\x20on\x20the\x20drug\x20chart\x20of\x20an\x20elderly\x20male\x20patient\x20admitted\x20in\x20the\x20ICU.\x20What\x20condition\x20is\x20he\x20most\x20likely\x20being\x20treated\x20for?','qPrGE','none','apply','Mpbhz','OkwvH','jgZvp','kamhF','sgvJp','ExBxs','ZYkWW','hidden','Lidocaine','incorrectCount','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','join','textContent','uIVzF','fhZbY','EmMTB','Teoan','padStart','Nucleic\x20acid','<p><strong>Selegiline\x20</strong>acts\x20as\x20a\x20selective<strong>\x20MAO-B\x20inhibitor.</strong></p>\x0a<p>At\x20<strong>higher\x20doses,\x20MAO-A</strong>\x20can\x20also\x20be\x20<strong>inhibited.</strong>\x20Higher\x20doses\x20are\x20used\x20for\x20depression\x20and\x20administered\x20in\x20the\x20form\x20of\x20the\x20<strong>transdermal\x20patch.</strong>&nbsp;</p>\x0a<p>Option\x20B:\x20Selective\x20MAO-B\x20inhibitors\x20do\x20not\x20interfere\x20significantly\x20with\x20the\x20peripheral\x20metabolism\x20of\x20dietary\x20amines\x20and\x20do\x20not\x20cause\x20cheese\x20reaction.</p>\x0a<p>Option\x20C:\x20&nbsp;It\x20has\x20lower\x20efficacy\x20than\x20levodopa\x20but\x20when\x20added\x20with\x20levodopa\x20it\x20prolongs\x20its\x20action\x20and\x20also\x20decreases\x20the\x20wearing-off\x20effect\x20of\x20levodopa.</p>\x0a<p>Option\x20D:&nbsp;Selegiline\x20forms\x20metabolites\x20like\x20amphetamine\x20and\x20methamphetamine\x20that\x20can\x20result\x20in\x20anxiety,\x20insomnia,\x20and\x20other\x20undesirable\x20effects.&nbsp;<strong>Rasagiline</strong>,\x20unlike\x20selegiline,\x20<strong>does\x20not</strong>\x20form\x20amphetamines\x20as\x20metabolites.</p>','<p>The\x20diuretic\x20of\x20choice\x20in\x20a\x20patient\x20with<strong>\x20cirrhotic\x20ascites&nbsp;</strong>is\x20<strong>spironolactone.</strong></p>\x0a<p><strong>Spironolactone</strong>\x20is\x20a\x20<strong>competitive\x20inhibitor</strong>\x20of\x20the\x20<strong>mineralocorticoid\x20receptor</strong>\x20in\x20the\x20<strong>late\x20distal\x20tubule</strong>\x20and<strong>\x20collecting\x20duct</strong>\x20of\x20the\x20kidneys.\x20It\x20causes\x20a\x20decrease\x20in\x20sodium\x20reabsorption\x20and\x20potassium\x20excretion\x20in\x20the\x20distal\x20tubule.\x20As\x20a\x20result,\x20spironolactone\x20<strong>promotes\x20sodium\x20diuresis</strong>\x20but\x20<strong>maintains\x20body\x20potassium\x20levels</strong>.</p>\x0a<p>Spironolactone\x20is\x20particularly\x20helpful\x20in\x20edematous\x20states\x20caused\x20or\x20exacerbated\x20by\x20hyperaldosteronism\x20such\x20as\x20in\x20cirrhotic\x20ascites.</p>','qlhOI','info','EKtzG','Switch\x20to\x20labetalol','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','An\x2018-year-old\x20boy\x20is\x20brought\x20to\x20the\x20casualty\x20with\x20complaints\x20of\x20swelling\x20of\x20his\x20face\x20and\x20lips\x20as\x20shown\x20in\x20the\x20image\x20below.\x20On\x20further\x20enquiry,\x20it\x20is\x20noted\x20that\x20he\x20has\x20suffered\x20from\x20similar\x20episodes\x20in\x20the\x20past\x20whenever\x20he\x20becomes\x20emotional.\x20He\x20is\x20prescribed\x20icatibant.\x20What\x20is\x20the\x20likely\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','application/vnd.apple.mpegurl','Nitroprusside\x20sodium','byxpv','WcPmD','display','Hhrkf','Diltiazem','navBtn_','A\x20researcher\x20who\x20was\x20studying\x20plasmodium\x20species\x20decided\x20to\x20visit\x20a\x20malaria-endemic\x20place\x20in\x20Odisha\x20to\x20do\x20his\x20clinical\x20study\x20for\x205\x20weeks.\x20He\x20is\x20planning\x20to\x20leave\x20after\x202\x20days.\x20\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20taken\x20as\x20prophylaxis\x20before\x20visiting\x20the\x20malaria-endemic\x20place?','Inhibition\x20of\x20alanine\x20racemase','YjHDc','<p>Indications\x20for\x20methotrexate\x20(inflammatory\x20conditions)\x20include:</p>\x0a<ul>\x0a<li>Rheumatoid\x20arthritis</li>\x0a<li><strong>Psoriasis&nbsp;</strong></li>\x0a<li>Psoriatic\x20arthritis</li>\x0a<li>Ankylosing\x20spondylitis</li>\x0a<li>Polymyositis</li>\x0a<li>Dermatomyositis</li>\x0a<li>Wegener&rsquo;s\x20granulomatosis</li>\x0a<li><strong>Giant\x20cell\x20arteritis&nbsp;</strong></li>\x0a<li>Systemic\x20lupus\x20erythematosus</li>\x0a<li>Other\x20systemic\x20vasculitis</li>\x0a<li><strong>Graft\x20versus\x20host\x20disease\x20associated\x20with\x20organ\x20transplantation.</strong></li>\x0a</ul>\x0a<p>Sickle\x20cell\x20anemia\x20appears\x20to\x20be\x20the\x20most\x20appropriate\x20answer\x20among\x20the\x20options.\x20Though\x20small\x20trials\x20have\x20shown\x20positive\x20results\x20in\x20sickle\x20cell\x20disease,\x20it\x20is\x20neither\x20extensively\x20used\x20nor\x20approved\x20for\x20this\x20indication.</p>','IJRVy','During\x20a\x20rotation\x20in\x20the\x20acute\x20medical\x20ward,\x20you\x20observe\x20a\x20patient\x20in\x20cardiogenic\x20shock\x20being\x20started\x20on\x20a\x20low-dose\x20dopamine\x20infusion.\x20Which\x20of\x20the\x20following\x20would\x20you\x20expect\x20to\x20increase\x20in\x20this\x20patient?','solution','totalQuestions','Not\x20Attempted','Heparin\x20should\x20be\x20replaced\x20with\x20warfarin','lszpW','resume','Rifaximin','Sildenafil','correctResult','OGYJz','UVIWK','bjPGw','Gliclazide','https://cdn1.dailyrounds.org/uploads/b062624679194d43acf969ad9e87358a.GIF','Direct\x20toxic\x20effect\x20on\x20mast\x20cells','1\x20and\x203\x20only','testModeReviewLegend','qmLrF','VdPSx','style','includes','pWmst','Ramipril','\x22\x20data-option-index=\x22','userHistory','Idioresistance','eHijL','endsWith','Procaine','index.html','MoUMU','questionMedia','replace','yjkUM','iEBht','Their\x20total\x20body\x20water\x20is\x20decreased','floor','mKnIm','zZpvL','NmjNR','ebEyy','CMtCP','Bookmark','WGsON','\x27Me-too\x20drugs\x27\x20do\x20not\x20differ\x20significantly\x20in\x20which\x20of\x20the\x20following\x20pharmacological\x20features\x20as\x20compared\x20to\x20the\x20prototypical\x20drug?','zjLnx','isSupported','H3\x20receptor\x20agonism','reviewQuestionsContainer','nav-btn-bookmarked','1426xaGCKB','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','timed_exam','Nalidixic\x20acid','OPKGg','title','Anaerobic\x20bacteria','click','push','tKRWT','dWxBP','apghg','cdtrl','VCQOl','ItjOt','Cisapride','OymNc','niAcV','not-attempted','solutionImages','YuwNL','CmXzc','jzHXK','ESDob','Flecainide','It\x20is\x20an\x20antibody\x20produced\x20entirely\x20from\x20mouse\x20containing\x20no\x20human\x20component','Allergic\x20reactions','TVNsz','currentMode','CxzoC','ovHiQ','add','No\x20increase\x20in\x20incidence\x20of\x20breast\x20carcinoma','GssjO','Roxithromycin','LWYSK','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','pVdqS','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','VgtLV','KrrkI','Verapamil'];_0xe69f=function(){return _0x57c0ff;};return _0xe69f();}(function(_0x5b42d,_0x7240e5){const _0x149243=_0x2096,_0x247077=_0x5b42d();while(!![]){try{const _0x80c4a=-parseInt(_0x149243(0x325))/0x1*(-parseInt(_0x149243(0xf3))/0x2)+parseInt(_0x149243(0x172))/0x3+-parseInt(_0x149243(0x352))/0x4*(-parseInt(_0x149243(0x225))/0x5)+parseInt(_0x149243(0x3fe))/0x6+parseInt(_0x149243(0x437))/0x7+parseInt(_0x149243(0x498))/0x8+parseInt(_0x149243(0x38d))/0x9*(-parseInt(_0x149243(0x283))/0xa);if(_0x80c4a===_0x7240e5)break;else _0x247077['push'](_0x247077['shift']());}catch(_0x242949){_0x247077['push'](_0x247077['shift']());}}}(_0xe69f,0x8ad7a));const _0x9f15bb=(function(){const _0x104bc6=_0x2096,_0x582748={'vrdgP':_0x104bc6(0x250),'udARK':_0x104bc6(0x121)};let _0x2e819b=!![];return function(_0x1aaa95,_0x2483e4){const _0x236bf0=_0x104bc6,_0x112f51={'Qbilv':_0x582748[_0x236bf0(0x23a)],'gVcMD':_0x236bf0(0x31b),'LaEmH':_0x582748[_0x236bf0(0x420)]},_0x585a06=_0x2e819b?function(){const _0x3e9bd4=_0x236bf0;if(_0x112f51[_0x3e9bd4(0x139)]!==_0x112f51[_0x3e9bd4(0x1ae)]){if(_0x2483e4){const _0x44b09d=_0x2483e4[_0x3e9bd4(0x2c9)](_0x1aaa95,arguments);return _0x2483e4=null,_0x44b09d;}}else _0x75a470[_0x44b85e][_0x3e9bd4(0x2b6)]=_0x112f51[_0x3e9bd4(0x117)],_0x6db75b['totalAttempted']++,_0x2b049b[_0x3e9bd4(0x19b)]--;}:function(){};return _0x2e819b=![],_0x585a06;};}()),_0x20a25f=_0x9f15bb(this,function(){const _0x4c2454=_0x2096,_0x2e9240={'CGHeQ':_0x4c2454(0x296)};return _0x20a25f[_0x4c2454(0x391)]()['search'](_0x2e9240[_0x4c2454(0xf4)])[_0x4c2454(0x391)]()[_0x4c2454(0xe1)](_0x20a25f)[_0x4c2454(0x3e8)](_0x2e9240[_0x4c2454(0xf4)]);});_0x20a25f();const _0x51b3b6=(function(){const _0x309bb1=_0x2096,_0x41b295={'tEnwW':_0x309bb1(0x30b),'qIKiB':_0x309bb1(0xe2),'NXdVm':function(_0x29a9f2,_0x5ad4b5){return _0x29a9f2!==_0x5ad4b5;},'sZtiG':_0x309bb1(0xd5)};let _0xa4e700=!![];return function(_0x5c13c9,_0x193cb6){const _0x483bd8=_0x309bb1,_0xf0008c={'ESDob':_0x41b295[_0x483bd8(0x1c1)],'zWvJT':_0x41b295[_0x483bd8(0x434)],'MNYkk':function(_0x3cc1e4,_0x36a8ce){const _0x42e0b3=_0x483bd8;return _0x41b295[_0x42e0b3(0x48f)](_0x3cc1e4,_0x36a8ce);},'IcFFy':_0x483bd8(0x332),'LWYSK':_0x41b295[_0x483bd8(0x173)]},_0x46603e=_0xa4e700?function(){const _0x2945d1=_0x483bd8;if(_0xf0008c[_0x2945d1(0x42e)](_0xf0008c[_0x2945d1(0x15d)],'HdeSE')){if(_0x193cb6){if(_0xf0008c[_0x2945d1(0x42e)](_0x2945d1(0xd5),_0xf0008c[_0x2945d1(0x348)])){const _0x527ada=_0x568710['parse'](_0x1e7a4c[_0x2945d1(0x14e)](_0xf0008c[_0x2945d1(0x33c)]))||{},_0x56ea47=_0x527ada[_0xa56c0e];if(_0x56ea47){const _0x273ac4=_0xf0008c[_0x2945d1(0x281)][_0x2945d1(0xea)]('|');let _0x235e8b=0x0;while(!![]){switch(_0x273ac4[_0x235e8b++]){case'0':_0x100524=_0x56ea47[_0x2945d1(0x341)];continue;case'1':_0xbe536b=_0x56ea47[_0x2945d1(0x42a)];continue;case'2':_0x16530f=_0x56ea47[_0x2945d1(0x359)];continue;case'3':return!![];case'4':_0x55b2a3=_0x56ea47[_0x2945d1(0x2c3)];continue;case'5':_0x43a536[_0x2945d1(0x127)]('Progress\x20loaded.');continue;}break;}}return![];}else{const _0xeaf757=_0x193cb6['apply'](_0x5c13c9,arguments);return _0x193cb6=null,_0xeaf757;}}}else _0x59f1d7[_0x2945d1(0xda)][_0x2945d1(0x344)](_0x2945d1(0x2d1));}:function(){};return _0xa4e700=![],_0x46603e;};}()),_0x3fa278=_0x51b3b6(this,function(){const _0x3fb335=_0x2096,_0x3d964e={'LDzHZ':function(_0x1703fd,_0x227b1c){return _0x1703fd!==_0x227b1c;},'wZlMP':'mBIXe','oBoLN':function(_0x453178,_0x17e1fb){return _0x453178(_0x17e1fb);},'CmXzc':function(_0x1237aa,_0x29f924){return _0x1237aa+_0x29f924;},'rXECK':function(_0x31b5cf,_0x1a3441){return _0x31b5cf+_0x1a3441;},'Bxpme':'return\x20(function()\x20','JLDXR':function(_0x5c2f77,_0x219ee5){return _0x5c2f77===_0x219ee5;},'FIpjb':_0x3fb335(0x3a7),'QuwtH':_0x3fb335(0x48e),'BTJGQ':_0x3fb335(0xd3),'priBD':_0x3fb335(0x491),'xHFFV':function(_0x5dea82){return _0x5dea82();},'jsnEX':_0x3fb335(0x127),'vcOWU':_0x3fb335(0x149),'uooFj':_0x3fb335(0x287),'QOAaM':_0x3fb335(0x209),'OPKGg':_0x3fb335(0x36e),'IhVlk':'trace','vaaCT':function(_0x36053e,_0x759e30){return _0x36053e<_0x759e30;},'QHpRK':_0x3fb335(0x3ed),'MYMlx':'HfvwT'},_0x28b5b7=function(){const _0x177688=_0x3fb335;if(_0x3d964e[_0x177688(0x37d)](_0x3d964e[_0x177688(0x19d)],_0x3d964e['wZlMP'])){if(_0x482cc4){const _0x38947a=_0x2b954f[_0x177688(0x2c9)](_0x289be1,arguments);return _0x12a7d3=null,_0x38947a;}}else{let _0x361544;try{_0x361544=_0x3d964e['oBoLN'](Function,_0x3d964e[_0x177688(0x33a)](_0x3d964e[_0x177688(0x39f)](_0x3d964e[_0x177688(0x24b)],_0x177688(0x109)),');'))();}catch(_0x2ed027){_0x361544=window;}return _0x361544;}},_0x2c1a50=_0x3d964e[_0x3fb335(0x4a6)](_0x28b5b7),_0x18710a=_0x2c1a50[_0x3fb335(0x36f)]=_0x2c1a50[_0x3fb335(0x36f)]||{},_0x4d83e1=[_0x3d964e[_0x3fb335(0x10a)],_0x3d964e[_0x3fb335(0x407)],_0x3fb335(0x2e0),_0x3d964e['uooFj'],_0x3d964e[_0x3fb335(0x3ca)],_0x3d964e[_0x3fb335(0x329)],_0x3d964e['IhVlk']];for(let _0x3e5b37=0x0;_0x3d964e['vaaCT'](_0x3e5b37,_0x4d83e1[_0x3fb335(0xdc)]);_0x3e5b37++){if(_0x3d964e[_0x3fb335(0x2af)]!==_0x3d964e[_0x3fb335(0x24d)]){const _0x9c96a9=_0x51b3b6[_0x3fb335(0xe1)]['prototype'][_0x3fb335(0x415)](_0x51b3b6),_0x1f3d94=_0x4d83e1[_0x3e5b37],_0x1448f4=_0x18710a[_0x1f3d94]||_0x9c96a9;_0x9c96a9[_0x3fb335(0x189)]=_0x51b3b6[_0x3fb335(0x415)](_0x51b3b6),_0x9c96a9['toString']=_0x1448f4[_0x3fb335(0x391)]['bind'](_0x1448f4),_0x18710a[_0x1f3d94]=_0x9c96a9;}else{const _0x56ba92=_0x4ea51b[_0x3fb335(0x226)][_0x83d4b7[_0x3fb335(0x2ae)]];_0x3d964e[_0x3fb335(0x477)](_0x56ba92['id'],_0x2a1819)?(_0x19e48b=_0x3d964e[_0x3fb335(0x22a)],_0x181e93=_0x3d964e[_0x3fb335(0x152)]):(_0x324a41=_0x3d964e[_0x3fb335(0x1ab)],_0x236657=_0x3d964e[_0x3fb335(0x2a6)]);}}});_0x3fa278();let questionsData=[{'text':_0x243729(0x47e),'choices':[{'id':0x1,'text':_0x243729(0x155)},{'id':0x2,'text':_0x243729(0x1bd)},{'id':0x3,'text':_0x243729(0x3cf)},{'id':0x4,'text':_0x243729(0x2e6)}],'correct_choice_id':0x1,'solution':_0x243729(0x21a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20is\x20a\x20prostacyclin\x20analog\x20that\x20can\x20be\x20added\x20to\x20the\x20treatment\x20regimen\x20of\x20a\x20patient\x20with\x20pulmonary\x20artery\x20hypertension?','choices':[{'id':0x1,'text':_0x243729(0x2fa)},{'id':0x2,'text':'Misoprostol'},{'id':0x3,'text':_0x243729(0x1cd)},{'id':0x4,'text':_0x243729(0x170)}],'correct_choice_id':0x4,'solution':_0x243729(0x128),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2045-year-old\x20woman\x20presents\x20with\x20complaints\x20of\x20swelling\x20of\x20both\x20feet\x20and\x20of\x20breathlessness\x20on\x20exertion.\x20After\x20evaluation,\x20she\x20was\x20diagnosed\x20with\x20congestive\x20cardiac\x20failure.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20contraindicated\x20in\x20this\x20patient?','choices':[{'id':0x1,'text':_0x243729(0x230)},{'id':0x2,'text':'Spironolactone'},{'id':0x3,'text':'Furosemide'},{'id':0x4,'text':_0x243729(0x15b)}],'correct_choice_id':0x1,'solution':'<p><strong>Mannitol</strong>\x20is\x20<strong>contraindicated</strong>\x20in\x20patients\x20with\x20cardiac\x20failure.</p>\x0a<p>Mannitol\x20is\x20an\x20<strong>osmotic</strong>\x20diuretic.\x20It\x20acts\x20by\x20extracting\x20water\x20from\x20the\x20intracellular\x20compartments,\x20which\x20results\x20in\x20the\x20<strong>expansion</strong>\x20of\x20the<strong>\x20extracellular\x20fluid</strong>.\x20This\x20results\x20in\x20<strong>volume\x20overload</strong>\x20and\x20frank\x20<strong>pulmonary\x20edema</strong>\x20in&nbsp;patients\x20with\x20cardiac\x20failure.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2023-year-old\x20hypothyroid\x20patient\x20taking\x20levothyroxine\x20regularly\x20has\x20now\x20become\x20pregnant.\x20What\x20would\x20your\x20advice\x20be\x20regarding\x20levothyroxine?','choices':[{'id':0x1,'text':'Switch\x20to\x20liothyronine\x20as\x20levothyroxine\x20is\x20teratogenic'},{'id':0x2,'text':_0x243729(0x44a)},{'id':0x3,'text':_0x243729(0xe6)},{'id':0x4,'text':_0x243729(0x3e9)}],'correct_choice_id':0x2,'solution':_0x243729(0x357),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x243),'choices':[{'id':0x1,'text':'Administration\x20of\x20nicotine\x20patches'},{'id':0x2,'text':_0x243729(0x1a8)},{'id':0x3,'text':_0x243729(0x28b)},{'id':0x4,'text':_0x243729(0x135)}],'correct_choice_id':0x3,'solution':_0x243729(0x2bf),'explanation_video':'','question_images':[],'explanation_images':[_0x243729(0x185)]},{'text':_0x243729(0xfe),'choices':[{'id':0x1,'text':'20\x20mg'},{'id':0x2,'text':'60\x20mg'},{'id':0x3,'text':_0x243729(0x1f8)},{'id':0x4,'text':_0x243729(0x120)}],'correct_choice_id':0x3,'solution':_0x243729(0x1a6),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1d9),'choices':[{'id':0x1,'text':_0x243729(0x1a9)},{'id':0x2,'text':_0x243729(0x3f7)},{'id':0x3,'text':_0x243729(0x3fb)},{'id':0x4,'text':_0x243729(0x36d)}],'correct_choice_id':0x2,'solution':'<p>All\x20strains\x20of&nbsp;<em><strong>Pseudomonas\x20aeruginosa</strong>\x20</em>are\x20<strong>resistant</strong>\x20to\x20the\x20action\x20of<strong>\x20tetracyclines</strong>.</p>\x0a<p>Tetracyclines\x20are\x20active\x20against\x20MRSA\x20and\x20MSSA.\x20Doxycycline\x20and\x20minocycline\x20can\x20be\x20used\x20in\x20cutaneous\x20MRSA\x20infections.</p>\x0a<p>Rickettsia\x20and\x20chlamydia\x20are\x20highly\x20susceptible\x20to\x20tetracyclines.&nbsp;Tetracyclines\x20are\x20considered\x20first\x20line\x20agents\x20for\x20<strong>chlamydial</strong>\x20<strong>infections</strong>\x20like\x20non-specific\x20urethritis/\x20endocervicitis\x20and\x20<strong>rickettsial\x20infections</strong>\x20like\x20typhus,\x20rocky\x20mountain\x20spotted\x20fever,\x20Q\x20fever.</p>\x0a<p>They\x20are\x20also\x20second-line\x20drugs\x20in\x20patients\x20with\x20syphilis\x20who\x20are\x20allergic\x20to\x20penicillin.</p>\x0a<p>Tetracyclines\x20are<strong>\x20bacteriostatic</strong>\x20drugs\x20which\x20are\x20more\x20active\x20against\x20gram-positive\x20than\x20gram-negative.\x20They\x20are\x20effective\x20against\x20spirochetes,\x20<em>Haemophilus\x20ducreyi,&nbsp;Vibrio\x20cholera,&nbsp;</em><em>Mycoplasma\x20pneumoniae.</em></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'An\x20infant\x20had\x20a\x20serum\x20bilirubin\x20level\x20of\x2033\x20mg/dL.\x20The\x20mother\x20might\x20have\x20taken\x20which\x20of\x20the\x20following\x20drugs\x20during\x20the\x20third\x20trimester\x20for\x20this\x20to\x20occur?','choices':[{'id':0x1,'text':'Ampicillin'},{'id':0x2,'text':_0x243729(0x1ca)},{'id':0x3,'text':'Azithromycin'},{'id':0x4,'text':_0x243729(0x271)}],'correct_choice_id':0x2,'solution':_0x243729(0x199),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x2c6),'choices':[{'id':0x1,'text':_0x243729(0x249)},{'id':0x2,'text':'Congestive\x20heart\x20failure'},{'id':0x3,'text':_0x243729(0xd0)},{'id':0x4,'text':'Atrial\x20fibrillation'}],'correct_choice_id':0x1,'solution':'<p><strong>Fenoldopam</strong>\x20is\x20primarily\x20indicated\x20in\x20the\x20management\x20of<strong>\x20hypertensive\x20emergencies</strong>.\x20It&nbsp;is\x20a\x20D<sub>1</sub>\x20agonist\x20at\x20peripheral\x20D1\x20receptors\x20and\x20acts\x20as\x20a\x20rapid-acting\x20vasodilator.</p>\x0a<p>Drugs\x20used\x20in\x20a\x20hypertensive\x20emergency\x20are:</p>\x0a<ul>\x0a<li>Nitroprusside</li>\x0a<li>Nicardipine</li>\x0a<li>Labetalol</li>\x0a<li>Hydralazine</li>\x0a<li>Esmolol</li>\x0a<li>Nitroglycerine</li>\x0a<li>Phentolamine</li>\x0a<li>Fenoldopam</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3b9),'choices':[{'id':0x1,'text':'Binds\x20to\x20the\x20receptor\x20and\x20causes\x20maximum\x20action'},{'id':0x2,'text':'Binds\x20to\x20the\x20receptor\x20and\x20causes\x20opposite\x20action\x20to\x20that\x20of\x20agonist'},{'id':0x3,'text':_0x243729(0x133)},{'id':0x4,'text':_0x243729(0x29c)}],'correct_choice_id':0x2,'solution':_0x243729(0x270),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3c3),'choices':[{'id':0x1,'text':'CCR5'},{'id':0x2,'text':_0x243729(0x279)},{'id':0x3,'text':'CD4'},{'id':0x4,'text':_0x243729(0x3b0)}],'correct_choice_id':0x1,'solution':_0x243729(0x26f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1a5),'choices':[{'id':0x1,'text':_0x243729(0x1eb)},{'id':0x2,'text':_0x243729(0x3bb)},{'id':0x3,'text':_0x243729(0x33d)},{'id':0x4,'text':'Propafenone'}],'correct_choice_id':0x1,'solution':_0x243729(0xf0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20diagnosed\x20with\x20wet\x20age-related\x20macular\x20degeneration\x20is\x20being\x20administered\x20ranibizumab\x20intravitreally.\x20All\x20of\x20the\x20following\x20are\x20known\x20side\x20effects\x20of\x20the\x20drug,\x20except\x20_______.','choices':[{'id':0x1,'text':'Eye\x20pain'},{'id':0x2,'text':_0x243729(0x1aa)},{'id':0x3,'text':_0x243729(0x3ac)},{'id':0x4,'text':_0x243729(0x21d)}],'correct_choice_id':0x2,'solution':_0x243729(0x238),'explanation_video':'','question_images':[],'explanation_images':[_0x243729(0x254)]},{'text':'The\x20chest\x20x-ray\x20of\x20a\x20patient\x20who\x20presented\x20with\x20fever\x20and\x20cough\x20with\x20expectoration\x20is\x20shown\x20below.\x20Following\x20discussion,\x20a\x20lincosamide\x20antibiotic\x20is\x20prescribed.\x20Which\x20of\x20the\x20following\x20will\x20you\x20choose?','choices':[{'id':0x1,'text':'Telithromycin'},{'id':0x2,'text':_0x243729(0x267)},{'id':0x3,'text':_0x243729(0x294)},{'id':0x4,'text':_0x243729(0x1f9)}],'correct_choice_id':0x3,'solution':_0x243729(0x2a8),'explanation_video':'','question_images':[_0x243729(0x450)],'explanation_images':[]},{'text':_0x243729(0x178),'choices':[{'id':0x1,'text':_0x243729(0x257)},{'id':0x2,'text':_0x243729(0x3a6)},{'id':0x3,'text':_0x243729(0x171)},{'id':0x4,'text':_0x243729(0x32b)}],'correct_choice_id':0x2,'solution':'<p><strong>Polymyxins</strong>\x20are\x20<strong>effective</strong>\x20against\x20<strong>gram-negative\x20bacteria.</strong></p>\x0a<p>Polymyxin\x20group\x20of\x20antibiotics\x20includes\x20<strong>polymyxin\x20B</strong>\x20and\x20<strong>colistin</strong>\x20which\x20have\x20their\x20antimicrobial\x20spectrum\x20limited\x20primarily\x20to<strong>\x20gram-negative</strong>\x20<strong>aerobic\x20bacteria</strong>.\x20They\x20interact\x20with\x20the\x20phospholipid\x20of\x20the\x20bacterial\x20cell\x20membranes\x20and\x20disrupt\x20it.</p>\x0a<p>Polymyxins\x20are\x20used\x20in\x20various\x20<strong>topical</strong>\x20formulations.\x20Parenteral\x20formulations\x20are\x20used\x20only\x20in\x20serious\x20systemic\x20infections\x20that\x20are\x20resistant\x20to\x20other\x20antimicrobials.<strong>\x20Nephrotoxicity</strong>\x20limits\x20widespread\x20systemic\x20use.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3b5),'choices':[{'id':0x1,'text':_0x243729(0x374)},{'id':0x2,'text':_0x243729(0x284)},{'id':0x3,'text':_0x243729(0x4a8)},{'id':0x4,'text':'GPCR\x20inhibition'}],'correct_choice_id':0x3,'solution':_0x243729(0x16f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20type\x20IIa\x20and\x20IIb\x20hyperlipoproteinemias?','choices':[{'id':0x1,'text':_0x243729(0x14a)},{'id':0x2,'text':_0x243729(0x1c6)},{'id':0x3,'text':'Niacin'},{'id':0x4,'text':'Bile\x20acid\x20sequestrants'}],'correct_choice_id':0x1,'solution':_0x243729(0x1c7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x13e),'choices':[{'id':0x1,'text':_0x243729(0x3f9)},{'id':0x2,'text':_0x243729(0x2f9)},{'id':0x3,'text':_0x243729(0x204)},{'id':0x4,'text':_0x243729(0x42b)}],'correct_choice_id':0x2,'solution':_0x243729(0x10e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3ab),'choices':[{'id':0x1,'text':'Chlorothiazide'},{'id':0x2,'text':'Acetazolamide'},{'id':0x3,'text':'Spironolactone'},{'id':0x4,'text':_0x243729(0x230)}],'correct_choice_id':0x3,'solution':_0x243729(0x2de),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x265),'choices':[{'id':0x1,'text':_0x243729(0x3d6)},{'id':0x2,'text':_0x243729(0x386)},{'id':0x3,'text':_0x243729(0x428)},{'id':0x4,'text':_0x243729(0x406)}],'correct_choice_id':0x1,'solution':_0x243729(0x3e0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x176),'choices':[{'id':0x1,'text':_0x243729(0x38b)},{'id':0x2,'text':_0x243729(0x17a)},{'id':0x3,'text':_0x243729(0x302)},{'id':0x4,'text':_0x243729(0x263)}],'correct_choice_id':0x3,'solution':_0x243729(0x107),'explanation_video':'','question_images':[_0x243729(0x2ba)],'explanation_images':[]},{'text':_0x243729(0x1ce),'choices':[{'id':0x1,'text':'Acarbose'},{'id':0x2,'text':'Insulin'},{'id':0x3,'text':_0x243729(0x2ff)},{'id':0x4,'text':_0x243729(0x49e)}],'correct_choice_id':0x1,'solution':_0x243729(0x3a8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x485),'choices':[{'id':0x1,'text':_0x243729(0x353)},{'id':0x2,'text':_0x243729(0x18e)},{'id':0x3,'text':_0x243729(0x30c)},{'id':0x4,'text':_0x243729(0x1b2)}],'correct_choice_id':0x2,'solution':'<p\x20style=\x22text-align:\x20left;\x22><strong>Heteroresistance</strong>\x20occurs\x20when\x20a\x20<strong>subset</strong>\x20of\x20the\x20total\x20microbial\x20population\x20is\x20<strong>resistant</strong>,\x20despite\x20the\x20<strong>total\x20microbial\x20population</strong>\x20being\x20<strong>susceptible</strong>\x20on\x20testing.\x20The\x20resistant\x20subpopulation\x20is\x20usually\x20well\x20below\x20the\x20assay-detection\x20limits.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Heteroresistant\x20<em>Staphylococc</em>i\x20and\x20<em>M.\x20tuberculosis</em>\x20have\x20led\x20to&nbsp;<strong>therapeutic\x20failures</strong>\x20and\x20<strong>mortality</strong>.\x20<em>C.\x20albicans</em>\x20and\x20<em>C.\x20neoformans\x20with\x20</em>heteroresistance&nbsp;to\x20fluconazole\x20have\x20resulted\x20in\x20increased\x20treatment\x20failures.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Note:&nbsp;For\x20viruses,\x20the\x20resistant\x20viral\x20species\x20occurring\x20due\x20to\x20the\x20above\x20phenomenon\x20is\x20termed\x20as\x20\x27quasi-species\x27.&nbsp;Quasi-species\x20resistant\x20to\x20antiretroviral\x20agents\x20have\x20resulted\x20in\x20the\x20failure\x20of\x20antiretroviral\x20therapy.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x116),'choices':[{'id':0x1,'text':'Cyclophosphamide'},{'id':0x2,'text':'Cisplatin'},{'id':0x3,'text':_0x243729(0x2b3)},{'id':0x4,'text':_0x243729(0x2b4)}],'correct_choice_id':0x1,'solution':_0x243729(0x492),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1b9),'choices':[{'id':0x1,'text':_0x243729(0x387)},{'id':0x2,'text':_0x243729(0x46d)},{'id':0x3,'text':_0x243729(0x4a1)},{'id':0x4,'text':_0x243729(0x1ac)}],'correct_choice_id':0x3,'solution':_0x243729(0x1e3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20culture\x20and\x20sensitivity\x20report\x20from\x20a\x20wound\x20swab\x20is\x20positive\x20for\x20penicillinase-producing\x20Staphylococcus\x20aureus.\x20Which\x20of\x20the\x20following\x20antimicrobials\x20can\x20be\x20administered?','choices':[{'id':0x1,'text':'Amoxicillin'},{'id':0x2,'text':_0x243729(0x1bc)},{'id':0x3,'text':'Piperacillin'},{'id':0x4,'text':'Cloxacillin'}],'correct_choice_id':0x4,'solution':'<p>The\x20drug\x20that\x20can\x20be\x20used\x20here\x20is<strong>\x20cloxacillin</strong>\x20since\x20it\x20is\x20not\x20penicillinase\x20susceptible.\x20It&nbsp;is&nbsp;<strong>penicillinase-resistant\x20penicillin</strong>.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201029\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Bacteria\x20can\x20inactivate\x20&beta;-lactam\x20antibiotics\x20by\x20the\x20action\x20of\x20the\x20<strong>&beta;-lactamase\x20enzyme</strong>.\x20The\x20&beta;-lactamases\x20enzyme\x20activity\x20can\x20be\x20narrow\x20or\x20broad\x20spectrum.\x20In\x20general,\x20gram-positive\x20bacteria\x20produce\x20and\x20secrete\x20a\x20large\x20amount\x20of\x20&beta;-lactamase.\x20Most\x20of\x20these\x20enzymes\x20are\x20penicillinases.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Penicillinase-resistant\x20penicillins\x20are:</p>\x0a<ul>\x0a<li>Cloxacillin</li>\x0a<li>Dicloxacillin</li>\x0a<li>Flucloxacillin</li>\x0a<li>Methicillin</li>\x0a<li>Nafcillin</li>\x0a</ul>\x0a<p>Option\x20B:\x20Penicillin\x20G\x20encompasses\x20the\x20natural\x20preparations\x20and\x20salts\x20of\x20penicillin.\x20They\x20have\x20a\x20narrow\x20spectrum\x20and\x20are\x20susceptible\x20to\x20penicillinase.</p>\x0a<p>Options\x20A\x20and\x20C:\x20Amoxicillin\x20and\x20piperacillin\x20are\x20extended-spectrum\x20penicillins\x20but\x20are\x20susceptible\x20to\x20penicillinase.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x2f2),'choices':[{'id':0x1,'text':_0x243729(0x371)},{'id':0x2,'text':_0x243729(0x18a)},{'id':0x3,'text':_0x243729(0x39b)},{'id':0x4,'text':_0x243729(0x19f)}],'correct_choice_id':0x2,'solution':_0x243729(0x42d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x399),'choices':[{'id':0x1,'text':_0x243729(0x23c)},{'id':0x2,'text':'It\x20interferes\x20with\x20the\x20action\x20of\x20choline\x20transferase'},{'id':0x3,'text':_0x243729(0x2c4)},{'id':0x4,'text':'It\x20interferes\x20with\x20the\x20action\x20of\x20acetylcholine\x20esterase'}],'correct_choice_id':0x4,'solution':_0x243729(0x29d),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/17de91627d8047d984a749fcc6eac33fx1280x2234.JPEG']},{'text':_0x243729(0x223),'choices':[{'id':0x1,'text':_0x243729(0x27f)},{'id':0x2,'text':_0x243729(0x38a)},{'id':0x3,'text':'They\x20have\x20\x20increased\x20baroreceptor\x20sensitivity'},{'id':0x4,'text':_0x243729(0x316)}],'correct_choice_id':0x3,'solution':_0x243729(0x14f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x18d),'choices':[{'id':0x1,'text':'Heparin\x20should\x20be\x20discontinued\x20immediately'},{'id':0x2,'text':_0x243729(0x43f)},{'id':0x3,'text':_0x243729(0x412)},{'id':0x4,'text':_0x243729(0x2f6)}],'correct_choice_id':0x4,'solution':_0x243729(0x367),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20who\x20is\x20on\x20statin\x20therapy\x20asks\x20about\x20a\x20new\x20drug\x20called\x20evolocumab\x20that\x20his\x20friend\x20is\x20taking\x20for\x20hyperlipidemia.\x20What\x20is\x20the\x20route\x20of\x20administration\x20of\x20this\x20drug?','choices':[{'id':0x1,'text':_0x243729(0x122)},{'id':0x2,'text':_0x243729(0x13d)},{'id':0x3,'text':_0x243729(0x3f5)},{'id':0x4,'text':_0x243729(0x113)}],'correct_choice_id':0x3,'solution':'<p\x20style=\x22text-align:\x20left;\x22><strong>Evolocumab\x20</strong>is\x20a\x20<strong>PCSK-9\x20inhibitor\x20</strong>that\x20is&nbsp;administered\x20as<strong>&nbsp;</strong>a\x20<strong>subcutaneous</strong>\x20injection.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>PCSK-9\x20is\x20a<strong>&nbsp;</strong>protease\x20that\x20binds\x20to\x20the\x20LDL\x20receptors\x20on\x20the\x20surface\x20of\x20hepatocyte\x20and\x20enhances\x20the\x20lysosomal\x20degradation\x20of\x20the\x20LDL\x20receptor.\x20This\x20results\x20in\x20higher\x20plasma\x20LDL\x20levels.\x20inhibition\x20of\x20PCSK-9\x20results\x20in\x20a\x20<strong>reduction\x20of\x20plasma\x20LDL</strong>\x20levels.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Two\x20approved\x20PCSK-9\x20inhibitors\x20are\x20alirocumab\x20and\x20evolocumab.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20true\x20about\x20pegylated-filgrastim?','choices':[{'id':0x1,'text':_0x243729(0x43a)},{'id':0x2,'text':'Added\x20advantage\x20is\x20that\x20it\x20can\x20be\x20taken\x20orally'},{'id':0x3,'text':'It\x20should\x20not\x20be\x20administered\x20in\x20sickle\x20cell\x20patients'},{'id':0x4,'text':_0x243729(0x1e2)}],'correct_choice_id':0x3,'solution':_0x243729(0x247),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x38e),'choices':[{'id':0x1,'text':_0x243729(0x488)},{'id':0x2,'text':_0x243729(0x1c2)},{'id':0x3,'text':_0x243729(0x15e)},{'id':0x4,'text':'Medial\x20part\x20of\x20thigh'}],'correct_choice_id':0x4,'solution':_0x243729(0x41c),'explanation_video':'','question_images':[],'explanation_images':[_0x243729(0x210)]},{'text':_0x243729(0x360),'choices':[{'id':0x1,'text':_0x243729(0x30f)},{'id':0x2,'text':_0x243729(0x23d)},{'id':0x3,'text':'Prilocaine'},{'id':0x4,'text':_0x243729(0x37f)}],'correct_choice_id':0x3,'solution':_0x243729(0xed),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x261),'choices':[{'id':0x1,'text':_0x243729(0x27a)},{'id':0x2,'text':_0x243729(0xfa)},{'id':0x3,'text':_0x243729(0x27b)},{'id':0x4,'text':_0x243729(0x2ee)}],'correct_choice_id':0x2,'solution':_0x243729(0xf5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20pregnant\x20woman\x20with\x20hypertension,\x20on\x20treatment\x20with\x20methyldopa,\x20comes\x20for\x20routine\x20evaluation.\x20She\x20is\x20found\x20to\x20have\x20a\x20positive\x20Coombs\x20test\x20but\x20is\x20asymptomatic.\x20What\x20is\x20the\x20next\x20course\x20of\x20action\x20for\x20this\x20patient?','choices':[{'id':0x1,'text':_0x243729(0x3db)},{'id':0x2,'text':_0x243729(0x398)},{'id':0x3,'text':_0x243729(0x132)},{'id':0x4,'text':_0x243729(0x2e2)}],'correct_choice_id':0x3,'solution':_0x243729(0xe4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x31f),'choices':[{'id':0x1,'text':_0x243729(0x197)},{'id':0x2,'text':_0x243729(0x1f3)},{'id':0x3,'text':_0x243729(0x236)},{'id':0x4,'text':_0x243729(0x1f1)}],'correct_choice_id':0x3,'solution':_0x243729(0x1fd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20organizations\x20regulates\x20the\x20clinical\x20trials\x20and\x20approval\x20of\x20investigational\x20new\x20drugs\x20in\x20India?','choices':[{'id':0x1,'text':'CPCSEA'},{'id':0x2,'text':'CDSCO'},{'id':0x3,'text':_0x243729(0x3e7)},{'id':0x4,'text':_0x243729(0xd4)}],'correct_choice_id':0x2,'solution':_0x243729(0x2b0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x2e4),'choices':[{'id':0x1,'text':_0x243729(0x227)},{'id':0x2,'text':_0x243729(0x232)},{'id':0x3,'text':_0x243729(0x45a)},{'id':0x4,'text':_0x243729(0x148)}],'correct_choice_id':0x2,'solution':_0x243729(0x4a7),'explanation_video':'','question_images':[_0x243729(0x459)],'explanation_images':[]},{'text':_0x243729(0x1a7),'choices':[{'id':0x1,'text':_0x243729(0x43d)},{'id':0x2,'text':_0x243729(0x44d)},{'id':0x3,'text':_0x243729(0x430)},{'id':0x4,'text':'Vorapaxar'}],'correct_choice_id':0x1,'solution':_0x243729(0x235),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1b6),'choices':[{'id':0x1,'text':_0x243729(0x33e)},{'id':0x2,'text':_0x243729(0xce)},{'id':0x3,'text':'It\x20is\x20a\x20polyclonal\x20antibody'},{'id':0x4,'text':'It\x20is\x20a\x20monoclonal\x20antibody\x20containing\x20only\x20human\x20component'}],'correct_choice_id':0x2,'solution':_0x243729(0x472),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x2ed),'choices':[{'id':0x1,'text':'Artesunate'},{'id':0x2,'text':_0x243729(0x1be)},{'id':0x3,'text':_0x243729(0x3ea)},{'id':0x4,'text':_0x243729(0x271)}],'correct_choice_id':0x3,'solution':_0x243729(0x20b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1ea),'choices':[{'id':0x1,'text':'Giant\x20cell\x20arteritis'},{'id':0x2,'text':_0x243729(0x3c8)},{'id':0x3,'text':_0x243729(0x2c1)},{'id':0x4,'text':_0x243729(0x12f)}],'correct_choice_id':0x3,'solution':_0x243729(0x2f0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20colchicine?','choices':[{'id':0x1,'text':_0x243729(0x1c8)},{'id':0x2,'text':_0x243729(0x268)},{'id':0x3,'text':'Inhibits\x20xanthine\x20oxidase\x20enzyme'},{'id':0x4,'text':_0x243729(0x111)}],'correct_choice_id':0x4,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>Colchicine\x20acts\x20by\x20binding\x20to\x20tubulin\x20and\x20inhibits\x20granulocyte\x20migration.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Colchicine\x20produces\x20its\x20anti-inflammatory\x20effects\x20by\x20binding\x20to\x20the\x20intracellular\x20protein\x20tubulin.\x20This\x20<strong>prevents</strong>\x20the&nbsp;<strong>polymerization\x20of\x20tubulin\x20</strong>into\x20microtubules&nbsp;which\x20is\x20necessary\x20for&nbsp;leukocyte\x20migration\x20and\x20phagocytosis.\x20Inhibition\x20of\x20microtubule\x20formation\x20prevents\x20granulocyte\x20migration\x20and\x20also\x20<strong>arrests\x20cell\x20division\x20at\x20G<sub>1&nbsp;</sub></strong>phase.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x168),'choices':[{'id':0x1,'text':_0x243729(0x35f)},{'id':0x2,'text':'Mexiletine'},{'id':0x3,'text':_0x243729(0x34e)},{'id':0x4,'text':_0x243729(0x2d2)}],'correct_choice_id':0x3,'solution':'<p>The\x20clinical\x20scenario\x20and\x20the\x20ECG\x20findings\x20are\x20suggestive\x20of&nbsp;<strong>paroxysmal\x20supraventricular\x20tachycardia</strong>\x20(PSVT).\x20<strong>Verapamil</strong>\x20and\x20<strong>diltiazem</strong>\x20are\x20used\x20in\x20both\x20<strong>acute\x20treatment</strong>\x20and\x20<strong>prophylaxis</strong>\x20of\x20PSVT.</p>\x0a<p>Their\x20mechanism\x20of\x20action\x20is\x20by\x20<strong>slowing\x20SA\x20node\x20</strong>automaticity\x20and<strong>\x20AV\x20nodal\x20conduction\x20velocity</strong>.\x20Additionally,\x20they\x20also\x20decrease\x20cardiac\x20contractility\x20and\x20reduce\x20blood\x20pressure.</p>\x0a<p>Dihydropyridines\x20like\x20nifedipine\x20and\x20amlodipine\x20do\x20not\x20have\x20any\x20antiarrhythmic\x20property.</p>\x0a<div\x20class=\x22O0\x22>Drugs\x20used\x20for\x20<strong>supraventricular</strong>\x20arrhythmias\x20are:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Adenosine</li>\x0a<li\x20class=\x22O1\x22>Verapamil</li>\x0a<li\x20class=\x22O1\x22>Diltiazem</li>\x0a<li\x20class=\x22O1\x22>Digoxin</li>\x0a</ul>\x0a<div\x20class=\x22O1\x22>Drugs\x20used\x20for\x20<strong>ventricular</strong>\x20arrhythmias\x20are:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Lidocaine&nbsp;</li>\x0a<li\x20class=\x22O1\x22>Mexiletine</li>\x0a</ul>\x0a<div\x20class=\x22O1\x22>Drugs\x20used\x20in\x20<strong>both</strong>\x20conditions\x20are:</div>\x0a<ul>\x0a<li\x20class=\x22O1\x22>Amiodarone</li>\x0a<li\x20class=\x22O1\x22>Beta-blockers</li>\x0a<li\x20class=\x22O1\x22>Class\x201A\x20/\x201C\x20antiarrhythmics</li>\x0a</ul>','explanation_video':'','question_images':[_0x243729(0x300)],'explanation_images':[_0x243729(0xf1)]},{'text':_0x243729(0x465),'choices':[{'id':0x1,'text':_0x243729(0x1fb)},{'id':0x2,'text':_0x243729(0xd7)},{'id':0x3,'text':_0x243729(0x43c)},{'id':0x4,'text':_0x243729(0x45d)}],'correct_choice_id':0x2,'solution':'<p><strong>Methadone</strong>&nbsp;is\x20used\x20as\x20a\x20substitute\x20drug\x20for\x20the\x20<strong>maintenance</strong>&nbsp;therapy\x20of\x20opioid\x20(heroin)\x20dependence.\x20This\x20is\x20because\x20of\x20its\x20<strong>good\x20oral\x20bioavailability</strong>\x20and\x20<strong>long\x20half-life</strong>.&nbsp;</p>\x0a<p>Methadone\x20is\x20substituted\x20for\x20opioids\x20during\x20detoxification<strong>\x20to\x20avoid\x20withdrawal</strong>\x20symptoms.&nbsp;Once\x20stabilized,\x20the\x20dose\x20is\x20gradually\x20reduced\x20and\x20the\x20drug\x20is\x20stopped\x20slowly\x20over\x20days.&nbsp;</p>\x0a<p>Due\x20to\x20its\x20long\x20half-life\x20and\x20accumulation\x20in\x20tissues,\x20discontinuing\x20the\x20drug\x20still\x20results\x20in\x20low\x20concentrations\x20of\x20the\x20drug\x20in\x20plasma\x20resulting\x20in\x20protracted\x20withdrawal\x20symptoms.</p>\x0a<p>Maintainance\x20therapy\x20for\x20opioid\x20dependence:</p>\x0a<ul>\x0a<li>Long-acting\x20opioid\x20agonist\x20-\x20a\x20safer\x20substitute\x20like\x20<strong>methadone</strong>\x20is\x20given\x20in\x20a\x20supervised\x20manner\x20to\x20<strong>prevent&nbsp;withdrawal</strong>\x20symptoms</li>\x0a<li>Partial\x20agonist\x20-&nbsp;<strong>buprenorphine</strong>\x20can\x20also\x20be\x20used</li>\x0a<li><strong>Clonidine,\x20lofexidine</strong>\x20-\x20alpha-2\x20agonists\x20act\x20as\x20sympatholytic\x20and\x20<strong>reduce\x20the\x20withdrawal</strong>\x20symptoms</li>\x0a<li><strong>LAAM</strong>(L-Alpha-Acetyl-Methadol)\x20-\x20opioid\x20agonist\x20which\x20<strong>reduces\x20craving</strong></li>\x0a<li><strong>Naltrexone\x20-</strong>&nbsp;is\x20an\x20opioid\x20antagonist\x20used\x20in&nbsp;maintenance\x20therapy\x20to&nbsp;<strong>prevent\x20relapses</strong></li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x10b),'choices':[{'id':0x1,'text':_0x243729(0x19e)},{'id':0x2,'text':'Incidence\x20of\x20cheese\x20reaction\x20is\x20minimal'},{'id':0x3,'text':_0x243729(0x392)},{'id':0x4,'text':_0x243729(0x3f8)}],'correct_choice_id':0x1,'solution':_0x243729(0x2dd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x457),'choices':[{'id':0x1,'text':'Sodium\x20bicarbonate'},{'id':0x2,'text':_0x243729(0x141)},{'id':0x3,'text':'Calcium\x20bicarbonate'},{'id':0x4,'text':_0x243729(0x478)}],'correct_choice_id':0x2,'solution':'<p><strong>Magnesium\x20salts</strong>\x20have\x20a\x20<strong>laxative</strong>\x20property\x20and\x20can\x20cause\x20<strong>diarrhoea</strong>.</p>\x0a<p><strong>Aluminium\x20salts</strong>\x20can\x20cause\x20<strong>constipation</strong>\x20by\x20relaxing\x20smooth\x20muscles.&nbsp;</p>\x0a<p>The<strong>\x20combination</strong>\x20of\x20aluminium\x20and\x20magnesium\x20salts\x20can\x20<strong>neutralize\x20</strong>each\x20other&rsquo;s\x20action,\x20thus\x20the\x20combination\x20is\x20preferred.</p>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x12e),'choices':[{'id':0x1,'text':_0x243729(0x328)},{'id':0x2,'text':'Ciprofloxacin'},{'id':0x3,'text':_0x243729(0x290)},{'id':0x4,'text':_0x243729(0x3f3)}],'correct_choice_id':0x3,'solution':_0x243729(0x244),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1b3),'choices':[{'id':0x1,'text':_0x243729(0xf9)},{'id':0x2,'text':_0x243729(0x215)},{'id':0x3,'text':_0x243729(0x2dc)},{'id':0x4,'text':'Ribosome'}],'correct_choice_id':0x1,'solution':_0x243729(0x411),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x383),'choices':[{'id':0x1,'text':_0x243729(0x1a4)},{'id':0x2,'text':_0x243729(0x220)},{'id':0x3,'text':_0x243729(0x2eb)},{'id':0x4,'text':_0x243729(0x34e)}],'correct_choice_id':0x2,'solution':'<p>Amongst\x20the\x20given\x20calcium\x20channel\x20blockers,<strong>\x20nifedipine\x20</strong>is\x20more\x20likely\x20to<strong>\x20precipitate\x20angina.</strong></p>\x0a<p><strong>Nifedipine\x20</strong>is\x20a\x20dihydropyridine\x20calcium\x20channel\x20blocker\x20having\x20a<strong>\x20rapid\x20onset\x20</strong>and<strong>\x20short\x20duration\x20of\x20action.</strong>&nbsp;It\x20results\x20in\x20an\x20abrupt\x20decrease\x20in\x20blood\x20pressure\x20resulting\x20in\x20<strong>reflex\x20tachycardia</strong>.\x20Increased\x20contractility\x20leads\x20to\x20an\x20<strong>increase\x20in\x20O<sub>2</sub>\x20demand</strong>\x20which\x20may\x20precipitate\x20angina.</p>\x0a<p>Option\x20A:\x20Amlodipine\x20and\x20extended-release\x20preparations\x20of\x20nifedipine\x20do\x20not\x20cause\x20a\x20steep\x20fall\x20in\x20blood\x20pressure\x20and\x20subsequent\x20activation\x20of\x20sympathetic\x20tone.\x20Therefore,\x20they\x20are\x20less\x20likely\x20to\x20precipitate\x20angina.&nbsp;</p>\x0a<p>Options\x20C\x20and\x20D:\x20Verapamil\x20and\x20diltiazem\x20have\x20relatively\x20less\x20action\x20on\x20peripheral\x20vascular\x20smooth\x20muscles.\x20They\x20have\x20a\x20direct\x20inhibitory\x20effect\x20on\x20cardiac\x20tissue\x20causing\x20<strong>negative\x20ionotropic\x20effect</strong>\x20(verapamil\x20&gt;\x20diltiazem).</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'An\x20elderly\x20patient\x20who\x20was\x20taken\x20up\x20for\x20an\x20emergency\x20laparotomy\x20showed\x20prolonged\x20respiratory\x20depression\x20which\x20did\x20not\x20resolve\x20with\x20neostigmine.\x20\x20On\x20inquiry,\x20the\x20attendant\x20confirmed\x20that\x20the\x20patient\x20was\x20on\x20aminoglycoside\x20therapy.\x20Which\x20of\x20the\x20following\x20is\x20least\x20likely\x20to\x20cause\x20this\x20effect?','choices':[{'id':0x1,'text':'Amikacin'},{'id':0x2,'text':'Kanamycin'},{'id':0x3,'text':_0x243729(0x144)},{'id':0x4,'text':_0x243729(0x389)}],'correct_choice_id':0x4,'solution':_0x243729(0x460),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x2ac),'choices':[{'id':0x1,'text':'Epothilones'},{'id':0x2,'text':_0x243729(0x25e)},{'id':0x3,'text':'Vinca\x20alkaloids'},{'id':0x4,'text':'Taxanes'}],'correct_choice_id':0x3,'solution':_0x243729(0xdd),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/8cfcd125db234466ab771d63e1ead398.JPEG'],'explanation_images':[]},{'text':'A\x20study\x20was\x20conducted\x20to\x20genotype\x20NAT2\x20gene\x20polymorphisms\x20in\x20patients\x20receiving\x20ATT.\x20Among\x20the\x20300\x20patients\x20genotyped,\x20200\x20were\x20slow\x20acetylators\x20(group\x20A),\x2070\x20were\x20intermediate\x20(group\x20B)\x20and\x2030\x20were\x20fast\x20acetylators\x20(group\x20C).\x20Patients\x20in\x20group\x20A\x20are\x20prone\x20to\x20develop\x20which\x20of\x20the\x20following?','choices':[{'id':0x1,'text':'Failure\x20of\x20therapy'},{'id':0x2,'text':'Peripheral\x20neuropathy'},{'id':0x3,'text':_0x243729(0x427)},{'id':0x4,'text':_0x243729(0x33f)}],'correct_choice_id':0x2,'solution':'<p><strong>Isoniazid,&nbsp;</strong>a\x20key\x20agent\x20in\x20the\x20ATT,<strong>&nbsp;</strong>is\x20metabolized\x20primarily\x20through<strong>\x20N-acetylation</strong>\x20by\x20the\x20genetically\x20polymorphic\x20N-acetyltransferase-2\x20<strong>(NAT2)\x20</strong>enzyme.\x20<strong>Slow\x20acetylators</strong>&nbsp;(group\x20A)\x20of\x20isoniazid\x20are\x20prone\x20to\x20develop\x20<strong>peripheral\x20neuropathy</strong>.</p>\x0a<p\x20class=\x22p1\x22>The\x20rate\x20of\x20metabolism\x20of\x20isoniazid\x20is\x20determined\x20by\x20the\x20genetic\x20polymorphism\x20of\x20NAT2\x20enzyme\x20and&nbsp;classified\x20broadly\x20into\x20two\x20groups\x20-&nbsp;<strong>slow\x20</strong>and<strong>\x20fast\x20acetylators</strong>.</p>\x0a<p\x20class=\x22p1\x22>In&nbsp;<strong>slow\x20acetylators,\x20</strong>the\x20drug\x20<strong>accumulates\x20</strong>due\x20to\x20slow\x20metabolism\x20resulting\x20in<strong>&nbsp;</strong>an\x20increased\x20risk\x20of<strong>&nbsp;side\x20effects,\x20</strong>and\x20hence\x20they\x20should\x20undergo\x20periodic\x20monitoring.\x20Peripheral\x20neuropathy\x20is\x20a\x20more\x20frequent\x20side\x20effect\x20of\x20INH\x20when\x20compared\x20to\x20hepatotoxicity.</p>\x0a<p\x20class=\x22p1\x22><strong>Fast\x20acetylators</strong>&nbsp;metabolize\x20the\x20drug\x20rapidly\x20and\x20<strong>show\x20less\x20response\x20</strong>to\x20standard\x20doses\x20and\x20the\x20therapy\x20may\x20be\x20less\x20effective.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20post-menopausal\x20lady\x20who\x20is\x20taking\x20estrogen\x20as\x20part\x20of\x20her\x20hormone\x20replacement\x20therapy\x20reads\x20about\x20raloxifene\x20on\x20the\x20internet\x20and\x20wants\x20to\x20change\x20her\x20current\x20treatment.\x20Which\x20of\x20the\x20following\x20is\x20not\x20an\x20advantage\x20of\x20using\x20raloxifene\x20over\x20estrogen?','choices':[{'id':0x1,'text':'Reduces\x20fracture\x20rates'},{'id':0x2,'text':_0x243729(0x47c)},{'id':0x3,'text':_0x243729(0x16a)},{'id':0x4,'text':_0x243729(0x345)}],'correct_choice_id':0x3,'solution':_0x243729(0x45b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x378),'choices':[{'id':0x1,'text':_0x243729(0x486)},{'id':0x2,'text':_0x243729(0x3ae)},{'id':0x3,'text':'Switch\x20to\x20sodium\x20valproate'},{'id':0x4,'text':_0x243729(0x1d4)}],'correct_choice_id':0x3,'solution':_0x243729(0x419),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x467),'choices':[{'id':0x1,'text':_0x243729(0x495)},{'id':0x2,'text':_0x243729(0x2a2)},{'id':0x3,'text':_0x243729(0xe8)},{'id':0x4,'text':_0x243729(0x490)}],'correct_choice_id':0x4,'solution':_0x243729(0x368),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1a0),'choices':[{'id':0x1,'text':'Actinomycin'},{'id':0x2,'text':'Mitomycin'},{'id':0x3,'text':_0x243729(0x3df)},{'id':0x4,'text':_0x243729(0x3b4)}],'correct_choice_id':0x2,'solution':_0x243729(0x3e4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presents\x20with\x20watery\x20diarrhea,\x20fever\x20and\x20abdominal\x20pain.\x20Investigations\x20reveal\x20a\x20WBC\x20count\x20of\x2016,000\x20cells/microL.\x20The\x20patient\x20has\x20been\x20on\x20treatment\x20with\x20ampicillin\x20for\x20a\x20few\x20days.\x20Which\x20of\x20the\x20following\x20antibiotics\x20is\x20approved\x20for\x20use\x20in\x20this\x20condition?','choices':[{'id':0x1,'text':'Azithromycin'},{'id':0x2,'text':_0x243729(0x347)},{'id':0x3,'text':_0x243729(0x2a3)},{'id':0x4,'text':_0x243729(0x294)}],'correct_choice_id':0x3,'solution':_0x243729(0x291),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x156),'choices':[{'id':0x1,'text':_0x243729(0x2c5)},{'id':0x2,'text':_0x243729(0x1ad)},{'id':0x3,'text':_0x243729(0x163)},{'id':0x4,'text':_0x243729(0x126)}],'correct_choice_id':0x3,'solution':_0x243729(0x15a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x241),'choices':[{'id':0x1,'text':'Cefuroxime'},{'id':0x2,'text':_0x243729(0x150)},{'id':0x3,'text':_0x243729(0x108)},{'id':0x4,'text':_0x243729(0x224)}],'correct_choice_id':0x2,'solution':_0x243729(0x4a0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x11a),'choices':[{'id':0x1,'text':_0x243729(0xd6)},{'id':0x2,'text':_0x243729(0x35f)},{'id':0x3,'text':_0x243729(0x364)},{'id':0x4,'text':'Glycopyrrolate'}],'correct_choice_id':0x3,'solution':_0x243729(0x1ff),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Subfamily\x20of\x20CYP3A4\x20is\x20_______','choices':[{'id':0x1,'text':_0x243729(0x370)},{'id':0x2,'text':'A'},{'id':0x3,'text':'3'},{'id':0x4,'text':'4'}],'correct_choice_id':0x2,'solution':_0x243729(0x231),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2060-year-old\x20man\x20presents\x20to\x20the\x20OPD\x20with\x20complaints\x20of\x20bluish\x20discoloration\x20of\x20the\x20skin\x20on\x20the\x20sun-exposed\x20areas.\x20He\x20has\x20been\x20on\x20medication\x20for\x20monomorphic\x20ventricular\x20tachycardia\x20for\x20the\x20past\x203\x20years.\x20Which\x20drug\x20is\x20most\x20likely\x20implicated\x20in\x20this\x20condition?','choices':[{'id':0x1,'text':_0x243729(0x2d2)},{'id':0x2,'text':_0x243729(0x38c)},{'id':0x3,'text':_0x243729(0x40f)},{'id':0x4,'text':_0x243729(0x1eb)}],'correct_choice_id':0x3,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>The\x20scenario\x20is\x20suggestive\x20of&nbsp;<strong>blue\x20man\x20syndrome\x20</strong>which<strong>&nbsp;</strong>is\x20most\x20likely\x20caused\x20by&nbsp;<strong>amiodarone.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>One\x20of\x20the\x20side\x20effects\x20of\x20amiodarone\x20is\x20<strong>photosensitivity</strong>.<strong>&nbsp;</strong>In\x20some\x20cases,\x20bluish\x20discoloration\x20of\x20the\x20skin\x20is\x20seen,\x20predominantly\x20in\x20the\x20sun-exposed\x20areas.\x20This\x20could\x20be\x20due\x20to\x20the\x20<strong>immune\x20response\x20in\x20dermal\x20layers</strong>\x20by\x20amiodarone\x20or\x20the\x20accumulation\x20of\x20amiodarone\x20in\x20superficial\x20layers\x20of\x20skin.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>The\x20symptoms\x20are\x20<strong>reversible</strong>\x20on\x20drug\x20discontinuation.\x20The\x20syndrome\x20is\x20related\x20to\x20both\x20dose\x20and\x20photosensitivity.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>The\x20side\x20effects\x20of\x20amiodarone\x20include:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Pulmonary\x20fibrosis</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Hypotension,\x20depressed\x20ventricular\x20function</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Torsades\x20de\x20pointes</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Corneal\x20microdeposits</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Hepatotoxicity</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Neuropathies</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Photosensitivity</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Thyroid\x20dysfunction</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Other\x20such\x20syndromes\x20associated\x20with\x20drugs\x20are:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Red\x20man\x20syndrome\x20-\x20Vancomycin</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Gray\x20baby\x20syndrome\x20-&nbsp;Chloramphenicol</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3ba),'choices':[{'id':0x1,'text':_0x243729(0x12a)},{'id':0x2,'text':_0x243729(0x28a)},{'id':0x3,'text':_0x243729(0x309)},{'id':0x4,'text':_0x243729(0x474)}],'correct_choice_id':0x4,'solution':'<p><strong>Lisinopril</strong>\x20is\x20not\x20a\x20prodrug.</p>\x0a<p>All\x20ACE\x20inhibitors\x20are\x20prodrugs\x20except\x20lisinopril\x20and\x20<strong>captopril.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'What\x20is\x20pegloticase\x20used\x20for?','choices':[{'id':0x1,'text':_0x243729(0x380)},{'id':0x2,'text':_0x243729(0x2c2)},{'id':0x3,'text':'Psoriatric\x20arthritis'},{'id':0x4,'text':'Paralytic\x20ileus'}],'correct_choice_id':0x1,'solution':'<p><strong>Pegloticase</strong>\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>chronic\x20gout.</strong></p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20711\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Pegloticase\x20is\x20a\x20<strong>pegylated\x20uricase</strong>\x20(urate\x20oxidase).\x20It\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20<strong>uric\x20acid\x20into\x20allantoin</strong>,\x20which\x20is\x20a\x20more\x20soluble\x20and\x20inactive\x20metabolite.</p>\x0a<p>It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>severe</strong>,&nbsp;<strong>refractory\x20chronic\x20gout</strong>\x20or\x20in\x20cases\x20where\x20other\x20urate-lowering\x20therapies\x20are\x20contraindicated.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x22f),'choices':[{'id':0x1,'text':_0x243729(0x20e)},{'id':0x2,'text':_0x243729(0x1b1)},{'id':0x3,'text':_0x243729(0x1db)},{'id':0x4,'text':_0x243729(0xee)}],'correct_choice_id':0x3,'solution':_0x243729(0x195),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x1dc),'choices':[{'id':0x1,'text':_0x243729(0x2a4)},{'id':0x2,'text':'Inhibition\x20of\x20breakdown\x20of\x20ACh'},{'id':0x3,'text':'Blockade\x20of\x20ACh\x20receptors'},{'id':0x4,'text':_0x243729(0x162)}],'correct_choice_id':0x4,'solution':_0x243729(0x1fa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x145),'choices':[{'id':0x1,'text':_0x243729(0x42f)},{'id':0x2,'text':_0x243729(0x1b7)},{'id':0x3,'text':'Valproate'},{'id':0x4,'text':_0x243729(0x37b)}],'correct_choice_id':0x2,'solution':_0x243729(0x3cb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0xff),'choices':[{'id':0x1,'text':_0x243729(0x3cc)},{'id':0x2,'text':_0x243729(0x159)},{'id':0x3,'text':_0x243729(0x1e0)},{'id':0x4,'text':_0x243729(0x3d5)}],'correct_choice_id':0x1,'solution':_0x243729(0x447),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3f6),'choices':[{'id':0x1,'text':_0x243729(0x3ff)},{'id':0x2,'text':_0x243729(0x2bb)},{'id':0x3,'text':_0x243729(0x26b)},{'id':0x4,'text':'Low\x20molecular\x20weight\x20heparin'}],'correct_choice_id':0x2,'solution':_0x243729(0x1d2),'explanation_video':'','question_images':[],'explanation_images':[_0x243729(0x185)]},{'text':_0x243729(0x28c),'choices':[{'id':0x1,'text':'Allergic\x20reaction'},{'id':0x2,'text':_0x243729(0x301)},{'id':0x3,'text':_0x243729(0x2ad)},{'id':0x4,'text':'Immune-complex\x20deposition'}],'correct_choice_id':0x2,'solution':_0x243729(0x46a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x282),'choices':[{'id':0x1,'text':_0x243729(0xef)},{'id':0x2,'text':_0x243729(0x1ee)},{'id':0x3,'text':'82-year-old\x20man\x20with\x20renal\x20failure'},{'id':0x4,'text':_0x243729(0xfd)}],'correct_choice_id':0x1,'solution':'<p>The\x20action\x20of\x20digoxin\x20is\x20not\x20affected\x20in\x20chronic\x20liver\x20disease.&nbsp;</p>\x0a<p>Option\x20B:&nbsp;<strong>Electrolyte\x20disturbances</strong>\x20like\x20hypokalemia,\x20hypomagnesemia,\x20and\x20hypercalcemia&nbsp;<strong>increase\x20digitalis\x20toxicity.</strong></p>\x0a<p>Option\x20C:\x20Digoxin\x20is<strong>&nbsp;excreted\x20</strong>unchanged\x20primarily\x20by<strong>\x20kidneys</strong>&nbsp;by\x20glomerular\x20filtration.\x20Therefore,\x20<strong>dose\x20adjustment</strong>\x20of\x20digoxin\x20has\x20to\x20be\x20done\x20in&nbsp;<strong>renal\x20failure</strong>.</p>\x0a<p>Option\x20D:\x20Chances\x20of\x20arrhythmias\x20increases\x20manifold\x20in\x20post-MI\x20duration.\x20Hence,\x20it\x20is\x20generally\x20avoided\x20post-MI\x20as\x20<strong>digitalis</strong>\x20itself\x20<strong>causes\x20arrhythmias</strong>.</p>\x0a<table\x20style=\x22width:\x20291px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2071px;\x22>&nbsp;</td>\x0a<td\x20style=\x22width:\x2074px;\x22><strong>Digitoxin&nbsp;</strong></td>\x0a<td\x20style=\x22width:\x20138px;\x22><strong>Digoxin&nbsp;</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2071px;\x22>Oral\x20absorption&nbsp;</td>\x0a<td\x20style=\x22width:\x2074px;\x22>Very\x20good\x20(90-100%)&nbsp;</td>\x0a<td\x20style=\x22width:\x20138px;\x22>Good\x20(\x2060-80%)&nbsp;i/v\x20also&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2071px;\x22>Plasma\x20protein\x20binding&nbsp;&nbsp;</td>\x0a<td\x20style=\x22width:\x2074px;\x22>95%&nbsp;</td>\x0a<td\x20style=\x22width:\x20138px;\x22>25%&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2071px;\x22>Elimination&nbsp;</td>\x0a<td\x20style=\x22width:\x2074px;\x22>Hepatic\x20metabolism&nbsp;</td>\x0a<td\x20style=\x22width:\x20138px;\x22>Renal\x20excretion\x20(by\x20glomerular\x20filtration)&nbsp;</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2071px;\x22>Dose\x20adjustment\x20in&nbsp;</td>\x0a<td\x20style=\x22width:\x2074px;\x22>Liver\x20failure&nbsp;</td>\x0a<td\x20style=\x22width:\x20138px;\x22>Kidney\x20failure&nbsp;</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0xdb),'choices':[{'id':0x1,'text':_0x243729(0x258)},{'id':0x2,'text':_0x243729(0x401)},{'id':0x3,'text':_0x243729(0x322)},{'id':0x4,'text':_0x243729(0x233)}],'correct_choice_id':0x1,'solution':_0x243729(0x3c2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x243729(0x3d2),'choices':[{'id':0x1,'text':_0x243729(0x10c)},{'id':0x2,'text':'Metoclopramide'},{'id':0x3,'text':'Domperidone'},{'id':0x4,'text':_0x243729(0x334)}],'correct_choice_id':0x3,'solution':'<p><strong>Domperidone</strong>\x20does\x20not\x20have\x20any\x205HT<sub>4</sub>\x20agonist\x20action.\x20It\x20mainly\x20acts\x20by\x20<strong>D<sub>2</sub>\x20antagonist</strong>\x20action.</p>\x0a<p><strong>5HT<sub>4</sub>\x20agonism</strong>\x20and<strong>\x20D<sub>2</sub>\x20antagonism</strong>\x20can\x20result\x20in\x20<strong>prokinetic\x20action</strong>\x20by\x20increasing\x20the\x20cholinergic\x20activity\x20of\x20the\x20gut.</p>\x0a<p>The\x205HT<sub>4</sub>\x20agonist\x20action\x20is\x20shown\x20by:</p>\x0a<ul>\x0a<li><strong>Metoclopramide</strong>&nbsp;</li>\x0a<li><strong>Cisapride</strong></li>\x0a<li>Mosapride</li>\x0a<li>Itopride</li>\x0a<li><strong>Renzapride</strong></li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x243729(0x3f1);const quizFilename='pharmacology-test-696fc98d.html';let hierarchy=[_0x243729(0x203),_0x243729(0x45c),_0x243729(0x10d)];if(window[_0x243729(0x3c9)][_0x243729(0x137)][_0x243729(0x30e)](_0x243729(0xe9))){const customData=JSON[_0x243729(0x497)](localStorage['getItem'](_0x243729(0x103)));customData&&(questionsData=customData[_0x243729(0x167)],quizName=customData[_0x243729(0x4a2)],hierarchy=customData[_0x243729(0x123)],document[_0x243729(0x32a)]=quizName+_0x243729(0x439),document['getElementById']('totalQuestions')[_0x243729(0x2d6)]=questionsData[_0x243729(0xdc)],document[_0x243729(0x453)]('quizHierarchy')[_0x243729(0x2d6)]=hierarchy[_0x243729(0x2d5)](_0x243729(0x25f)));}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x243729(0x481),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x243729(0x13f)](),quizStartTime=Date[_0x243729(0x13f)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x243729(0xdc)])['fill'](null)[_0x243729(0x482)](()=>({'status':_0x243729(0x466),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x243729(0xdc)]};function saveProgress(){const _0x506c9f=_0x243729,_0x309114={'PhmIL':'userHistory','eiAeZ':_0x506c9f(0x393)};if(isQuizCompleted)return;const _0x34a041=JSON[_0x506c9f(0x497)](localStorage['getItem'](_0x309114[_0x506c9f(0x3ad)]))||{};_0x34a041[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x309114[_0x506c9f(0x3a1)],'lastSeen':new Date()[_0x506c9f(0x1af)]()},localStorage['setItem'](_0x506c9f(0x30b),JSON[_0x506c9f(0x273)](_0x34a041));}function loadProgress(){const _0x270914=_0x243729,_0x1755b3={'WcPmD':'2|0|3|4|1|5'},_0x217c09=JSON[_0x270914(0x497)](localStorage[_0x270914(0x14e)]('userHistory'))||{},_0x484631=_0x217c09[quizFilename];if(_0x484631){const _0x44530e=_0x1755b3[_0x270914(0x2e8)]['split']('|');let _0x36860e=0x0;while(!![]){switch(_0x44530e[_0x36860e++]){case'0':stats=_0x484631[_0x270914(0x2c3)];continue;case'1':console[_0x270914(0x127)](_0x270914(0x487));continue;case'2':questionStates=_0x484631[_0x270914(0x42a)];continue;case'3':currentQuestionIndex=_0x484631[_0x270914(0x359)];continue;case'4':currentMode=_0x484631['currentMode'];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x4d2b98=_0x243729,_0x2861ea={'ODsIu':function(_0x1012cb,_0x169ba0){return _0x1012cb===_0x169ba0;},'EYIql':_0x4d2b98(0x2c7),'NUjZP':_0x4d2b98(0x30b),'zZpvL':_0x4d2b98(0xe7)},_0x2379ab=JSON[_0x4d2b98(0x497)](localStorage[_0x4d2b98(0x14e)]('userHistory'))||{};_0x2379ab[quizFilename]&&(_0x2861ea[_0x4d2b98(0x298)](_0x2861ea['EYIql'],_0x4d2b98(0x2c7))?(delete _0x2379ab[quizFilename],localStorage['setItem'](_0x2861ea[_0x4d2b98(0x27d)],JSON[_0x4d2b98(0x273)](_0x2379ab)),console[_0x4d2b98(0x127)](_0x2861ea[_0x4d2b98(0x319)])):_0x2b6f0a());}function markQuizAsCompleted(){const _0x259e03=_0x243729,_0x355119={'QhQVw':'completed','lIfaN':_0x259e03(0x30b)},_0x15125a=JSON[_0x259e03(0x497)](localStorage[_0x259e03(0x14e)]('userHistory'))||{},_0x197fba=questionsData['length'],_0x25a912=stats['correctAnswers']||0x0;_0x15125a[quizFilename]={'score':_0x25a912,'total':_0x197fba,'status':_0x355119[_0x259e03(0x13c)],'completedOn':new Date()[_0x259e03(0x1af)]()},localStorage['setItem'](_0x355119['lIfaN'],JSON[_0x259e03(0x273)](_0x15125a));}const urlParams=new URLSearchParams(window[_0x243729(0x3c9)]['search']),startAt=parseInt(urlParams[_0x243729(0x35b)](_0x243729(0x388))),resume=urlParams[_0x243729(0x35b)](_0x243729(0x2f8))==='true';function goBack(){const _0x485aaa=_0x243729,_0x325b54={'VwBZI':'index.html'};if(!isQuizCompleted)saveProgress();window['location'][_0x485aaa(0x26e)]=document[_0x485aaa(0x21f)]||_0x325b54[_0x485aaa(0x266)];}function selectMode(_0x1efaf4){const _0x474319=_0x243729,_0x407987={'fchYU':_0x474319(0x421),'TsMsj':_0x474319(0x2c8),'haloh':function(_0xeca8e8){return _0xeca8e8();}};currentMode=_0x1efaf4,document['getElementById'](_0x407987['fchYU'])['style'][_0x474319(0x2e9)]=_0x407987[_0x474319(0x1c0)],_0x407987[_0x474319(0x1b5)](initializeQuiz);}function initializeQuiz(){const _0x1a7154=_0x243729,_0x502b3b={'XSvFr':'bookmarkBtn','Pxeyz':_0x1a7154(0x425),'yDnAd':_0x1a7154(0x303),'gSLvC':function(_0x2772b4,_0x4499f9){return _0x2772b4===_0x4499f9;},'ovQmH':_0x1a7154(0x3eb),'bPKSi':'timed_exam','ajOsn':_0x1a7154(0x2c8),'sdhFC':_0x1a7154(0x181),'HdKcV':'studyModeLegend','VGCcV':'testModeLegend','dQMJY':_0x1a7154(0x3f0),'NnVKO':function(_0x5a0a72,_0x8913a9){return _0x5a0a72===_0x8913a9;},'DLGSY':function(_0x4f6bac,_0x8478da){return _0x4f6bac===_0x8478da;},'mKnIm':_0x1a7154(0xeb),'tWEGL':_0x1a7154(0x3b6),'KrrkI':function(_0x4fc239,_0x1cacfe){return _0x4fc239>=_0x1cacfe;},'jgZvp':function(_0x107654,_0x54ab95){return _0x107654<_0x54ab95;},'ROyQK':function(_0x481b87){return _0x481b87();},'lEbfw':function(_0x1507fe){return _0x1507fe();},'Ytiuw':function(_0x49b004){return _0x49b004();},'BtgGT':function(_0x317225){return _0x317225();}};quizStartTime=Date[_0x1a7154(0x13f)]();const _0x2b58f5=document['getElementById'](_0x502b3b[_0x1a7154(0xf7)]),_0x195d8b=document[_0x1a7154(0x453)](_0x502b3b[_0x1a7154(0x435)]),_0x1b45c0=document[_0x1a7154(0x453)](_0x502b3b['yDnAd']),_0x55973c=_0x502b3b['gSLvC'](currentMode,_0x502b3b[_0x1a7154(0x219)])||_0x502b3b['gSLvC'](currentMode,_0x502b3b['bPKSi']);document['getElementById']('statsBar')['style']['display']=_0x55973c?_0x502b3b[_0x1a7154(0x44e)]:_0x502b3b[_0x1a7154(0x45e)],document['getElementById'](_0x502b3b['HdKcV'])['style'][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b[_0x1a7154(0x44e)]:_0x502b3b[_0x1a7154(0x45e)],document[_0x1a7154(0x453)](_0x502b3b[_0x1a7154(0x26c)])[_0x1a7154(0x306)][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b['sdhFC']:_0x502b3b['ajOsn'],document[_0x1a7154(0x453)](_0x1a7154(0x182))[_0x1a7154(0x306)][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b[_0x1a7154(0x45e)]:_0x502b3b[_0x1a7154(0x44e)],_0x2b58f5['style'][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b[_0x1a7154(0x44e)]:_0x502b3b[_0x1a7154(0x229)],_0x195d8b[_0x1a7154(0x306)][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b[_0x1a7154(0x229)]:_0x502b3b[_0x1a7154(0x44e)],_0x1b45c0[_0x1a7154(0x306)][_0x1a7154(0x2e9)]=_0x55973c?_0x502b3b[_0x1a7154(0x229)]:_0x502b3b['ajOsn'],(_0x502b3b[_0x1a7154(0x47d)](currentMode,_0x1a7154(0x48b))||_0x502b3b[_0x1a7154(0x3a9)](currentMode,_0x502b3b[_0x1a7154(0x2c0)]))&&(_0x502b3b[_0x1a7154(0x1c3)](_0x502b3b['mKnIm'],_0x502b3b[_0x1a7154(0x318)])?document[_0x1a7154(0x453)](_0x502b3b[_0x1a7154(0x24c)])[_0x1a7154(0xda)]['remove'](_0x1a7154(0x2d1)):_0x4cd27d=_0x58ff47),!isNaN(startAt)&&_0x502b3b[_0x1a7154(0x34d)](startAt,0x0)&&_0x502b3b[_0x1a7154(0x2cc)](startAt,questionsData[_0x1a7154(0xdc)])&&(currentQuestionIndex=startAt),_0x502b3b[_0x1a7154(0x2a5)](loadBookmarkedQuestions),_0x502b3b[_0x1a7154(0x468)](generateQuestionNav),_0x502b3b[_0x1a7154(0x440)](updateStats),_0x502b3b[_0x1a7154(0x1d7)](displayQuestion);}function generateQuestionNav(){const _0x148bbf=_0x243729,_0x5eb5bc={'AeLex':'questionNav','TPZWz':function(_0x451170,_0x19c7ff){return _0x451170<_0x19c7ff;},'NLPqx':function(_0x4a0fad,_0x1a1161){return _0x4a0fad!==_0x1a1161;},'BlZMV':_0x148bbf(0x193),'TlGti':function(_0x2d5522,_0x5d0590){return _0x2d5522+_0x5d0590;},'ixmxg':_0x148bbf(0xd1),'UVIWK':function(_0x960698){return _0x960698();}},_0x1209a1=document[_0x148bbf(0x453)](_0x5eb5bc[_0x148bbf(0x19c)]);_0x1209a1['innerHTML']='';for(let _0x2bb7c9=0x0;_0x5eb5bc[_0x148bbf(0x216)](_0x2bb7c9,questionsData[_0x148bbf(0xdc)]);_0x2bb7c9++){if(_0x5eb5bc[_0x148bbf(0x436)](_0x5eb5bc[_0x148bbf(0xfc)],_0x5eb5bc['BlZMV'])){const _0x540616=_0x483768[_0x148bbf(0x497)](_0x49d500[_0x148bbf(0x14e)]('bookmarkedQuestions'))||[];_0x540616[_0x148bbf(0x14b)](_0x4318cd=>{const _0x244987=_0x148bbf;_0x4318cd[_0x244987(0xf8)][_0x244987(0x307)](_0x54c9c9[_0x244987(0x49f)]()[_0x244987(0x313)](/ /g,'-'))&&(_0x4318cd[_0x244987(0x461)]<_0x8dc4a3[_0x244987(0xdc)]&&(_0x29e3d5[_0x4318cd[_0x244987(0x461)]][_0x244987(0x366)]=!![]));});}else{const _0x409c20=document[_0x148bbf(0x292)](_0x148bbf(0x414));_0x409c20[_0x148bbf(0x2d6)]=_0x5eb5bc[_0x148bbf(0x147)](_0x2bb7c9,0x1),_0x409c20[_0x148bbf(0x45f)]=_0x5eb5bc['ixmxg'],_0x409c20['onclick']=()=>jumpToQuestion(_0x2bb7c9),_0x409c20['id']=_0x148bbf(0x2ec)+_0x2bb7c9,_0x1209a1['appendChild'](_0x409c20);}}_0x5eb5bc[_0x148bbf(0x2fd)](updateQuestionNav);}function updateQuestionNav(){const _0x4a904a=_0x243729,_0x13f440={'SwrWg':function(_0x2b83bb){return _0x2b83bb();},'TCXpo':'modeModal','Icquc':function(_0x21bc79,_0x491b51){return _0x21bc79===_0x491b51;},'edXCC':_0x4a904a(0x4a3),'XLLfM':function(_0x26da77,_0x352c79){return _0x26da77!==_0x352c79;},'CUpoL':_0x4a904a(0x20f),'ttIkl':_0x4a904a(0x324),'JoqET':'study','byxpv':_0x4a904a(0x3a7),'qELeI':_0x4a904a(0x3b3),'IcEtQ':_0x4a904a(0xd3),'HHipp':_0x4a904a(0x3ce),'ccTSR':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','cXnRz':_0x4a904a(0x207)};for(let _0x391935=0x0;_0x391935<questionsData[_0x4a904a(0xdc)];_0x391935++){const _0x502fb7=document['getElementById']('navBtn_'+_0x391935),_0x539857=questionStates[_0x391935];let _0x3bbfe3='';if(_0x13f440[_0x4a904a(0x384)](_0x391935,currentQuestionIndex))_0x3bbfe3=_0x13f440[_0x4a904a(0x22e)];else{if(_0x539857[_0x4a904a(0x366)])_0x13f440[_0x4a904a(0x1f0)](_0x13f440[_0x4a904a(0x402)],_0x4a904a(0x20f))?(_0x13f440[_0x4a904a(0x237)](_0xc7a34d),_0x530555[_0x4a904a(0x453)](_0x13f440[_0x4a904a(0x1cc)])['style'][_0x4a904a(0x2e9)]=_0x4a904a(0x3f0)):_0x3bbfe3=_0x13f440['ttIkl'];else{if(_0x539857[_0x4a904a(0x143)])_0x3bbfe3='nav-btn-marked-review';else{if(_0x13f440[_0x4a904a(0x384)](currentMode,_0x13f440[_0x4a904a(0x3be)])||_0x13f440[_0x4a904a(0x384)](currentMode,_0x4a904a(0x48b))){if(_0x13f440[_0x4a904a(0x384)](_0x539857[_0x4a904a(0x2b6)],_0x13f440[_0x4a904a(0x2e7)]))_0x3bbfe3=_0x13f440[_0x4a904a(0x20c)];else{if(_0x539857[_0x4a904a(0x2b6)]===_0x13f440['IcEtQ'])_0x3bbfe3=_0x13f440[_0x4a904a(0x395)];else _0x3bbfe3=_0x13f440[_0x4a904a(0xcf)];}}else{if(_0x13f440[_0x4a904a(0x1f0)](_0x539857['selectedAnswer'],null))_0x3bbfe3=_0x13f440[_0x4a904a(0x448)];else _0x3bbfe3=_0x13f440[_0x4a904a(0xcf)];}}}}_0x502fb7['className']=_0x4a904a(0x16e)+_0x3bbfe3;}}function jumpToQuestion(_0x114365){const _0x4994c0=_0x243729,_0x52cd1f={'WBObA':_0x4994c0(0x1cb),'ePTrf':_0x4994c0(0x2d1),'OKMQF':function(_0xf9384e,_0xb9fe53){return _0xf9384e>=_0xb9fe53;},'OQjnp':function(_0x7a8488,_0x83b0a5){return _0x7a8488<_0x83b0a5;},'UPmYr':function(_0x216891,_0x2c6d55){return _0x216891===_0x2c6d55;},'zDaES':'XmhTC','rTRdu':'zufXP','sdzXt':function(_0x1e8d75,_0x317e6b){return _0x1e8d75-_0x317e6b;},'hoWIo':function(_0x938180){return _0x938180();}};_0x52cd1f[_0x4994c0(0x29f)](_0x114365,0x0)&&_0x52cd1f[_0x4994c0(0x11e)](_0x114365,questionsData['length'])&&(_0x52cd1f[_0x4994c0(0x19a)](_0x52cd1f[_0x4994c0(0x3e6)],_0x52cd1f[_0x4994c0(0x3bc)])?_0x4f192e[_0x4994c0(0x453)](_0x52cd1f['WBObA'])[_0x4994c0(0xda)]['add'](_0x52cd1f[_0x4994c0(0x475)]):(questionStartTime&&(questionStates[currentQuestionIndex][_0x4994c0(0x2b5)]+=_0x52cd1f[_0x4994c0(0x101)](Date[_0x4994c0(0x13f)](),questionStartTime)),currentQuestionIndex=_0x114365,_0x52cd1f[_0x4994c0(0x37e)](displayQuestion),_0x52cd1f['hoWIo'](saveProgress)));}function updateStats(){const _0x3d2033=_0x243729,_0x4bee0f={'pfzeZ':function(_0x58457b,_0x3cd1a0){return _0x58457b===_0x3cd1a0;},'YJlWZ':function(_0xc09151,_0x256424){return _0xc09151===_0x256424;},'ExBxs':_0x3d2033(0x48b),'kMpQJ':'correctCount','kZqtI':_0x3d2033(0x2d3),'IDzmO':function(_0x3612f3,_0x5c68eb){return _0x3612f3*_0x5c68eb;},'OGYJz':_0x3d2033(0xde),'BIZfW':function(_0x5e80b8,_0x2847f9){return _0x5e80b8+_0x2847f9;},'BgdfZ':function(_0x39df9b,_0x3f96a6){return _0x39df9b/_0x3f96a6;},'UTnfm':function(_0x1ee315,_0x3eb52b){return _0x1ee315%_0x3eb52b;}};if(_0x4bee0f['pfzeZ'](currentMode,'study')||_0x4bee0f['YJlWZ'](currentMode,_0x4bee0f[_0x3d2033(0x2cf)])){document[_0x3d2033(0x453)](_0x4bee0f[_0x3d2033(0x48c)])[_0x3d2033(0x2d6)]=stats[_0x3d2033(0x39a)],document[_0x3d2033(0x453)](_0x4bee0f[_0x3d2033(0xf6)])['textContent']=stats[_0x3d2033(0x47b)],document[_0x3d2033(0x453)](_0x3d2033(0x12b))[_0x3d2033(0x2d6)]=stats[_0x3d2033(0x12b)];const _0x409370=stats[_0x3d2033(0x12b)]>0x0?Math['round'](_0x4bee0f[_0x3d2033(0x213)](stats[_0x3d2033(0x39a)]/stats[_0x3d2033(0x12b)],0x64)):0x0;document[_0x3d2033(0x453)](_0x4bee0f[_0x3d2033(0x2fc)])['textContent']=_0x4bee0f['BIZfW'](_0x409370,'%'),stats[_0x3d2033(0x44b)]=questionStates['reduce']((_0x2d7a68,_0x2d71a5)=>_0x2d7a68+_0x2d71a5[_0x3d2033(0x2b5)],0x0);const _0x4fb0e0=Math[_0x3d2033(0x317)](_0x4bee0f[_0x3d2033(0x37a)](stats[_0x3d2033(0x44b)],0x3e8)),_0x2c8107=Math[_0x3d2033(0x317)](_0x4bee0f[_0x3d2033(0x37a)](_0x4fb0e0,0x3c)),_0x161635=_0x4bee0f[_0x3d2033(0x102)](_0x4fb0e0,0x3c);document['getElementById'](_0x3d2033(0x2b5))[_0x3d2033(0x2d6)]=_0x4bee0f[_0x3d2033(0x246)](_0x4bee0f[_0x3d2033(0x246)](_0x2c8107,':'),_0x161635[_0x3d2033(0x391)]()[_0x3d2033(0x2db)](0x2,'0'));}}function setupVideo(_0x184204,_0x3ebe99){const _0xcb171a=_0x243729,_0x2ff07c={'VdPSx':_0xcb171a(0x2e5)};if(Hls['isSupported']()){const _0x5c5cb4=new Hls();_0x5c5cb4['loadSource'](_0x3ebe99),_0x5c5cb4[_0xcb171a(0x382)](_0x184204);}else _0x184204['canPlayType'](_0x2ff07c[_0xcb171a(0x305)])&&(_0x184204[_0xcb171a(0x3a5)]=_0x3ebe99);}function displayQuestion(){const _0x54570c=_0x243729,_0x8c4518={'sgSGs':_0x54570c(0x296),'lTXFh':_0x54570c(0x11c),'Spury':function(_0x4f3ef7,_0x2ff252){return _0x4f3ef7===_0x2ff252;},'dfEyZ':_0x54570c(0x3b7),'YeMgD':function(_0x27f81c,_0x1dc0d8){return _0x27f81c+_0x1dc0d8;},'dRhjm':function(_0x52198f,_0x37c88f){return _0x52198f===_0x37c88f;},'elQmu':_0x54570c(0x426),'DSONv':'selected','LKOzD':'Option\x20','iYdKO':_0x54570c(0x48d),'asOWg':_0x54570c(0x262),'qbCot':function(_0x5b1ad1,_0x41e1a2){return _0x5b1ad1+_0x41e1a2;},'UnSYZ':_0x54570c(0x425),'FzcsP':_0x54570c(0x3a3),'qlhOI':_0x54570c(0x46e),'OCliH':_0x54570c(0x1e6),'FthpF':_0x54570c(0x1e1),'UDQan':_0x54570c(0x10f),'OfFrd':function(_0x4b3e83,_0x244e46){return _0x4b3e83!==_0x244e46;},'qaRSU':_0x54570c(0x299),'QoGCL':'.option-button','vpXEr':_0x54570c(0x14c),'bDory':_0x54570c(0x336),'MZzZi':function(_0x1a2ecf,_0x124b0b){return _0x1a2ecf(_0x124b0b);},'NlCUN':_0x54570c(0xf2),'fbleJ':_0x54570c(0x396),'DYHzn':function(_0x2f0970,_0x5be6f4){return _0x2f0970*_0x5be6f4;},'iaDyd':function(_0x48177a,_0x1eed65){return _0x48177a/_0x1eed65;},'ovHiQ':_0x54570c(0x114),'noHEa':'currentQuestion','TGdOj':function(_0x36ce6b){return _0x36ce6b();},'xKFJN':_0x54570c(0x165),'jDHEZ':function(_0x22cbb4,_0x3eb5cb){return _0x22cbb4===_0x3eb5cb;},'BSlUR':_0x54570c(0x2d1),'ZYkWW':_0x54570c(0x3c7),'kamhF':_0x54570c(0x312),'iseAS':_0x54570c(0x250),'NrzNL':_0x54570c(0x32c),'CDxLS':function(_0x5b42dd){return _0x5b42dd();},'fhZbY':function(_0x43a606,_0x519236){return _0x43a606===_0x519236;},'GwJoX':_0x54570c(0x327),'jcTbh':function(_0xd3604a,_0x410ad3){return _0xd3604a!==_0x410ad3;},'QYron':'dWxBP'};if(!questionsData||questionsData[_0x54570c(0xdc)]===0x0){document[_0x54570c(0x453)](_0x8c4518[_0x54570c(0x3b8)])[_0x54570c(0x22c)]=_0x8c4518[_0x54570c(0x3e2)];return;};const _0x3c101e=questionsData[currentQuestionIndex];questionStartTime=Date[_0x54570c(0x13f)](),selectedOption=questionStates[currentQuestionIndex][_0x54570c(0x2ae)];const _0x25ee05=_0x8c4518[_0x54570c(0x112)](_0x8c4518[_0x54570c(0x221)](_0x8c4518[_0x54570c(0x205)](currentQuestionIndex,0x1),questionsData[_0x54570c(0xdc)]),0x64);document['getElementById'](_0x8c4518[_0x54570c(0x343)])['style'][_0x54570c(0x222)]=_0x8c4518[_0x54570c(0x205)](_0x25ee05,'%'),document['getElementById'](_0x8c4518[_0x54570c(0x180)])[_0x54570c(0x2d6)]=_0x8c4518[_0x54570c(0x17e)](currentQuestionIndex,0x1),_0x8c4518[_0x54570c(0xd9)](updateQuestionNav),document['getElementById'](_0x8c4518['xKFJN'])[_0x54570c(0x25d)]=_0x8c4518[_0x54570c(0x417)](currentQuestionIndex,0x0),document[_0x54570c(0x453)](_0x54570c(0x134))['classList'][_0x54570c(0x344)](_0x8c4518[_0x54570c(0x16d)]),document[_0x54570c(0x453)](_0x8c4518[_0x54570c(0x3b8)])[_0x54570c(0x22c)]=_0x3c101e['text']||_0x8c4518[_0x54570c(0x2d0)];let _0xe8f072='';if(_0x3c101e[_0x54570c(0x4a4)])_0xe8f072+=_0x54570c(0x21b)+_0x3c101e[_0x54570c(0x4a4)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x3c101e[_0x54570c(0x129)])_0xe8f072+=_0x54570c(0x154)+_0x3c101e['question_video']+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x3c101e[_0x54570c(0x2b8)]&&_0x3c101e[_0x54570c(0x2b8)][_0x54570c(0x14b)](_0x44efac=>{const _0x3385c3=_0x54570c;if(_0x3385c3(0x11c)===_0x8c4518[_0x3385c3(0x46f)]){if(_0x44efac)_0xe8f072+=_0x3385c3(0x463)+_0x44efac+_0x3385c3(0x2b1);}else return _0x585894[_0x3385c3(0x391)]()[_0x3385c3(0x3e8)](uIICmo[_0x3385c3(0x423)])['toString']()[_0x3385c3(0xe1)](_0x44a1c1)[_0x3385c3(0x3e8)](uIICmo[_0x3385c3(0x423)]);});document[_0x54570c(0x453)](_0x8c4518[_0x54570c(0x2cd)])[_0x54570c(0x22c)]=_0xe8f072;const _0x161ce2=document[_0x54570c(0x453)]('optionsContainer');_0x161ce2['innerHTML']='',_0x161ce2['classList'][_0x54570c(0x381)](_0x8c4518['iseAS']);_0x3c101e[_0x54570c(0x226)]&&Array['isArray'](_0x3c101e[_0x54570c(0x226)])&&(_0x3c101e['choices'][_0x54570c(0x14b)]((_0x3153ec,_0x41160f)=>{const _0x151e8b=_0x54570c;if(_0x8c4518[_0x151e8b(0x179)](_0x8c4518[_0x151e8b(0x400)],_0x151e8b(0x3b7))){const _0x4abb79=String[_0x151e8b(0x13a)](_0x8c4518['YeMgD'](0x41,_0x41160f)),_0x7d87fd=_0x8c4518[_0x151e8b(0x390)](selectedOption,_0x41160f),_0x3b35c0=document[_0x151e8b(0x292)](_0x8c4518['elQmu']);_0x3b35c0[_0x151e8b(0x22c)]=_0x151e8b(0x214)+(_0x7d87fd?_0x8c4518['DSONv']:'')+_0x151e8b(0x30a)+_0x41160f+_0x151e8b(0x119)+_0x4abb79+_0x151e8b(0x376)+(_0x3153ec['text']||_0x8c4518['LKOzD']+_0x8c4518[_0x151e8b(0x17e)](_0x41160f,0x1))+_0x151e8b(0x1fc),_0x161ce2[_0x151e8b(0x1ed)](_0x3b35c0);}else _0x1f0025[_0x151e8b(0x3a5)]=_0x570bb1;}),_0x161ce2[_0x54570c(0x25a)](_0x8c4518[_0x54570c(0x2a7)],function(_0x458313){const _0x32df8c=_0x54570c,_0x9a39d6={'rspoY':function(_0x7e9ce3,_0x5426e8){const _0x2d3bc5=_0x2096;return _0x8c4518[_0x2d3bc5(0x390)](_0x7e9ce3,_0x5426e8);},'kqkgM':_0x8c4518['iYdKO'],'WeRXQ':_0x8c4518['asOWg'],'qWyJU':_0x32df8c(0x3ee),'SHqiL':function(_0x14f5e9,_0xfc7fcf){const _0x2518c0=_0x32df8c;return _0x8c4518[_0x2518c0(0x205)](_0x14f5e9,_0xfc7fcf);},'oTuHx':_0x8c4518[_0x32df8c(0x138)],'IpGKK':_0x8c4518[_0x32df8c(0x48a)],'eHFkG':_0x8c4518[_0x32df8c(0x2df)],'wiWWp':_0x8c4518[_0x32df8c(0x160)],'Mpbhz':_0x8c4518['FthpF'],'xOaau':_0x8c4518[_0x32df8c(0x3c0)]};if(_0x8c4518[_0x32df8c(0x35e)](_0x8c4518['qaRSU'],_0x32df8c(0x142))){const _0x2e8715=_0x458313[_0x32df8c(0x1f4)][_0x32df8c(0x20a)](_0x8c4518[_0x32df8c(0x455)]);if(_0x2e8715){if(_0x8c4518[_0x32df8c(0x390)](_0x8c4518[_0x32df8c(0x49d)],_0x8c4518['bDory'])){const _0x18fbd1=_0x44892a[_0x32df8c(0x2ae)]===_0x7e021c,_0x2bda95=_0x9a39d6[_0x32df8c(0x3dd)](_0x312f02['id'],_0x21818f);let _0x25f7bc=_0x9a39d6[_0x32df8c(0x480)];if(_0x2bda95)_0x25f7bc=_0x9a39d6[_0x32df8c(0x3f2)];else{if(_0x18fbd1)_0x25f7bc=_0x9a39d6[_0x32df8c(0x158)];}return _0x32df8c(0x2e3)+_0x25f7bc+_0x32df8c(0x410)+_0x502008[_0x32df8c(0x13a)](_0x9a39d6[_0x32df8c(0x493)](0x41,_0x4ee8a0))+'</span><span>'+_0x56137d[_0x32df8c(0x15f)]+_0x32df8c(0x12d);}else{const _0x3e777c=parseInt(_0x2e8715['getAttribute'](_0x32df8c(0x443)));_0x8c4518[_0x32df8c(0x11f)](selectOption,_0x3e777c);}}}else{const _0x4d0024=_0x48e0c5[_0x32df8c(0x453)](_0x9a39d6[_0x32df8c(0x20d)]),_0x17f70b=_0x3bdd56[_0x32df8c(0x453)](_0x9a39d6[_0x32df8c(0x192)]),_0x5b1648=_0x17b170[_0x43b8a8]['markedForReview'];_0x4d0024[_0x32df8c(0x45f)]=_0x5b1648?_0x9a39d6[_0x32df8c(0x4a5)]:_0x9a39d6[_0x32df8c(0x385)],_0x17f70b['textContent']=_0x5b1648?_0x9a39d6[_0x32df8c(0x2ca)]:_0x9a39d6[_0x32df8c(0x1de)];}}));_0x8c4518[_0x54570c(0xd9)](updateBookmarkButton),_0x8c4518[_0x54570c(0x26d)](updateMarkReviewButton);if((currentMode===_0x54570c(0x48b)||_0x8c4518[_0x54570c(0x2d8)](currentMode,_0x8c4518[_0x54570c(0x161)]))&&!isQuizCompleted){if(_0x8c4518['jcTbh'](_0x54570c(0x32f),_0x8c4518[_0x54570c(0x295)])){if(_0x27407a)_0x5cd4ad+=_0x54570c(0x463)+_0xd3cad2+_0x54570c(0x2b1);}else startTimer();}}function selectOption(_0x37226a){const _0x102fff=_0x243729,_0x3ec208={'OZefP':_0x102fff(0x39c),'mylOR':function(_0xf7ab85,_0x631858){return _0xf7ab85===_0x631858;},'GMvPK':_0x102fff(0x499),'IBQvO':'answered','yvATo':function(_0x69f56d,_0xd79b7f){return _0x69f56d!==_0xd79b7f;},'mUjYY':'eJRlC','hCQeO':function(_0x52137e,_0x15c43b){return _0x52137e-_0x15c43b;},'xckgo':_0x102fff(0x3dc),'sspOV':function(_0x3d4965,_0x28890d){return _0x3d4965===_0x28890d;},'KLQHE':function(_0x5eb548,_0x3111d0){return _0x5eb548===_0x3111d0;},'ylHHH':_0x102fff(0x48b),'xdvkW':function(_0xbbf2a4){return _0xbbf2a4();},'TslfA':_0x102fff(0x466)},_0x3eab55=document[_0x102fff(0x453)](_0x3ec208['GMvPK']);if(_0x3eab55[_0x102fff(0xda)]['contains'](_0x3ec208[_0x102fff(0x373)]))return;if(questionStartTime){if(_0x3ec208[_0x102fff(0x479)](_0x3ec208[_0x102fff(0x47a)],_0x3ec208[_0x102fff(0x47a)])){const _0x693bde=_0x1a9434['parse'](_0x16cab7[_0x102fff(0x14e)](_0x102fff(0x30b)))||{};_0x693bde[_0x3b6dd4]&&(delete _0x693bde[_0x581612],_0x36cbd8[_0x102fff(0x39d)]('userHistory',_0x37dbb0['stringify'](_0x693bde)),_0x336f56[_0x102fff(0x127)](_0x102fff(0xe7)));}else questionStates[currentQuestionIndex][_0x102fff(0x2b5)]+=_0x3ec208[_0x102fff(0x377)](Date['now'](),questionStartTime),questionStartTime=Date[_0x102fff(0x13f)]();}selectedOption=_0x37226a,questionStates[currentQuestionIndex][_0x102fff(0x2ae)]=_0x37226a,document[_0x102fff(0x473)](_0x3ec208[_0x102fff(0xd8)])[_0x102fff(0x14b)]((_0x2d3578,_0x27d7ad)=>{const _0x489928=_0x102fff;_0x2d3578['classList'][_0x489928(0x106)](_0x3ec208[_0x489928(0x3d4)],_0x3ec208[_0x489928(0x37c)](_0x27d7ad,_0x37226a));}),_0x3ec208['sspOV'](currentMode,_0x102fff(0x481))||_0x3ec208[_0x102fff(0x363)](currentMode,_0x3ec208['ylHHH'])?_0x3ec208[_0x102fff(0x2a0)](processAnswer):(_0x3ec208[_0x102fff(0x12c)](questionStates[currentQuestionIndex][_0x102fff(0x2b6)],_0x3ec208[_0x102fff(0x255)])&&(questionStates[currentQuestionIndex][_0x102fff(0x2b6)]=_0x3ec208[_0x102fff(0x373)],stats['totalAttempted']++,stats[_0x102fff(0x19b)]--),_0x3ec208[_0x102fff(0x2a0)](updateQuestionNav)),_0x3ec208[_0x102fff(0x2a0)](saveProgress);}function processAnswer(){const _0x2d5791=_0x243729,_0x6a221a={'PzYZH':function(_0x43c5af,_0x12e915){return _0x43c5af===_0x12e915;},'mfCAF':function(_0x158f54,_0xa14454){return _0x158f54===_0xa14454;},'jzHXK':'not_attempted','sDKlj':'correct','DxJyN':_0x2d5791(0xd3),'DmsBI':function(_0x1ac4f3){return _0x1ac4f3();},'kRhBw':function(_0x4b43b5,_0xb68deb){return _0x4b43b5(_0xb68deb);},'ZbxDf':function(_0x3d8057){return _0x3d8057();}},_0x5ebea8=questionsData[currentQuestionIndex],_0x3dfc5c=_0x5ebea8[_0x2d5791(0x251)];if(_0x6a221a[_0x2d5791(0x17d)](selectedOption,null))return;const _0x434bd7=_0x5ebea8[_0x2d5791(0x226)][selectedOption],_0xc23fef=_0x6a221a[_0x2d5791(0x17d)](_0x434bd7['id'],_0x3dfc5c);if(_0x6a221a[_0x2d5791(0x118)](questionStates[currentQuestionIndex][_0x2d5791(0x2b6)],_0x6a221a[_0x2d5791(0x33b)])){stats['totalAttempted']++,stats[_0x2d5791(0x19b)]--;if(_0xc23fef)stats[_0x2d5791(0x39a)]++;else stats[_0x2d5791(0x47b)]++;}questionStates[currentQuestionIndex][_0x2d5791(0x2b6)]=_0xc23fef?_0x6a221a['sDKlj']:_0x6a221a[_0x2d5791(0x44f)],_0x6a221a[_0x2d5791(0x484)](updateStats),_0x6a221a[_0x2d5791(0x1e8)](showInlineFeedback,_0xc23fef),_0x6a221a[_0x2d5791(0x1d8)](updateQuestionNav);}function showInlineFeedback(_0x46a3e7){const _0x3004ae=_0x243729,_0x53857a={'gowfH':function(_0x5955b5,_0x4bfe6e){return _0x5955b5-_0x4bfe6e;},'yCCar':function(_0x132e0f,_0x1d9c16){return _0x132e0f!==_0x1d9c16;},'nHFUU':'hYfUp','UdceU':_0x3004ae(0x218),'QkffV':_0x3004ae(0x39c),'rBRXa':_0x3004ae(0x3a7),'cdtrl':function(_0x434276,_0x225e66){return _0x434276===_0x225e66;},'vitND':'timed_study','yTcoO':_0x3004ae(0x499),'yjkUM':_0x3004ae(0x3dc),'uUNrx':_0x3004ae(0x250)};if(_0x53857a[_0x3004ae(0x17c)](currentMode,_0x3004ae(0x481))&&currentMode!==_0x53857a[_0x3004ae(0x164)])return;const _0x42c907=document[_0x3004ae(0x453)](_0x53857a[_0x3004ae(0x351)]),_0x1a88c2=_0x42c907[_0x3004ae(0x473)](_0x53857a[_0x3004ae(0x314)]),_0xf2b165=questionsData[currentQuestionIndex],_0x27e909=_0xf2b165[_0x3004ae(0x251)];let _0x176911=_0xf2b165[_0x3004ae(0x226)][_0x3004ae(0x17f)](_0x2eb9c9=>_0x2eb9c9['id']===_0x27e909);_0x42c907['classList'][_0x3004ae(0x344)](_0x53857a[_0x3004ae(0x1f7)]),_0x1a88c2['forEach']((_0x3b8a1d,_0x54dd2e)=>{const _0x3108b5=_0x3004ae,_0x1585e4={'RnahG':function(_0x2fe4f3,_0x27354c){const _0x8000e8=_0x2096;return _0x53857a[_0x8000e8(0x361)](_0x2fe4f3,_0x27354c);}};if(_0x53857a[_0x3108b5(0x17c)](_0x53857a[_0x3108b5(0x4aa)],_0x53857a['UdceU'])){_0x3b8a1d[_0x3108b5(0xda)][_0x3108b5(0x381)](_0x53857a[_0x3108b5(0x184)]);if(_0x54dd2e===_0x176911)_0x3b8a1d[_0x3108b5(0xda)][_0x3108b5(0x344)](_0x53857a[_0x3108b5(0x38f)]);else{if(_0x53857a[_0x3108b5(0x331)](_0x54dd2e,selectedOption)&&!_0x46a3e7)_0x3b8a1d['classList'][_0x3108b5(0x344)](_0x3108b5(0xd3));}}else _0x4d7dbe[_0x3a6682]['timeSpent']+=_0x1585e4[_0x3108b5(0x1df)](_0x1d985a[_0x3108b5(0x13f)](),_0x1bf5f6),_0x469569=_0x8fe7[_0x3108b5(0x13f)]();}),showSolution();}function showSolution(){const _0x1baa0a=_0x243729,_0x3ed27b={'QnUkN':_0x1baa0a(0x414),'eLxYk':function(_0x5aa141,_0x171d5f){return _0x5aa141+_0x171d5f;},'VtCge':_0x1baa0a(0xd1),'ohXPF':_0x1baa0a(0x310),'VgtLV':function(_0x421e6b,_0x30dc14){return _0x421e6b(_0x30dc14);},'gkODo':_0x1baa0a(0x3af),'FjOyQ':function(_0x31dbf5){return _0x31dbf5();},'aIrXv':function(_0xabbc0d,_0x1efbe3){return _0xabbc0d!==_0x1efbe3;},'nZlbc':_0x1baa0a(0x2be),'qEzcE':_0x1baa0a(0xd3),'furaA':'study','lTgAK':function(_0x160582,_0x4f8731){return _0x160582!==_0x4f8731;},'zZJNB':_0x1baa0a(0x48b),'nniJk':'solutionText','QJnFZ':_0x1baa0a(0x44c),'LJAkM':_0x1baa0a(0xe3),'aqFde':_0x1baa0a(0xfb),'ezDQX':function(_0x47dd58,_0x1a61fe){return _0x47dd58===_0x1a61fe;},'IJRVy':_0x1baa0a(0x125),'glKgT':_0x1baa0a(0x444),'xAtsY':_0x1baa0a(0x2d1),'NlwAa':'.m3u8','NmLBY':function(_0x5871d3,_0xabeb87,_0x361821){return _0x5871d3(_0xabeb87,_0x361821);},'kNsNx':_0x1baa0a(0x1da),'mfaYw':function(_0x2d700e,_0x32ac75){return _0x2d700e===_0x32ac75;},'rPYyr':_0x1baa0a(0x2b9),'KMQWU':_0x1baa0a(0x338),'iiMjU':_0x1baa0a(0x1ec),'KRSbo':'lHrvQ','NWzLm':_0x1baa0a(0x134)};if(_0x3ed27b[_0x1baa0a(0x1a3)](currentMode,_0x3ed27b['furaA'])&&_0x3ed27b['lTgAK'](currentMode,_0x3ed27b['zZJNB']))return;const _0x2c1d13=questionsData[currentQuestionIndex];document['getElementById'](_0x3ed27b['nniJk'])[_0x1baa0a(0x22c)]=_0x2c1d13['solution']||_0x3ed27b['QJnFZ'];const _0x192cef=document[_0x1baa0a(0x453)](_0x3ed27b[_0x1baa0a(0x2bc)]),_0x23630c=document[_0x1baa0a(0x453)](_0x3ed27b[_0x1baa0a(0x431)]),_0x4519e2=_0x2c1d13[_0x1baa0a(0x42c)];if(_0x4519e2){if(_0x3ed27b[_0x1baa0a(0x11d)](_0x3ed27b[_0x1baa0a(0x2f1)],_0x3ed27b[_0x1baa0a(0x1e7)])){const _0x3beef4=_0x26c283['createElement'](_0x3ed27b[_0x1baa0a(0x14d)]);_0x3beef4['textContent']=_0x3ed27b[_0x1baa0a(0x196)](_0x514ad3,0x1),_0x3beef4[_0x1baa0a(0x45f)]=_0x3ed27b[_0x1baa0a(0x288)],_0x3beef4[_0x1baa0a(0x2ab)]=()=>_0x7d3265(_0x446ebb),_0x3beef4['id']=_0x1baa0a(0x2ec)+_0x31d90f,_0x349fbb[_0x1baa0a(0x1ed)](_0x3beef4);}else{_0x192cef[_0x1baa0a(0xda)]['remove'](_0x3ed27b[_0x1baa0a(0x18c)]);if(_0x4519e2['includes'](_0x3ed27b[_0x1baa0a(0x28f)]))_0x3ed27b[_0x1baa0a(0x2a1)](setupVideo,_0x23630c,_0x4519e2);else _0x23630c[_0x1baa0a(0x3a5)]=_0x4519e2;}}else _0x192cef[_0x1baa0a(0xda)][_0x1baa0a(0x344)](_0x1baa0a(0x2d1));const _0x39bae0=document[_0x1baa0a(0x453)](_0x3ed27b[_0x1baa0a(0x1fe)]);_0x39bae0[_0x1baa0a(0x22c)]='';_0x2c1d13[_0x1baa0a(0x26a)]&&(_0x39bae0[_0x1baa0a(0x22c)]+=_0x1baa0a(0x2d4)+_0x2c1d13[_0x1baa0a(0x26a)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');if(_0x2c1d13['explanation_audio_hin']){if(_0x3ed27b['mfaYw'](_0x3ed27b[_0x1baa0a(0x470)],_0x3ed27b['rPYyr']))_0x39bae0[_0x1baa0a(0x22c)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22'+_0x2c1d13[_0x1baa0a(0x115)]+_0x1baa0a(0x326);else{if(!_0x35f9e4)_0xa5491a();_0x400fa4[_0x1baa0a(0x3c9)][_0x1baa0a(0x26e)]=_0x5bff24[_0x1baa0a(0x21f)]||_0x3ed27b[_0x1baa0a(0x130)];}}const _0x4bbf2b=document['getElementById'](_0x3ed27b[_0x1baa0a(0x100)]);_0x4bbf2b[_0x1baa0a(0x22c)]='',_0x2c1d13[_0x1baa0a(0x40d)]&&(_0x3ed27b[_0x1baa0a(0x188)]!==_0x3ed27b['KRSbo']?_0x2c1d13[_0x1baa0a(0x40d)][_0x1baa0a(0x14b)](_0x4742d0=>{const _0x4b5670=_0x1baa0a,_0x5ede3f={'dYSuB':function(_0x479d8a,_0x4e7a67){const _0xa2b20c=_0x2096;return _0x3ed27b[_0xa2b20c(0x34c)](_0x479d8a,_0x4e7a67);},'GssjO':_0x3ed27b[_0x4b5670(0x1e9)],'lAqJe':function(_0x11d170){const _0x2f934f=_0x4b5670;return _0x3ed27b[_0x2f934f(0x146)](_0x11d170);}};if(_0x3ed27b[_0x4b5670(0x1a3)]('mXfrM',_0x3ed27b[_0x4b5670(0x483)])){if(_0x4742d0)_0x4bbf2b[_0x4b5670(0x22c)]+=_0x4b5670(0x449)+_0x4742d0+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else _0x5ede3f[_0x4b5670(0x462)](_0x541b2e,_0x5ede3f[_0x4b5670(0x346)])&&_0x5ede3f['lAqJe'](_0x2d0226);}):(_0x4df4ad++,_0x10e3b6[_0x1baa0a(0x2b6)]=_0x3ed27b[_0x1baa0a(0x46c)])),document[_0x1baa0a(0x453)](_0x3ed27b[_0x1baa0a(0x29e)])[_0x1baa0a(0xda)][_0x1baa0a(0x381)](_0x3ed27b[_0x1baa0a(0x18c)]);}function submitQuiz(){const _0x1c80ff=_0x243729,_0x46fdaf={'hTIDl':_0x1c80ff(0x421),'CMtCP':_0x1c80ff(0x2c8),'GipuE':function(_0x4e135c){return _0x4e135c();},'hwxja':function(_0x38a807,_0xece479){return _0x38a807+_0xece479;},'cwSYe':'\x20-\x20Brain\x20And\x20Scalpel','YduiL':_0x1c80ff(0x2f4),'wUXgV':_0x1c80ff(0x169),'llRUV':function(_0x534d90,_0x36aae5){return _0x534d90!==_0x36aae5;},'Wvjbp':function(_0x13e223,_0x5af1e7){return _0x13e223===_0x5af1e7;},'tKRWT':_0x1c80ff(0x22d),'Utrlo':'incorrect','MgODO':function(_0x553a9d,_0x4a0940){return _0x553a9d(_0x4a0940);},'KWhVF':_0x1c80ff(0x3ef),'ovqET':function(_0x9b588,_0x246f98){return _0x9b588-_0x246f98;},'TifQR':_0x1c80ff(0x11b),'FNyps':function(_0x237ac8,_0x2d903c){return _0x237ac8+_0x2d903c;},'FHbVO':function(_0x10fcbd){return _0x10fcbd();},'OTijL':function(_0xb9f77,_0x5bccd5,_0x3b4f35,_0x2903aa,_0x411015){return _0xb9f77(_0x5bccd5,_0x3b4f35,_0x2903aa,_0x411015);},'OEcRf':function(_0x32c95e,_0x5931fb){return _0x32c95e+_0x5931fb;}};if(timer)_0x46fdaf[_0x1c80ff(0x1c9)](clearInterval,timer);if(!_0x46fdaf[_0x1c80ff(0x1c9)](confirm,_0x46fdaf[_0x1c80ff(0x187)]))return;isQuizCompleted=!![];let _0x3e3ea0=0x0,_0x234f75=0x0;const _0x4b17bd=_0x46fdaf['ovqET'](Date[_0x1c80ff(0x13f)](),quizStartTime);questionsData[_0x1c80ff(0x14b)]((_0x4b2618,_0x3a5009)=>{const _0x548b3a=_0x1c80ff,_0x274f9a={'qScKK':function(_0x32fad9,_0x5f0742){const _0x26508c=_0x2096;return _0x46fdaf[_0x26508c(0x41f)](_0x32fad9,_0x5f0742);},'lyiXF':_0x46fdaf[_0x548b3a(0x469)],'AReGs':_0x46fdaf[_0x548b3a(0x3d8)],'yLYlj':_0x548b3a(0x1c4)};if(_0x46fdaf[_0x548b3a(0x3d3)]==='AjnQd'){const _0x88074c=questionStates[_0x3a5009];_0x46fdaf['llRUV'](_0x88074c[_0x548b3a(0x2ae)],null)&&(_0x4b2618['choices'][_0x88074c[_0x548b3a(0x2ae)]]['id']===_0x4b2618[_0x548b3a(0x251)]?_0x46fdaf[_0x548b3a(0x289)](_0x548b3a(0x22d),_0x46fdaf[_0x548b3a(0x32e)])?(_0x3e3ea0++,_0x88074c[_0x548b3a(0x2b6)]=_0x548b3a(0x3a7)):(_0x4519b9['getElementById'](_0x46fdaf[_0x548b3a(0x2aa)])['style']['display']=_0x46fdaf[_0x548b3a(0x31c)],_0x46fdaf['GipuE'](_0x2bce77)):(_0x234f75++,_0x88074c[_0x548b3a(0x2b6)]=_0x46fdaf[_0x548b3a(0x1b8)]));}else _0x2ccd2e=_0x369547['questions'],_0x5389d2=_0x45921c[_0x548b3a(0x4a2)],_0x2f3c18=_0x38ca45[_0x548b3a(0x123)],_0x1ebcad[_0x548b3a(0x32a)]=_0x274f9a[_0x548b3a(0x3cd)](_0x2de579,_0x274f9a[_0x548b3a(0x3e5)]),_0x2fbf7d[_0x548b3a(0x453)](_0x274f9a[_0x548b3a(0x1f6)])['textContent']=_0x1cbbc3['length'],_0x56cc78[_0x548b3a(0x453)](_0x274f9a[_0x548b3a(0x3a0)])['textContent']=_0xbe8bf6[_0x548b3a(0x2d5)](_0x548b3a(0x25f));});const _0x3c631a=JSON[_0x1c80ff(0x497)](localStorage['getItem'](_0x46fdaf[_0x1c80ff(0x2a9)]))||[];_0x3c631a[_0x1c80ff(0x32d)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x1c80ff(0x13f)](),'totalTime':_0x4b17bd,'stats':{'correct':_0x3e3ea0,'incorrect':_0x234f75,'notAttempted':_0x46fdaf[_0x1c80ff(0x285)](questionsData[_0x1c80ff(0xdc)],_0x46fdaf[_0x1c80ff(0x194)](_0x3e3ea0,_0x234f75))}}),localStorage[_0x1c80ff(0x39d)]('quizPerformanceData',JSON['stringify'](_0x3c631a)),stats[_0x1c80ff(0x39a)]=_0x3e3ea0,stats[_0x1c80ff(0x47b)]=_0x234f75,_0x46fdaf[_0x1c80ff(0x29b)](markQuizAsCompleted),_0x46fdaf[_0x1c80ff(0x362)](showPerformanceAnalysis,_0x3e3ea0,_0x234f75,_0x46fdaf['ovqET'](questionsData[_0x1c80ff(0xdc)],_0x46fdaf['OEcRf'](_0x3e3ea0,_0x234f75)),_0x4b17bd);}function showPerformanceAnalysis(_0x2e5a6d,_0x2f9653,_0x5595fc,_0x2df71d){const _0x17b0d6=_0x243729,_0x36e022={'QRiLz':_0x17b0d6(0x1cb),'PYkNG':function(_0x3960c0,_0x347af6){return _0x3960c0>_0x347af6;},'hNHMT':function(_0x284372,_0x5aac83){return _0x284372+_0x5aac83;},'OymNc':function(_0xd69bdb,_0x25221e){return _0xd69bdb/_0x25221e;},'pWfuW':function(_0x885134,_0x15e03d){return _0x885134+_0x15e03d;},'Anizg':function(_0x3e7017,_0xa5e1dc){return _0x3e7017*_0xa5e1dc;},'pdWLg':function(_0x5dc509,_0x201e4e){return _0x5dc509-_0x201e4e;},'ZrnFk':function(_0x34f87e,_0x2acebc){return _0x34f87e/_0x2acebc;},'PMjSo':'accuracyScore','dVlBu':_0x17b0d6(0x260),'mBmcX':'notAttemptedResult','UxCAt':'totalTimeResult','DVGYg':function(_0x4eb9a5,_0x249c79){return _0x4eb9a5%_0x249c79;},'bTIML':'avgTimeResult','slIdZ':_0x17b0d6(0x2d1)},_0x4010b8=document[_0x17b0d6(0x453)](_0x36e022[_0x17b0d6(0x438)]),_0x8e8377=_0x36e022['PYkNG'](_0x36e022[_0x17b0d6(0x471)](_0x2e5a6d,_0x2f9653),0x0)?Math['round'](_0x36e022[_0x17b0d6(0x335)](_0x2e5a6d,_0x36e022[_0x17b0d6(0x375)](_0x2e5a6d,_0x2f9653))*0x64):0x0,_0x1bdbaf=_0x36e022[_0x17b0d6(0x278)](_0x36e022[_0x17b0d6(0x278)](0x2,Math['PI']),0x41),_0x7f65a6=document[_0x17b0d6(0x453)](_0x17b0d6(0x252));_0x7f65a6[_0x17b0d6(0x306)][_0x17b0d6(0x40e)]=_0x1bdbaf+'\x20'+_0x1bdbaf,_0x7f65a6['style']['strokeDashoffset']=_0x36e022[_0x17b0d6(0x1f2)](_0x1bdbaf,_0x36e022[_0x17b0d6(0x3fc)](_0x8e8377,0x64)*_0x1bdbaf),document[_0x17b0d6(0x453)](_0x36e022[_0x17b0d6(0x186)])[_0x17b0d6(0x2d6)]=_0x8e8377+'%',document[_0x17b0d6(0x453)](_0x17b0d6(0x17b))['textContent']=questionsData['length'],document[_0x17b0d6(0x453)](_0x17b0d6(0x2fb))[_0x17b0d6(0x2d6)]=_0x2e5a6d,document[_0x17b0d6(0x453)](_0x36e022[_0x17b0d6(0x464)])[_0x17b0d6(0x2d6)]=_0x2f9653,document[_0x17b0d6(0x453)](_0x36e022[_0x17b0d6(0x35d)])[_0x17b0d6(0x2d6)]=_0x5595fc;const _0x4a0722=Math[_0x17b0d6(0x317)](_0x2df71d/0xea60),_0x3b09a9=Math['floor'](_0x36e022[_0x17b0d6(0x335)](_0x2df71d%0xea60,0x3e8));document[_0x17b0d6(0x453)](_0x36e022[_0x17b0d6(0x28e)])[_0x17b0d6(0x2d6)]=_0x4a0722+':'+_0x3b09a9[_0x17b0d6(0x391)]()[_0x17b0d6(0x2db)](0x2,'0');const _0xc2afa9=_0x36e022[_0x17b0d6(0x335)](_0x2df71d,questionsData[_0x17b0d6(0xdc)]),_0x44fdd7=Math[_0x17b0d6(0x317)](_0x36e022['ZrnFk'](_0xc2afa9,0xea60)),_0x221933=Math['floor'](_0x36e022[_0x17b0d6(0x335)](_0x36e022[_0x17b0d6(0x25c)](_0xc2afa9,0xea60),0x3e8));document['getElementById'](_0x36e022[_0x17b0d6(0x1bf)])[_0x17b0d6(0x2d6)]=_0x44fdd7+':'+_0x221933[_0x17b0d6(0x391)]()[_0x17b0d6(0x2db)](0x2,'0'),_0x4010b8[_0x17b0d6(0xda)][_0x17b0d6(0x381)](_0x36e022[_0x17b0d6(0x23f)]);}function _0x2096(_0x78ede5,_0x24c9a1){const _0x3b1f56=_0xe69f();return _0x2096=function(_0x3fa278,_0x51b3b6){_0x3fa278=_0x3fa278-0xce;let _0x391c09=_0x3b1f56[_0x3fa278];return _0x391c09;},_0x2096(_0x78ede5,_0x24c9a1);}function closePerformanceModal(){const _0xa1845d=_0x243729,_0x37e014={'PHStm':_0xa1845d(0x1cb),'tvRXN':'hidden'};document[_0xa1845d(0x453)](_0x37e014['PHStm'])[_0xa1845d(0xda)]['add'](_0x37e014['tvRXN']);}function reviewQuestions(){const _0x5994d8=_0x243729,_0x2b6573={'unGVe':function(_0x5306a2,_0x318649){return _0x5306a2%_0x318649;},'wLZdp':function(_0x52d8c7,_0x4c0dfe){return _0x52d8c7+_0x4c0dfe;},'ZBZgg':function(_0x41c512,_0x4f4627){return _0x41c512+_0x4f4627;},'rAhjg':function(_0x3e14b2,_0x36f3a0){return _0x3e14b2===_0x36f3a0;},'syLVF':function(_0x1d8c6d,_0x42d5c9){return _0x1d8c6d===_0x42d5c9;},'SpmUU':_0x5994d8(0x426),'pVdqS':_0x5994d8(0x39c),'TeATk':function(_0x3e8d81,_0x20a1a5,_0x3732){return _0x3e8d81(_0x20a1a5,_0x3732);},'iEBht':_0x5994d8(0x340),'Hhrkf':_0x5994d8(0x337),'MzesB':_0x5994d8(0x2f5),'qtRCl':function(_0x3423bb,_0x12663f){return _0x3423bb!==_0x12663f;},'vfCht':function(_0x27059f,_0x237c70){return _0x27059f===_0x237c70;},'SuMVG':'DJJeQ','tQUJE':'tpZEq','Bkwco':function(_0x533fa9,_0x42670c){return _0x533fa9===_0x42670c;},'NyhRU':_0x5994d8(0x13b),'WArqc':'Correct','uWSPm':_0x5994d8(0xd3),'qORnQ':_0x5994d8(0x491),'GvlIk':function(_0x27d4a8,_0x348b77){return _0x27d4a8+_0x348b77;},'KwZdZ':_0x5994d8(0x3a7),'CUgBq':_0x5994d8(0x41b),'CwAad':_0x5994d8(0x3f4),'wfYaB':_0x5994d8(0x3aa),'SmOgq':'No\x20solution\x20available.','JKfrL':'questionReviewSection','yeXJs':_0x5994d8(0x2d1),'FPfKK':_0x5994d8(0x323),'Tztmr':function(_0x37748d){return _0x37748d();}};document['getElementById'](_0x2b6573[_0x5994d8(0xec)])[_0x5994d8(0xda)]['remove'](_0x2b6573['yeXJs']);const _0x39e13f=document[_0x5994d8(0x453)](_0x2b6573[_0x5994d8(0x24e)]);_0x39e13f['innerHTML']='',questionsData[_0x5994d8(0x14b)]((_0x3e24bf,_0x241261)=>{const _0x282ac1=_0x5994d8,_0x180a06={'gANBI':function(_0x1fbbbb,_0x3ea0b7){const _0x551faa=_0x2096;return _0x2b6573[_0x551faa(0x234)](_0x1fbbbb,_0x3ea0b7);},'NmjNR':_0x2b6573[_0x282ac1(0x21c)],'uIVzF':_0x2b6573[_0x282ac1(0x34a)],'DTtuc':function(_0x532165,_0x5a50d5){return _0x532165+_0x5a50d5;},'HkWws':_0x282ac1(0x43e),'WGsON':function(_0x1ea6f0,_0x559979,_0x50feba){const _0x3827ef=_0x282ac1;return _0x2b6573[_0x3827ef(0x269)](_0x1ea6f0,_0x559979,_0x50feba);}};if(_0x2b6573[_0x282ac1(0x234)](_0x2b6573[_0x282ac1(0x315)],_0x2b6573[_0x282ac1(0x315)])){const _0x1a863c=questionStates[_0x241261],_0x2652e4=_0x3e24bf['correct_choice_id'];let _0x5321d7=_0x2b6573[_0x282ac1(0x2ea)],_0x442c13=_0x2b6573[_0x282ac1(0x41d)];if(_0x2b6573['qtRCl'](_0x1a863c[_0x282ac1(0x2ae)],null)){if(_0x2b6573['vfCht'](_0x2b6573[_0x282ac1(0x49c)],_0x2b6573[_0x282ac1(0x286)])){const _0x4992fa=_0xa0c3[_0x282ac1(0x317)](_0x5eba72/0x3c),_0x50ea7b=_0x2b6573['unGVe'](_0x59c106,0x3c);_0x1368d4['getElementById'](_0x282ac1(0x274))[_0x282ac1(0x2d6)]=_0x2b6573['wLZdp'](_0x2b6573[_0x282ac1(0x190)](_0x4992fa,':'),_0x50ea7b[_0x282ac1(0x391)]()[_0x282ac1(0x2db)](0x2,'0'));}else{const _0x130c02=_0x3e24bf[_0x282ac1(0x226)][_0x1a863c[_0x282ac1(0x2ae)]];if(_0x2b6573[_0x282ac1(0x4a9)](_0x130c02['id'],_0x2652e4)){if(_0x2b6573['NyhRU']!=='iwwqg')_0x5321d7=_0x282ac1(0x3a7),_0x442c13=_0x2b6573['WArqc'];else{const _0x206fe9=_0x12365d[_0x282ac1(0x13a)](0x41+_0x56167b),_0x195f76=_0x180a06[_0x282ac1(0x36a)](_0x26dd8d,_0x4bf974),_0x298a49=_0x5edb62[_0x282ac1(0x292)](_0x180a06[_0x282ac1(0x31a)]);_0x298a49[_0x282ac1(0x22c)]=_0x282ac1(0x214)+(_0x195f76?_0x180a06[_0x282ac1(0x2d7)]:'')+_0x282ac1(0x30a)+_0x41266e+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x206fe9+_0x282ac1(0x376)+(_0x4e69e5[_0x282ac1(0x15f)]||_0x180a06['DTtuc'](_0x180a06[_0x282ac1(0x275)],_0x180a06[_0x282ac1(0x405)](_0x4116dd,0x1)))+_0x282ac1(0x1fc),_0x5e635d['appendChild'](_0x298a49);}}else _0x5321d7=_0x2b6573[_0x282ac1(0x24f)],_0x442c13=_0x2b6573[_0x282ac1(0x1d3)];}}const _0x4a8bc2=document[_0x282ac1(0x292)](_0x282ac1(0x426));_0x4a8bc2[_0x282ac1(0x45f)]=_0x282ac1(0xdf)+_0x5321d7;let _0x59dffc=(_0x3e24bf['choices']||[])['map']((_0xbbc29,_0x1f4a8c)=>{const _0x3bc532=_0x282ac1,_0x34482a=_0x1a863c['selectedAnswer']===_0x1f4a8c,_0x16f855=_0x2b6573[_0x3bc532(0x3a4)](_0xbbc29['id'],_0x2652e4);let _0xa04bf2='border-gray-600';if(_0x16f855)_0xa04bf2=_0x3bc532(0x262);else{if(_0x34482a)_0xa04bf2=_0x3bc532(0x3ee);}return _0x3bc532(0x2e3)+_0xa04bf2+_0x3bc532(0x410)+String[_0x3bc532(0x13a)](_0x2b6573[_0x3bc532(0x293)](0x41,_0x1f4a8c))+'</span><span>'+_0xbbc29[_0x3bc532(0x15f)]+_0x3bc532(0x12d);})['join']('');const _0x550bc6=_0x3e24bf[_0x282ac1(0x42c)]?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x241261+_0x282ac1(0x356)+_0x3e24bf[_0x282ac1(0x42c)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x481a84='';if(_0x3e24bf[_0x282ac1(0x26a)])_0x481a84+=_0x282ac1(0x264)+_0x3e24bf[_0x282ac1(0x26a)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x3e24bf[_0x282ac1(0x115)])_0x481a84+=_0x282ac1(0x276)+_0x3e24bf[_0x282ac1(0x115)]+_0x282ac1(0x326);let _0x449329=(_0x3e24bf[_0x282ac1(0x40d)]||[])['map'](_0x22f194=>_0x22f194?_0x282ac1(0x449)+_0x22f194+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')[_0x282ac1(0x2d5)]('');_0x4a8bc2['innerHTML']=_0x282ac1(0x34b)+_0x2b6573['GvlIk'](_0x241261,0x1)+_0x282ac1(0x245)+(_0x2b6573[_0x282ac1(0x4a9)](_0x5321d7,_0x2b6573[_0x282ac1(0x458)])?_0x2b6573[_0x282ac1(0x29a)]:_0x5321d7===_0x2b6573[_0x282ac1(0x24f)]?_0x2b6573[_0x282ac1(0x416)]:_0x2b6573[_0x282ac1(0x34f)])+_0x282ac1(0x429)+_0x442c13+_0x282ac1(0x349)+_0x3e24bf[_0x282ac1(0x15f)]+_0x282ac1(0x140)+_0x59dffc+_0x282ac1(0x16b)+(_0x3e24bf[_0x282ac1(0x2f3)]||_0x2b6573[_0x282ac1(0x372)])+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x550bc6+_0x282ac1(0x1c5)+_0x481a84+_0x282ac1(0x1c5)+_0x449329+_0x282ac1(0x3d0),_0x39e13f[_0x282ac1(0x1ed)](_0x4a8bc2);}else{_0x39f7b0['classList']['remove'](_0x282ac1(0x2d1));if(_0x1290fd['includes'](_0x282ac1(0x104)))_0x180a06[_0x282ac1(0x31e)](_0x7646e9,_0xce717d,_0x45b2ca);else _0x3ccdfe[_0x282ac1(0x3a5)]=_0x162e41;}}),_0x2b6573[_0x5994d8(0x41e)](initializeReviewVideos);}function initializeReviewVideos(){const _0x161dbd=_0x243729,_0x42a322={'zlEbu':_0x161dbd(0x104),'NNBEq':_0x161dbd(0x174),'ZLJeE':_0x161dbd(0x1e5),'wENwt':'video[data-src]'};document[_0x161dbd(0x473)](_0x42a322['wENwt'])['forEach'](_0x2b9f13=>{const _0x11dcc5=_0x161dbd,_0x32d6b9={'NwQTC':_0x11dcc5(0x3b6)},_0x1a92b1=_0x2b9f13[_0x11dcc5(0x177)][_0x11dcc5(0x3a5)];if(_0x1a92b1&&_0x1a92b1[_0x11dcc5(0x307)](_0x42a322[_0x11dcc5(0x1b4)]))setupVideo(_0x2b9f13,_0x1a92b1);else _0x1a92b1&&(_0x42a322[_0x11dcc5(0x3bd)]===_0x42a322[_0x11dcc5(0x272)]?_0x36ac0b['getElementById'](_0x32d6b9[_0x11dcc5(0x35a)])[_0x11dcc5(0xda)][_0x11dcc5(0x381)](_0x11dcc5(0x2d1)):_0x2b9f13[_0x11dcc5(0x3a5)]=_0x1a92b1);});}function retakeQuiz(){const _0x45014e=_0x243729,_0xfc19ec={'bTxfT':function(_0x252a9d,_0x481922){return _0x252a9d===_0x481922;},'PvgxI':'selected','pnjLb':function(_0x330d99,_0x186da6){return _0x330d99+_0x186da6;},'TSXsu':function(_0xc6ed02,_0x19f2a3){return _0xc6ed02+_0x19f2a3;},'RxOxt':_0x45014e(0x3dc),'CjgFL':function(_0x1ed18b,_0x5cf55d){return _0x1ed18b(_0x5cf55d);},'Itivd':'data-option-index','GKBHz':function(_0x2685ca,_0x265b4a){return _0x2685ca(_0x265b4a);},'UtcXK':_0x45014e(0x32c),'hqIku':function(_0x3aec86,_0x3580bf){return _0x3aec86(_0x3580bf);},'qZjAf':_0x45014e(0xe9),'oXTnA':_0x45014e(0x175),'RmIzL':_0x45014e(0x2da),'snWqk':function(_0xb3df4d){return _0xb3df4d();}};if(_0xfc19ec['hqIku'](confirm,_0x45014e(0x1ba))){if(window[_0x45014e(0x3c9)]['pathname'][_0x45014e(0x30e)](_0xfc19ec[_0x45014e(0x217)])){if(_0xfc19ec[_0x45014e(0x358)]===_0xfc19ec['RmIzL']){const _0x2af427={'QdYgu':function(_0x3613a3,_0x2a4330){return _0xfc19ec['bTxfT'](_0x3613a3,_0x2a4330);},'rFCeS':_0xfc19ec['PvgxI'],'FSWKW':function(_0x390321,_0x325653){const _0x3b857b=_0x45014e;return _0xfc19ec[_0x3b857b(0x248)](_0x390321,_0x325653);},'GEUBY':function(_0x3de50c,_0x420369){const _0xbbaee7=_0x45014e;return _0xfc19ec[_0xbbaee7(0x49a)](_0x3de50c,_0x420369);},'zuQeD':_0xfc19ec['RxOxt'],'AfbwM':function(_0x358eb2,_0x30b57d){const _0x271f94=_0x45014e;return _0xfc19ec[_0x271f94(0x239)](_0x358eb2,_0x30b57d);},'mNORg':_0xfc19ec[_0x45014e(0x198)],'SLAbK':function(_0x39f316,_0x221b8d){const _0xed79d1=_0x45014e;return _0xfc19ec[_0xed79d1(0x452)](_0x39f316,_0x221b8d);}};_0x4d3351[_0x45014e(0x226)][_0x45014e(0x14b)]((_0x568e49,_0x57bd17)=>{const _0x3be9a5=_0x45014e,_0x2b8d37=_0x24b7fd['fromCharCode'](0x41+_0x57bd17),_0x17aea8=_0x2af427[_0x3be9a5(0x2b7)](_0x404d88,_0x57bd17),_0xba7571=_0x4b4c7b[_0x3be9a5(0x292)](_0x3be9a5(0x426));_0xba7571[_0x3be9a5(0x22c)]=_0x3be9a5(0x214)+(_0x17aea8?_0x2af427['rFCeS']:'')+_0x3be9a5(0x30a)+_0x57bd17+_0x3be9a5(0x119)+_0x2b8d37+_0x3be9a5(0x376)+(_0x568e49[_0x3be9a5(0x15f)]||_0x2af427['FSWKW'](_0x3be9a5(0x43e),_0x2af427[_0x3be9a5(0x3bf)](_0x57bd17,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x30d50e['appendChild'](_0xba7571);}),_0x53946d['addEventListener'](_0xfc19ec[_0x45014e(0x105)],function(_0xeb2343){const _0x54ba38=_0x45014e,_0x48ee87=_0xeb2343['target'][_0x54ba38(0x20a)](_0x2af427[_0x54ba38(0x413)]);if(_0x48ee87){const _0x50adef=_0x2af427['AfbwM'](_0x143395,_0x48ee87['getAttribute'](_0x2af427[_0x54ba38(0x1f5)]));_0x2af427[_0x54ba38(0x1d6)](_0x307654,_0x50adef);}});}else localStorage[_0x45014e(0x494)](_0x45014e(0x103));}_0xfc19ec[_0x45014e(0x1cf)](clearProgress),location[_0x45014e(0x183)]();}}function loadBookmarkedQuestions(){const _0x2a1a54=_0x243729,_0x5f20a0={'JmPAG':function(_0x15ba73,_0x11bf51){return _0x15ba73!==_0x11bf51;},'yFOWY':_0x2a1a54(0x2bd),'zbtSw':function(_0xca884e,_0x447e74){return _0xca884e!==_0x447e74;},'dcpsh':_0x2a1a54(0x2cb),'apghg':function(_0x2b8469,_0x184fd1){return _0x2b8469<_0x184fd1;},'EIvJT':_0x2a1a54(0xe5)},_0x3c48a7=JSON[_0x2a1a54(0x497)](localStorage[_0x2a1a54(0x14e)](_0x5f20a0[_0x2a1a54(0x228)]))||[];_0x3c48a7[_0x2a1a54(0x14b)](_0x281be1=>{const _0x4e25c4=_0x2a1a54,_0x2b534b={'ljeHP':function(_0x3995e8){return _0x3995e8();}};_0x5f20a0['JmPAG'](_0x5f20a0[_0x4e25c4(0x131)],_0x5f20a0[_0x4e25c4(0x131)])?_0x709e25=_0x762cd8:_0x281be1[_0x4e25c4(0xf8)][_0x4e25c4(0x307)](quizName['toLowerCase']()[_0x4e25c4(0x313)](/ /g,'-'))&&(_0x5f20a0[_0x4e25c4(0x40c)]('WAwcQ',_0x5f20a0['dcpsh'])?_0x5f20a0[_0x4e25c4(0x330)](_0x281be1[_0x4e25c4(0x461)],questionsData[_0x4e25c4(0xdc)])&&(questionStates[_0x281be1[_0x4e25c4(0x461)]][_0x4e25c4(0x366)]=!![]):(_0x5e2fff[_0x479c45][_0x4e25c4(0x143)]=!_0x1c5190[_0x1edec7]['markedForReview'],_0x2b534b[_0x4e25c4(0x46b)](_0x527c47),_0x340e50()));});}function toggleBookmark(){const _0x28923e=_0x243729,_0x433bf8={'QoGoP':function(_0x5c10c5){return _0x5c10c5();},'URbtZ':'bookmarkedQuestions','jgAOX':function(_0x575dd4,_0x535be2){return _0x575dd4!==_0x535be2;},'ZXjbK':_0x28923e(0x16c),'IsVvD':function(_0x50754f){return _0x50754f();}},_0x3b995b=!questionStates[currentQuestionIndex][_0x28923e(0x366)];questionStates[currentQuestionIndex][_0x28923e(0x366)]=_0x3b995b;let _0xb7d401=JSON[_0x28923e(0x497)](localStorage[_0x28923e(0x14e)](_0x433bf8[_0x28923e(0x277)]))||[];if(_0x3b995b){const _0x5729e7={'quizName':quizName,'quizFile':window['location']['pathname']['split']('/')[_0x28923e(0x25b)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0xb7d401[_0x28923e(0x32d)](_0x5729e7);}else _0x433bf8['jgAOX'](_0x433bf8[_0x28923e(0x36c)],_0x433bf8[_0x28923e(0x36c)])?_0x433bf8[_0x28923e(0x157)](_0x41f4c5):_0xb7d401=_0xb7d401[_0x28923e(0x49b)](_0x3da46c=>!(_0x3da46c['quizFile'][_0x28923e(0x307)](quizName[_0x28923e(0x49f)]()[_0x28923e(0x313)](/ /g,'-'))&&_0x3da46c[_0x28923e(0x461)]===currentQuestionIndex));localStorage[_0x28923e(0x39d)](_0x433bf8[_0x28923e(0x277)],JSON[_0x28923e(0x273)](_0xb7d401)),updateBookmarkButton(),_0x433bf8[_0x28923e(0x1a2)](updateQuestionNav);}function updateBookmarkButton(){const _0x11080a=_0x243729,_0x4ffc82={'RJiTp':_0x11080a(0x489),'IjNmx':_0x11080a(0x3ec),'kpyeE':_0x11080a(0x3d9),'tORyM':'Bookmarked','FoWlm':_0x11080a(0x31d)},_0x3465a6=document[_0x11080a(0x453)](_0x4ffc82[_0x11080a(0x1ef)]),_0x31cb98=document[_0x11080a(0x453)](_0x4ffc82[_0x11080a(0x3c1)]),_0x117d61=questionStates[currentQuestionIndex][_0x11080a(0x366)];_0x3465a6[_0x11080a(0x45f)]=_0x117d61?_0x11080a(0x211):_0x4ffc82['kpyeE'],_0x31cb98[_0x11080a(0x2d6)]=_0x117d61?_0x4ffc82['tORyM']:_0x4ffc82[_0x11080a(0x409)];}function toggleMarkForReview(){const _0x57c364=_0x243729,_0x37f49d={'AeQEH':function(_0x3ad102){return _0x3ad102();}};questionStates[currentQuestionIndex][_0x57c364(0x143)]=!questionStates[currentQuestionIndex][_0x57c364(0x143)],_0x37f49d[_0x57c364(0x433)](updateMarkReviewButton),updateQuestionNav();}function updateMarkReviewButton(){const _0x5a16fc=_0x243729,_0x31d9b5={'UDypI':_0x5a16fc(0x425),'LQwjo':_0x5a16fc(0x3a3),'ZiafO':_0x5a16fc(0x46e),'eHijL':_0x5a16fc(0x1e6),'EKtzG':_0x5a16fc(0x10f)},_0x2b41f8=document['getElementById'](_0x31d9b5[_0x5a16fc(0x1a1)]),_0x43d83d=document['getElementById'](_0x31d9b5['LQwjo']),_0x537afe=questionStates[currentQuestionIndex][_0x5a16fc(0x143)];_0x2b41f8[_0x5a16fc(0x45f)]=_0x537afe?_0x31d9b5['ZiafO']:_0x31d9b5[_0x5a16fc(0x30d)],_0x43d83d[_0x5a16fc(0x2d6)]=_0x537afe?'Marked':_0x31d9b5[_0x5a16fc(0x2e1)];}function previousQuestion(){const _0x55f424=_0x243729,_0x25bb09={'LQgPW':function(_0x195921,_0x38e6ff){return _0x195921>_0x38e6ff;},'BcVnh':_0x55f424(0x151),'btFia':_0x55f424(0x3fa),'TELAj':function(_0x50e67d,_0x37ed15){return _0x50e67d-_0x37ed15;},'ujvxU':function(_0xee4984){return _0xee4984();}};_0x25bb09[_0x55f424(0x212)](currentQuestionIndex,0x0)&&(_0x25bb09[_0x55f424(0x408)]===_0x25bb09[_0x55f424(0xd2)]?_0x58258d['src']=_0x55d69a:(questionStartTime&&(questionStates[currentQuestionIndex][_0x55f424(0x2b5)]+=_0x25bb09[_0x55f424(0x18b)](Date[_0x55f424(0x13f)](),questionStartTime)),currentQuestionIndex--,_0x25bb09[_0x55f424(0x280)](displayQuestion),_0x25bb09[_0x55f424(0x280)](saveProgress)));}function nextQuestion(){const _0x56a06f=_0x243729,_0x3bfb88={'cRvJX':function(_0x3755d7,_0x599289){return _0x3755d7===_0x599289;},'usgrv':_0x56a06f(0x48b),'UQKGA':_0x56a06f(0x28d),'uAcYk':_0x56a06f(0x2d3),'zyJZP':_0x56a06f(0x12b),'bjPGw':function(_0x54a978,_0x3e3018){return _0x54a978>_0x3e3018;},'aAaYI':function(_0x3e8dcc,_0x2afafc){return _0x3e8dcc*_0x2afafc;},'fIRWY':function(_0x33ed51,_0x410016){return _0x33ed51/_0x410016;},'vYOwW':_0x56a06f(0xde),'UVOpJ':function(_0x4d5fd1,_0x28444f){return _0x4d5fd1+_0x28444f;},'wlDbt':function(_0xb85514,_0x3cc1be){return _0xb85514/_0x3cc1be;},'dUjMt':function(_0x34ddaf,_0x5efad7){return _0x34ddaf%_0x5efad7;},'XKRtO':function(_0x57ab95,_0x219483){return _0x57ab95===_0x219483;},'CvZHW':_0x56a06f(0x3c6),'kjBYs':function(_0x3f8830,_0x506361){return _0x3f8830-_0x506361;},'wUPMQ':function(_0x36fd49,_0x1a705a){return _0x36fd49<_0x1a705a;},'YuwNL':function(_0x200c7c){return _0x200c7c();},'OsuwC':_0x56a06f(0x327),'yJcyT':function(_0x1e3d88,_0x33b0c2){return _0x1e3d88(_0x33b0c2);},'cGcxi':_0x56a06f(0x3af),'QnsWh':function(_0x11a155,_0x175588){return _0x11a155!==_0x175588;},'ibsrJ':function(_0x32ea3b){return _0x32ea3b();}};if(questionStartTime){if(_0x3bfb88[_0x56a06f(0x3b1)](_0x3bfb88[_0x56a06f(0x418)],_0x56a06f(0x3c6)))questionStates[currentQuestionIndex][_0x56a06f(0x2b5)]+=_0x3bfb88['kjBYs'](Date[_0x56a06f(0x13f)](),questionStartTime);else{if(_0x3bfb88[_0x56a06f(0x355)](_0x501339,_0x56a06f(0x481))||_0x3e53a3===_0x3bfb88[_0x56a06f(0x432)]){_0x361884['getElementById'](_0x3bfb88[_0x56a06f(0x379)])['textContent']=_0x7160bd[_0x56a06f(0x39a)],_0x948b5f['getElementById'](_0x3bfb88['uAcYk'])[_0x56a06f(0x2d6)]=_0x5be8fc[_0x56a06f(0x47b)],_0x32a521[_0x56a06f(0x453)](_0x3bfb88[_0x56a06f(0x23e)])[_0x56a06f(0x2d6)]=_0x13d1d8[_0x56a06f(0x12b)];const _0x1b83ad=_0x3bfb88[_0x56a06f(0x2fe)](_0x4de729[_0x56a06f(0x12b)],0x0)?_0x4009c9[_0x56a06f(0x350)](_0x3bfb88[_0x56a06f(0x476)](_0x3bfb88['fIRWY'](_0x117dc5['correctAnswers'],_0x1e3080[_0x56a06f(0x12b)]),0x64)):0x0;_0x59d2a5[_0x56a06f(0x453)](_0x3bfb88[_0x56a06f(0x2b2)])[_0x56a06f(0x2d6)]=_0x3bfb88['UVOpJ'](_0x1b83ad,'%'),_0x3a6e7a['totalTime']=_0x59bdb5[_0x56a06f(0x1e4)]((_0x410df3,_0x5975a6)=>_0x410df3+_0x5975a6['timeSpent'],0x0);const _0x21f055=_0x519c77[_0x56a06f(0x317)](_0x3bfb88['fIRWY'](_0x435b2d['totalTime'],0x3e8)),_0x1ceb40=_0x313587[_0x56a06f(0x317)](_0x3bfb88['wlDbt'](_0x21f055,0x3c)),_0x1604dd=_0x3bfb88[_0x56a06f(0x201)](_0x21f055,0x3c);_0x5ed52c[_0x56a06f(0x453)](_0x56a06f(0x2b5))[_0x56a06f(0x2d6)]=_0x3bfb88[_0x56a06f(0x35c)](_0x1ceb40+':',_0x1604dd[_0x56a06f(0x391)]()[_0x56a06f(0x2db)](0x2,'0'));}}}if(_0x3bfb88[_0x56a06f(0x191)](currentQuestionIndex,_0x3bfb88[_0x56a06f(0x354)](questionsData[_0x56a06f(0xdc)],0x1)))currentQuestionIndex++,_0x3bfb88[_0x56a06f(0x339)](displayQuestion),_0x3bfb88[_0x56a06f(0x339)](saveProgress);else{if(currentMode===_0x56a06f(0x3eb)||_0x3bfb88[_0x56a06f(0x355)](currentMode,_0x3bfb88[_0x56a06f(0x451)]))_0x3bfb88['yJcyT'](confirm,_0x3bfb88['cGcxi'])&&submitQuiz();else{if(_0x3bfb88[_0x56a06f(0x47f)](confirm,'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?')){if(_0x3bfb88[_0x56a06f(0x39e)](_0x56a06f(0x1bb),_0x56a06f(0x454)))currentQuestionIndex=0x0,_0x3bfb88['ibsrJ'](displayQuestion),_0x3bfb88[_0x56a06f(0x339)](saveProgress);else{const _0x2d5c71=new _0x4668ae();_0x2d5c71[_0x56a06f(0xe0)](_0x1b8aca),_0x2d5c71[_0x56a06f(0x382)](_0x79b16b);}}}}}function startTimer(){const _0x4083a3=_0x243729,_0xb1c817={'CxzoC':function(_0x5644d5){return _0x5644d5();},'QiWvX':_0x4083a3(0x39c),'fjNTV':function(_0x1bcaa0,_0x19cbb5){return _0x1bcaa0===_0x19cbb5;},'wfsYW':'ukyXD','JFVgd':function(_0x47d0da,_0x5d5f48){return _0x47d0da<=_0x5d5f48;},'paCdK':function(_0x551cc2,_0x260c85){return _0x551cc2(_0x260c85);},'ZlGXJ':'timed_exam','idFwG':_0x4083a3(0x18f),'wxSUc':function(_0x3a3a14){return _0x3a3a14();},'NhGml':function(_0x171a83,_0x420a28,_0x3ce38d){return _0x171a83(_0x420a28,_0x3ce38d);}};if(timer)clearInterval(timer);timeRemaining=0x78,_0xb1c817[_0x4083a3(0x3a2)](updateTimerDisplay),timer=_0xb1c817[_0x4083a3(0x3c4)](setInterval,()=>{const _0x4f27fa=_0x4083a3,_0x1f2ee9={'SUZBr':_0xb1c817[_0x4f27fa(0x3e3)],'GxAbM':function(_0x24d13c,_0x23b822){const _0x4b8fce=_0x4f27fa;return _0xb1c817[_0x4b8fce(0x446)](_0x24d13c,_0x23b822);}};if(_0xb1c817['wfsYW']===_0x4f27fa(0x253))_0x284ed0['classList']['toggle'](_0x1f2ee9[_0x4f27fa(0x3da)],_0x1f2ee9[_0x4f27fa(0x496)](_0x54ef98,_0x254a89));else{timeRemaining--,_0xb1c817[_0x4f27fa(0x342)](updateTimerDisplay);if(_0xb1c817['JFVgd'](timeRemaining,0x0)){_0xb1c817[_0x4f27fa(0x43b)](clearInterval,timer);if(_0xb1c817[_0x4f27fa(0x446)](currentMode,_0xb1c817[_0x4f27fa(0x365)]))_0xb1c817[_0x4f27fa(0x446)](_0xb1c817[_0x4f27fa(0x206)],_0xb1c817[_0x4f27fa(0x206)])?submitQuiz():_0xb1c817[_0x4f27fa(0x342)](_0x353b7e);else{if(_0xb1c817['fjNTV'](_0x4f27fa(0x445),_0x4f27fa(0x394))){if(_0x559487){const _0x113fb1=_0x1ba777[_0x4f27fa(0x2c9)](_0x24fbaa,arguments);return _0x4f8a7c=null,_0x113fb1;}}else nextQuestion();}}}},0x3e8);}function updateTimerDisplay(){const _0x567c8f=_0x243729,_0x19f9e2={'SANQR':function(_0x2d7d55,_0x775eb9){return _0x2d7d55/_0x775eb9;},'ThmaT':function(_0x449258,_0x54f666){return _0x449258%_0x54f666;},'pWmst':_0x567c8f(0x274),'PDOPJ':function(_0x9edcfa,_0x3b7582){return _0x9edcfa+_0x3b7582;}},_0x34616f=Math['floor'](_0x19f9e2['SANQR'](timeRemaining,0x3c)),_0x276d9e=_0x19f9e2[_0x567c8f(0x27e)](timeRemaining,0x3c);document[_0x567c8f(0x453)](_0x19f9e2[_0x567c8f(0x308)])[_0x567c8f(0x2d6)]=_0x19f9e2['PDOPJ'](_0x19f9e2[_0x567c8f(0x456)](_0x34616f,':'),_0x276d9e['toString']()['padStart'](0x2,'0'));}function toggleSidebar(){const _0x5416ea=_0x243729,_0x22e1c6={'XOhNC':'quizSidebar','NZoWv':'open'};document['getElementById'](_0x22e1c6[_0x5416ea(0x153)])[_0x5416ea(0xda)][_0x5416ea(0x106)](_0x22e1c6[_0x5416ea(0x21e)]);}document[_0x243729(0x25a)](_0x243729(0x110),()=>{const _0x1da5b3=_0x243729,_0x3840ce={'ukhxY':function(_0xe2b220){return _0xe2b220();},'OFFDh':_0x1da5b3(0x421),'HbBCI':_0x1da5b3(0x2c8),'XaBhe':function(_0x12d08e){return _0x12d08e();},'eJBHU':_0x1da5b3(0x3f0),'QUPzc':_0x1da5b3(0xe9),'uMylb':function(_0x4c1f5b){return _0x4c1f5b();}};if(resume)_0x3840ce['ukhxY'](loadProgress)?(document[_0x1da5b3(0x453)](_0x3840ce[_0x1da5b3(0x3d7)])['style'][_0x1da5b3(0x2e9)]=_0x3840ce[_0x1da5b3(0x41a)],_0x3840ce[_0x1da5b3(0x3de)](initializeQuiz)):(_0x3840ce[_0x1da5b3(0x202)](clearProgress),document[_0x1da5b3(0x453)](_0x1da5b3(0x421))[_0x1da5b3(0x306)][_0x1da5b3(0x2e9)]=_0x3840ce[_0x1da5b3(0x24a)]);else!window[_0x1da5b3(0x3c9)]['pathname'][_0x1da5b3(0x30e)](_0x3840ce[_0x1da5b3(0x22b)])?(_0x3840ce[_0x1da5b3(0x397)](clearProgress),document[_0x1da5b3(0x453)](_0x3840ce[_0x1da5b3(0x3d7)])['style']['display']=_0x3840ce[_0x1da5b3(0x24a)]):_0x3840ce['XaBhe'](initializeQuiz);}),document[_0x243729(0x25a)]('keydown',function(_0x758ed5){const _0x2bf19b=_0x243729,_0x1ef3dc={'MoUMU':_0x2bf19b(0x30b),'maMfd':'application/vnd.apple.mpegurl','rKEwR':function(_0x25f421){return _0x25f421();},'JgZLE':_0x2bf19b(0x421),'YjHDc':_0x2bf19b(0x2c8),'zyYTk':function(_0x237a12){return _0x237a12();},'qmLrF':_0x2bf19b(0x3f0),'kKeZu':_0x2bf19b(0x1cb),'gAogd':'hidden','AsUJi':function(_0x18d0f0,_0x6adcfa){return _0x18d0f0>=_0x6adcfa;},'EMoCQ':function(_0x33e0e8,_0x346065){return _0x33e0e8<=_0x346065;},'LDupS':function(_0x1ce043,_0x54cf6d){return _0x1ce043!==_0x54cf6d;},'EmMTB':_0x2bf19b(0x36b),'sgvJp':function(_0x2ef5c2,_0x3ba6dd){return _0x2ef5c2-_0x3ba6dd;},'kVvjo':function(_0x12317c,_0x417d9f){return _0x12317c(_0x417d9f);},'kIRKk':_0x2bf19b(0x3dc),'xQRTo':function(_0xc44ffc,_0x51ffa8){return _0xc44ffc(_0x51ffa8);},'ZHLoU':function(_0x582cf9,_0x28b19c){return _0x582cf9===_0x28b19c;},'cbUrG':'ArrowLeft','hcCfL':'auhZv','fAJsO':function(_0x2d0e27,_0x2c1962){return _0x2d0e27===_0x2c1962;},'sflXJ':'ArrowRight','gyAyp':function(_0x3714bd,_0x5b5699){return _0x3714bd===_0x5b5699;},'EHDbA':_0x2bf19b(0x136),'KsGIz':_0x2bf19b(0x441),'bUxWh':_0x2bf19b(0x481),'BYrQN':function(_0x4cbe94,_0x561ccb){return _0x4cbe94===_0x561ccb;},'sgRNq':_0x2bf19b(0x404),'zjLnx':function(_0x1225cc){return _0x1225cc();},'NtESj':function(_0x4d0e8a,_0x19c465){return _0x4d0e8a===_0x19c465;},'KIgwe':_0x2bf19b(0x3eb),'ejejN':function(_0x56ee92,_0x55ec43){return _0x56ee92===_0x55ec43;},'jsKzD':'timed_exam','XJIJR':function(_0x3334c6,_0x4ef50f){return _0x3334c6===_0x4ef50f;},'vuBfZ':'inyZF','rWCtl':_0x2bf19b(0x166),'ItjOt':function(_0x318328){return _0x318328();},'lczdN':function(_0x2997a1,_0x3c7d53){return _0x2997a1===_0x3c7d53;},'lszpW':function(_0x10060b){return _0x10060b();}};if(document[_0x2bf19b(0x453)](_0x1ef3dc[_0x2bf19b(0x208)])[_0x2bf19b(0x306)][_0x2bf19b(0x2e9)]!==_0x1ef3dc['YjHDc'])return;if(document[_0x2bf19b(0x453)](_0x1ef3dc[_0x2bf19b(0x27c)])[_0x2bf19b(0xda)]['contains'](_0x1ef3dc[_0x2bf19b(0x3fd)])===![])return;if(_0x1ef3dc['AsUJi'](_0x758ed5[_0x2bf19b(0x3b2)],'1')&&_0x1ef3dc['EMoCQ'](_0x758ed5[_0x2bf19b(0x3b2)],'4')){if(_0x1ef3dc[_0x2bf19b(0x3c5)](_0x1ef3dc['EmMTB'],_0x1ef3dc[_0x2bf19b(0x2d9)])){if(_0x185470)return;const _0x555dff=_0x64f98b[_0x2bf19b(0x497)](_0x3107a1['getItem'](_0x1ef3dc[_0x2bf19b(0x311)]))||{};_0x555dff[_0x4783ed]={'questionStates':_0x446c22,'stats':_0x461070,'currentQuestionIndex':_0x183f5e,'currentMode':_0x123d2f,'status':_0x2bf19b(0x393),'lastSeen':new _0x3c0ff1()[_0x2bf19b(0x1af)]()},_0x4e0fe9[_0x2bf19b(0x39d)](_0x1ef3dc[_0x2bf19b(0x311)],_0x403a9f[_0x2bf19b(0x273)](_0x555dff));}else{const _0x11fe1c=_0x1ef3dc[_0x2bf19b(0x2ce)](_0x1ef3dc[_0x2bf19b(0x242)](parseInt,_0x758ed5[_0x2bf19b(0x3b2)]),0x1),_0x5f40ff=document[_0x2bf19b(0x473)](_0x1ef3dc['kIRKk']);if(_0x11fe1c<_0x5f40ff[_0x2bf19b(0xdc)])_0x1ef3dc['xQRTo'](selectOption,_0x11fe1c);}}else{if(_0x1ef3dc['ZHLoU'](_0x758ed5[_0x2bf19b(0x3b2)],_0x1ef3dc[_0x2bf19b(0x1b0)]))_0x1ef3dc[_0x2bf19b(0x1d0)]!==_0x2bf19b(0x124)?previousQuestion():_0x212274=_0x2bf19b(0x4a3);else{if(_0x1ef3dc[_0x2bf19b(0x3d1)](_0x758ed5[_0x2bf19b(0x3b2)],_0x1ef3dc[_0x2bf19b(0x240)])||_0x758ed5[_0x2bf19b(0x3b2)]==='\x20'){if(_0x1ef3dc[_0x2bf19b(0x259)](_0x1ef3dc[_0x2bf19b(0x1d1)],_0x1ef3dc[_0x2bf19b(0x40a)])){if(_0x1ffed1[_0x2bf19b(0x321)]()){const _0x37b92a=new _0x16e126();_0x37b92a[_0x2bf19b(0xe0)](_0x145f9f),_0x37b92a[_0x2bf19b(0x382)](_0x1f58c4);}else _0x45304a[_0x2bf19b(0x422)](_0x1ef3dc[_0x2bf19b(0x3e1)])&&(_0x524d77['src']=_0x5668e4);}else _0x758ed5[_0x2bf19b(0x23b)](),_0x1ef3dc[_0x2bf19b(0x297)](nextQuestion);}else{if(_0x758ed5[_0x2bf19b(0x3b2)]['toLowerCase']()==='b'&&(_0x1ef3dc[_0x2bf19b(0x3d1)](currentMode,_0x1ef3dc[_0x2bf19b(0x256)])||_0x1ef3dc[_0x2bf19b(0x200)](currentMode,_0x2bf19b(0x48b))))_0x1ef3dc[_0x2bf19b(0x1d5)]!==_0x1ef3dc[_0x2bf19b(0x1d5)]?_0x1ef3dc[_0x2bf19b(0x297)](_0x64e1e9)?(_0x378774[_0x2bf19b(0x453)](_0x1ef3dc[_0x2bf19b(0x208)])[_0x2bf19b(0x306)][_0x2bf19b(0x2e9)]=_0x1ef3dc[_0x2bf19b(0x2ef)],_0x1ef3dc[_0x2bf19b(0x297)](_0x42c3d8)):(_0x1ef3dc['zyYTk'](_0x230edd),_0x203521[_0x2bf19b(0x453)](_0x1ef3dc[_0x2bf19b(0x208)])['style'][_0x2bf19b(0x2e9)]=_0x1ef3dc[_0x2bf19b(0x304)]):_0x1ef3dc[_0x2bf19b(0x320)](toggleBookmark);else{if(_0x1ef3dc[_0x2bf19b(0x200)](_0x758ed5[_0x2bf19b(0x3b2)][_0x2bf19b(0x49f)](),'m')&&(_0x1ef3dc[_0x2bf19b(0x442)](currentMode,_0x1ef3dc['KIgwe'])||_0x1ef3dc['ejejN'](currentMode,_0x1ef3dc[_0x2bf19b(0x4ab)]))){if(_0x1ef3dc[_0x2bf19b(0x369)](_0x1ef3dc['vuBfZ'],_0x1ef3dc[_0x2bf19b(0x1dd)])){const _0x37a494=_0x5a2974[_0x2bf19b(0x2c9)](_0x149b0b,arguments);return _0x5de9e9=null,_0x37a494;}else _0x1ef3dc[_0x2bf19b(0x333)](toggleMarkForReview);}else _0x1ef3dc[_0x2bf19b(0x424)](_0x758ed5[_0x2bf19b(0x3b2)][_0x2bf19b(0x49f)](),'s')&&(_0x1ef3dc[_0x2bf19b(0x15c)](currentMode,_0x1ef3dc[_0x2bf19b(0x40b)])||_0x1ef3dc[_0x2bf19b(0x403)](currentMode,_0x2bf19b(0x327)))&&_0x1ef3dc[_0x2bf19b(0x2f7)](submitQuiz);}}}}});</script>

</body></html>